Strukturelle Charakterisierung von Amyloiden aus Pilzen und Bakterien mittels Wasserstoff/Deuterium Austausch NMR-Spektroskopie by Zimmer, Agnes
 Structural Characterisation of Fungal and 
Bacterial Amyloids by Hydrogen/Deuterium 
Exchange NMR Spectroscopy 
 
 
 
 
 
Von der Fakultät für Lebenswissenschaften 
 
der Technischen Universität Carolo-Wilhelmina 
 
zu Braunschweig 
 
zur Erlangung des Grades einer 
 
Doktorin der Naturwissenschaften 
 
(Dr. rer. nat.) 
 
genehmigte 
 
D i s s e r t a t i o n 
 
 
 
 
 
 
 
 
von Agnes Zimmer 
aus Weißenfels 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Referentin:  Prof. Dr. Christiane Ritter 
2. Referent:  Prof. Dr. Michael Steinert 
eingereicht am: 15.08.2011 
mündliche Prüfung (Disputation) am: 05.12.2011 
 
 
Druckjahr 2012  
 
Vorveröffentlichungen der Dissertation 
 
Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für 
Lebenswissenschaften, vertreten durch die Mentorin der Arbeit, in folgenden Beiträgen 
vorab veröffentlicht: 
 
Publikationen: 
 
Wasmer, C., Zimmer, A., Sabaté, R., Soragni, A., Saupe, S. J., Ritter, C., and Meier, B. H. 
(2010). Structural similarity between the prion domain of HET-s and a homologue can 
explain amyloid cross-seeding in spite of limited sequence identity. J Mol Biol 402, 311-
325 
 
Tagungsbeiträge: 
 
Ritter, C., Nagaraj, M., Zimmer, A.,: NMR Structural investigations of the curli subunits 
CsgA and CsgB (Poster) FASEB Summer Research Conference - The Basic Origins and 
Medical Consequences of Protein Aggregation, Snowmass Village, USA (2011) 
 
Zimmer, A., Eberth A., Lührs T., Ritter C.: Structural investigations of the major curlin 
subunit CsgA – a functional amyloid (Poster) 18th International MPSA conference, 
Uppsala, Sweden (2010) 
 
Zimmer, A., Benkemoun, L., Wasmer, C., Meier, B.H., Saupe, S.J., Ritter, C.: Hydrogen 
exchange studies of HET-s homologue capable for species barrier breaching (Poster) 
Benzon Symposium 56 – Functioanal and Pathogenic Protein Aggregation, Copenhagen, 
Denmark (2009) 
 
Zimmer, A., Wasmer, C., Saupe, S.J., Meier, B.H., Ritter C.: Hydrogen exchange studies 
of a HET-s homolog from Fusarium graminearum (Poster) International Bunsen 
Discussion Meeting on Structure of Amyloid Fibrils and Mechanism of Amyloid 
Formation, Halle/Saale (2009) 
 
Zimmer, A., Lührs, T., Ritter, C.: Characterization of amyloid fibrils by quenched 
hydrogen exchange NMR. (Vortrag) 1st International Meeting “Conformational Transitions 
in Macromolecular Interactions”, Halle/Saale (2008) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Des Nutzens wegen ist die Natur gezwungen, 
so zu verfahren, wie sie es tut. 
 
Mark Aurel, Selbstbetrachtungen 
 
 
 
 
 
 
 
 
CONTENTS 
 
1 
Contents 
 
 
Abbreviations .......................................................................................................5 
Zusammenfasung.................................................................................................7 
Summary ..............................................................................................................8 
1 Introduction.....................................................................................................9 
1.1 Amyloids and Prions – Friends or Foes?...................................................9 
1.1.1 Protein Folding...............................................................................9 
1.1.2 Amyloid Fibrils Exhibit Unique Properties .................................11 
1.1.3 The Toxicity of Amyloid Fibril Formation..................................13 
1.1.4 Amyloid Fibrils as Functional Fold .............................................15 
1.2 HET-s – A Prion Controls Heterokaryon Incompatibility.......................18 
1.2.1 The Phenomenon of Heterokaryon Incompatibility ....................18 
1.2.2 Structure-Function Relationship of HET-s and HET-S ...............19 
1.2.3 A HET-s Homologue Capable for Species Barrier Breaching ....22 
1.3 Curli Fibrils and Their Major Subunit CsgA...........................................24 
1.3.1 Curli Biogenesis Is Highly Controlled.........................................24 
1.3.2 The Manifold Roles of Curli........................................................26 
1.3.3 The Major Curli Subunit CsgA....................................................27 
1.4 Techniques to Study Amyloid Structures ................................................28 
1.4.1 Low Resolution Techniques ........................................................28 
1.4.2 High Resolution Techniques........................................................29 
1.4.3 Theoretical Background of NMR Spectroscopy..........................29 
1.4.4 The H/D Exchange NMR Experiment.........................................31 
1.4.5 Solid State NMR Spectroscopy ...................................................34 
2 Aims and Scope .............................................................................................37 
3 Material and Methods ..................................................................................39 
3.1 Standard Materials ...................................................................................39 
3.1.1 Chemicals, Enzymes, Antibodies and Kits ..................................39 
3.1.2 Molecular Weight Standards........................................................40 
3.1.3 Bacterial Strains ...........................................................................40 
3.1.4 Plasmids .......................................................................................41 
3.1.5 Oligonucleotides ..........................................................................43 
3.2 Media and Buffer .....................................................................................46 
 
CONTENTS 
 
2  
3.3 Microbiological and Molecular Biological Methods .............................. 48 
3.3.1 General Conditions of Bacterial Culture ..................................... 48 
3.3.2 DNA Analytical Methods ............................................................ 48 
3.3.3 Molecular Cloning....................................................................... 48 
3.3.4 Generation of Plasmid Constructs to Obtain Fusion Proteins ..... 49 
3.4 Protein Production and Purification ........................................................ 51 
3.4.1 Test Expression............................................................................ 51 
3.4.2 Recombinant Protein Synthesis ................................................... 51 
3.4.3 Production of Isotope Labelled Protein ....................................... 51 
3.4.4 Cell Lysis ..................................................................................... 52 
3.4.5 Purification under Denaturing Conditions and Fibrillisation ...... 52 
 Purification and Solubilisation of Inclusion Bodies ............... 53 
 Affinity Chromatography........................................................ 53 
 Buffer Exchange and Fibrillisation......................................... 53 
 Preparation of Seeds ............................................................... 54 
3.4.6 Purification under Native Conditions .......................................... 55 
3.5 Protein Analytical Methods..................................................................... 55 
3.5.1 Physico-Chemical Parameters of the Studied Proteins................ 55 
3.5.2 Photometric Quantification of Protein Concentration ................. 56 
3.5.3 NaDOC/TCA Precipitation.......................................................... 56 
3.5.4 SDS-Polyacrylamide Gel Electrophoresis................................... 56 
3.5.5 Transfer of Proteins to Membranes (Western Blot) and                   
Immunodetection ......................................................................... 56 
3.5.6 N-Terminal Sequencing............................................................... 57 
3.5.7 Mass Spectrometry ...................................................................... 57 
3.6 Protein Structure Analysis....................................................................... 57 
3.6.1 Secondary Structure Analysis...................................................... 57 
 Circular Dichroism.................................................................. 58 
 Fourier Transform Infrared Spectroscopy .............................. 58 
3.6.2 Probing the Amyloid fold as Tertiary/Quaternary Structure ....... 58 
 Electron Microscopy............................................................... 58 
 Congo Red Labelling and Birefringence ................................ 59 
 Thioflavin-T Fluorescence Studies ......................................... 59 
 Limited Proteolysis ................................................................. 59 
3.6.3 Analysis of Side-Chain Solvent Accessibility and Inter- and                
Intramolecular Contacts............................................................... 60 
 Specific Thiol-Labelling ......................................................... 60 
 Detection of Specific Thiol-Labelling .................................... 61 
 
 
CONTENTS 
 
3  
3.6.4 NMR spectroscopy.......................................................................61 
 General Measurement Conditions...........................................61 
 Sequence Specific Resonance Backbone Assignment ............63 
 H/D Exchange NMR Experiments..........................................63 
4 Results ............................................................................................................65 
4.1 Choice of Experimental Strategy.............................................................65 
4.2 Structural Characterisation of the FgHET-s Prion Domain ....................67 
4.2.1 Protein Production and Purification.............................................67 
4.2.2 Recombinant FgHET-s218-289 Forms Amyloid Fibrils in Vitro ....68 
4.2.3 Sequence-Specific Secondary Structure Analysis .......................70 
 Sequence-Specific Backbone-Resonance Assignment ...........70 
 H/D Exchange NMR and Location of β-sheets.......................71 
4.3 Structural Characterisation of EcCsgA Fibrils ........................................75 
4.3.1 Starting Point of EcCsgA Structure Elucidation..........................75 
4.3.2 Sequence Analysis and Design of New EcCsgA Constructs.......75 
4.3.3 Protein Production and Purification.............................................76 
4.3.4 EcCsgA21-151 and EcCsgA40-151 Have Similar Biophysical                          
Properties .....................................................................................77 
4.3.5 Strategies to Improve NMR Spectra and the Assignment ...........79 
 ctHSQC Experiments Resulted in Spectra With High                            
Resolution ...............................................................................79 
 Improved Spectra of New EcCsgA Variants ..........................81 
4.3.6 Sequence-Specific Analysis of Secondary Structure Elements ...82 
 Sequence-Specific Backbone-Resonance Assignment ...........83 
 H/D Exchange NMR Analysis of EcCsgA40-151 Fibrils ..........85 
 H/D Exchange NMR Analysis of EcCsgA21-151 Fibrils ..........89 
 H/D Exchange Analysis of Heteronucleated Fibrils ...............93 
4.3.7 Characterisation of the β-Sheet Architecture...............................95 
 Initial Labelling Experiments..................................................95 
 Side-Chain Solvent Accessibility............................................97 
4.4 Stable Oligomers – Initial Experiments on Analogues of CsgA                                
Oligomers ..............................................................................................100 
4.4.1 Design and Expression of CsgA Fusion Constructs ..................100 
4.4.2 Protein Production and Purification...........................................103 
4.4.3 Insoluble Expression Products Behave like EcCsgA wt............104 
4.4.4 Folding Behaviour of Soluble Expression Products ..................105 
5 Discussion ....................................................................................................109 
5.1 H/D Exchange NMR Is Capable to Explain HET-s Species Barrier                           
Breaching...............................................................................................109 
CONTENTS 
 
4  
5.1.1 H/D Exchange Explains Remarkable Cross-Seeding................ 109 
5.1.2 Solid State NMR Results Are Complementary and Reveal                               
Further Structural Details .......................................................... 112 
5.1.3 The β-Solenoid Fold of HET-s Is Evolutionary Conserved ...... 113 
5.1.4 Conclusion ................................................................................. 115 
5.2 The Sophisticated Topology of the Major Curli Subunit ...................... 117 
5.2.1 H/D Exchange NMR Experiments and Thiol-Labelling Reveal                                        
a Possible Fold of EcCsgA ........................................................ 117 
5.2.2 The Repetitive Primary Structure of EcCsgA Enables a                                      
β-Solenoid Fold ......................................................................... 120 
5.2.3 Biphasic EcCsgA Exchange Behaviour Indicated Local                                  
Heterogeneity in EcCsgA Fibrils............................................... 123 
5.2.4 Heterogeneity of Heteronucleated EcCsgA Fibrils ................... 124 
5.2.5 Aspects of Curli Biogenesis in CsgA Polymerisation ............... 125 
5.2.6 Conclusion ................................................................................. 126 
5.3 Monomeric Analogues of CsgA Oligomers – A Challenging Target ... 128 
5.3.1 EcCsgA Protein Design Resulted in Insoluble and Soluble                                                  
Fusion Proteins .......................................................................... 128 
5.3.2 The Single EcCsgA Moiety Is not Capable to Fold Regularly.. 129 
5.3.3 Conclusion ................................................................................. 130 
6 Outlook ........................................................................................................ 131 
References ........................................................................................................ 133 
Appendix .......................................................................................................... 149 
Danksagung...................................................................................................... 159 
Lebenslauf ........................................................................................................ 161 
 
ABBREVATIONS 
 
5 
Abbreviations 
 
 
Ax    Absorption (x is any wavelength) 
aa    Amino acid 
Å    Ångström 
AFM    Atomic force microscopy 
AF488    AlexaFluor488 
AP    Alkaline phosphatise 
App    Appendix 
APS    Ammonium persulphate 
BMRB   Biological magnetic resonance data bank 
BCIP    5-bromo-4-chloro-3-indolylphosphate 
Bis-Tris   Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methan 
CD    Circular dichroism 
CR    Congo red 
CsgX    Genproduct of curli specific gene X 
CV    Column volume 
Da    Dalton 
E. coli   Escherichia coli 
Ec    Escherichia coli 
EM    Electron microscopy 
ECL    Electrochemiluminescence 
DMSO   Dimethyl sulfoxide 
EDTA   Ethylenediaminetetraacetic acid 
EM    Electron microscopy 
FA    Formic acid 
Fg    Fusarium gramineaum 
H/D    Hydrogen/Deuterium 
hNOE   Heteronuclear Overhauser effect 
HSQC   Heteronuclear single quantum coherence 
FT-IR   Fourier transform infrared  
HRP    Horse radish peroxidase 
IAA    Iodoacetic acid 
ABBREVATIONS 
 
6  
IAM    Iodoacetamide 
IB    Inclusion body 
IMAC   Immobilized metal ion affinity chromatography 
IPTG    Isopropyl-β-D-thiolgalactoside 
KPi    KH2PO4/K2HPO4 
MHC    Major histocompatibility complex 
MWCO   Molecular weight cut off 
NBT    Nitro blue tetrazolium 
Ni-NTA   Nickel-nitrilotriacetic acid-agarose 
NOE    Nuclear Overhauser Effect 
NMR    Nuclear magnetic resonance 
NOESY   Nuclear Overhauser enhancement spectroscopy 
OD600   Optical density at 600 nm 
Pa    Podospora anserina 
PAGE   Polyacrylamid gel electrophoresis 
PCR    Polymerase chain reaction 
PDB    Protein data bank 
PM    N-(1-pyrene)maleimide 
R    Repeat 
SDS    Sodium dodecyl sulphate 
Sec    Secretory 
TAE    Tris-acetate-EDTA 
TBS    Tris buffered saline 
TCA    Trichloroacetic acid 
TCEP   Tris(2-carboxyethyl)phosphine 
TEM    Transmission electron microscopy 
TEMED   N, N, N’, N’ – Tetramethylendiamin 
TFA     Trifluoroacetic acid 
ThT    Thioflavin T 
Tris    Tris(hydroxymethyl)aminomethane 
wt    Wild type 
 
 
Amino acids are abbreviated using 1 or 3 letter code. 
Latinisms are written in italic. 
ZUSAMMENFASSUNG 
 
7 
Zusammenfasung 
 
In den letzten Jahren wurde für eine steigende Anzahl von Amyloiden gezeigt, dass diese 
physiologisch relevante Zellfunktionen übernehmen. Im Gegensatz zu 
krankheitsassoziierten Amyloiden fibrillisieren die Proteine ohne toxischen Nebeneffekt in 
geordnete, β-faltblattreiche Strukturen. Das HET-s Prion aus Podospora anserina und die 
Curli-Fibrillen aus E. coli gehören zu den bisher bestuntersuchten funktionalen Amyloiden. 
Entsprechend ihrer Funktionen stellen sie einzigartige Systeme dar, um den Prozess der 
Fibrillenbildung und auch die strukturellen Grundlagen von Prionentransmission und die 
Rolle bakterieller Amyloide als Pathogenitätsfaktoren zu untersuchen.  
Im Vorfeld wurde gezeigt, dass die Priondomäne des HET-s Homologen aus 
Fusarium graminearum FgHET-s218-289 in vitro Fibrillen bildet, die trotz geringer 
Sequenzidentität die Fibrillisierung von PaHET-s218-289 nukleieren. In der vorliegenden 
Arbeit wurde FgHET-s218-289 rekombinant hergestellt, gereinigt, fibrillisiert und mittels 
Wasserstoff/Deuterium Austauschexperimenten untersucht. Zusammen mit Festkörper-
NMR Daten belegten die Austauschraten den Grund für den Nukleationseffekt: Es wurde 
gezeigt, dass die Proteine strukturell eng verwandt sind. Beide Priondomänen formen eine 
sehr ähnliche β-Solenoidstruktur, die die Nukleation ermöglicht. Der dreieckige 
hydrophobe Kern und wichtige Strukturelemente sind evolutiv konserviert. 
Die Topologie des Hauptbestandteils der Curli-Fibrillen CsgA aus E. coli wurde 
erfolgreich mittels Austauschexperimenten und Thiol-Markierungsexperimenten 
untersucht. Diesbezüglich wurde die Herstellung der Fibrillen optimiert, zusätzliche 
NMR-Experimente, selektive Isotopenmarkierung sowie zahlreiche EcCsgA Varianten 
wurden eingesetzt. Die nachfolgende Analyse zeigte, dass der Amyloidkern strukturell 
repetitiv aufgebaut ist. Es wurde vorgeschlagen, dass EcCsgA eine β-Solenoidstruktur 
bildet. Zudem wurden heteronukleierte Fibrillen untersucht. Die Untersuchungen zeigten, 
dass in vitro generierte EcCsgB Fibrillen kein geeigneter Nukleationskeim sind.  
Um lösliche amyloid-ähnliche Faltungsintermediate von EcCsgA zu untersuchen, wurde 
ein Set von Fusionsproteinen generiert und hinsichtlich Löslichkeit und amyloidogener 
Faltung untersucht. Es wurden zwei Analoge identifiziert, die löslich hergestellt werden 
können und teilweise stabil gefaltet sind  
Die erzielten Ergebnisse stellen die ersten Sequenz-spezifischen Strukturdaten für EcCsgA 
Fibrillen dar und bilden die Grundlage für weiterführende Untersuchungen möglicher 
Struktur-Funktionsbeziehungen. 
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Summary 
 
In recent years, an increasing number of proteins has been shown to form amyloids that are 
involved in a large variety of cellular processes. Contrary to disease-related amyloids, 
these proteins fibrillise without toxic side effect into well ordered β-sheet rich structures. 
The HET-s prion of Podospora anserina and the curli system of E. coli are two of the most 
studied functional amyloids. Owing to their biological roles, these two amyloids constitute 
a group of unique systems that allows the analysis of amyloidogenesis as well as the 
structural background of prion transmission and the role of bacterial amyloids in 
pathogenicity.  
The prion domain of a distinct homologue of HET-s from Fusarium graminearum 
FgHET-s218-289 was previously shown to fibrillise in vitro and to cross-seed PaHET-s218-289 
prion formation despite low sequence identity. In the present study, FgHET-s218-289 was 
recombinantly produced, purified and fibrillised for hydrogen/deuterium exchange NMR 
experiments. In conjunction with solid state NMR experiments, obtained exchange data 
readily explained the HET-s cross-seeding phenomenon. The analysis demonstrated that 
the structures of both prion domains are closely related. Both prion domains constitute the 
same β-solenoid fold enabling the nucleation effect. The triangular hydrophobic core and 
major structural elements were identified to be conserved. 
The topology of the major curli subunit CsgA of E. coli was further described by 
hydrogen/deuterium exchange analysis and thiol-labelling studies. The analysis comprised 
an optimised sample preparation, the implementation of different NMR experiments, new 
EcCsgA constructs and selective isotope labelling. The approach revealed a repetitive 
structural pattern with five imperfect repeat sequences forming each a strand-turn-strand 
motif. Altogether the amyloid core of EcCsgA was suggested to fold into a β-solenoid. 
Furthermore, heteronucleated EcCsgA fibrils were also subjected to hydrogen/deuterium 
exchange experiments. The corresponding experiments revealed that in vitro formed 
EcCsgB fibrils are no adequate seed. 
In order to analyse amyloid-like intermediates of EcCsgA, numerous fusion proteins were 
generated and analysed in consideration of their solubility and (non)amyloidogenic 
behaviour. At least two protein constructs were identified to be soluble and folded to a 
certain extend. 
These results present the first sequence-specific data of structural elements of EcCsgA 
fibrils and provide the background for following structure-function analyses.
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1 Introduction 
 
 
1.1 Amyloids and Prions – Friends or Foes? 
1.1.1 Protein Folding 
Proteins are essential components of the living organism and involved in nearly every 
process taking place in the cell. Thus, proteins are key players in the cell with regard to 
biochemical catalysis, regulation, transport and storage, immune response, maintaining the 
structure of other macromolecules, signalling processes and converting chemical into 
mechanical energy (Stryer, 1996). The native, three-dimensional structure of every protein 
dictates its function and is thus indispensable for the underlying biological processes.  
The specific three-dimensional structure of every protein is encoded by its primary 
structure (Anfinsen, 1973). The polypeptide chain is folded through hydrogen bonds, ionic 
and hydrophobic interactions as well as covalent bonds (disulfide bridges) forming typical 
secondary structural elements and finally a characteristic tertiary structure. Oligomeric 
proteins assemble from more than one polypeptide chain and they feature a quaternary 
structure (Linderstrøm-Lang, 1952). Although protein folding has been studied intensely 
during the last decades, the correlation between primary structure and folding process still 
remains unclear. Nevertheless it is known that the folding pathway is driven 
thermodynamically to adopt the energetically most favourable conformation (Jaenicke, 
1996). Considering the energy landscape scheme of protein folding and aggregation, 
misfolding and even alternative conformations are possible (Hartl and Hayer-Hartl, 2009; 
Herczenik and Gebbink, 2008). Thus, proteins are highly flexible structures and can adopt 
a large variety of conformations also leading to misfolding and aggregation (Figure 1-1) as 
well as enhancing functionality of a protein (Boehr and Wright, 2008; Murzin, 2008). 
Nevertheless, exposing hydrophobic amino acid residues and flexible regions, normally 
buried in the native fold, partially folded/unfolded and misfolded states are quite 
aggregation prone as aggregation is largely driven by hydrophobic forces. The aggregation 
pathway can result in amorphous/disordered aggregates or alternatively in highly ordered 
fibrillar aggregates called amyloid fibrils. These fibrils are characterised by the extreme 
robust cross-β structure (Sunde et al., 1997). In the case of prions, this conformation is 
self-propagating and horizontally transmissible (Aguzzi et al., 2008; Prusiner, 1998). 
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Figure 1-1:  Some of the conformational states proteins can adopt. Proteins can adopt different 
conformations. The transition of protein conformations is highly regulated in the living cell by chaperons, 
degradation and protein quality control. Most conformations are functional but in case of failed regulation 
misfolding diseases occur (original figure from Chiti and Dobson, 2006). 
 
In vivo, a certain degree of protein misfolding occurs regularly and is usually regulated and 
eliminated by the protein quality control via chaperones and degradation (Gregersen et al., 
2006). A number of misfolding events overwhelms the protein quality control and leads to 
protein misfolding diseases. These diseases are described by large deposits of aggregates, 
which can consist of amyloid or non-amyloid systems. An increasing number of proteins 
has been shown to form amyloid fibrils related to devastating amyloidoses like 
Alzheimer´s disease, type 2 diabetes, polyneuropathy syndromes and prion diseases 
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illustrated in Table 1-1 (reviewed by Chiti and Dobson, 2006; Herczenik and Gebbink, 
2008).  
In contrast to disease related aggregates, more and more proteins have been shown to form 
amyloids as their native fold, which fulfil normal cellular functions summarised in Table 
1-2. In bacteria these functions comprise for example biofilm formation, cell-cell 
recognition, host attachment and invasion, as well as sporulation, resistance and adaptation 
to environmental stress (reviewed by Chiti and Dobson, 2006; Gebbink et al., 2005; 
Wickner et al., 2007). At the beginning of the 21st century it was shown for the first time 
that proteins, which do not form amyloids in vivo, are able to form amyloid fibrils in vitro 
(Damaschun et al., 2000; Fandrich et al., 2001). These findings already suggested that 
amyloid formation is a generic property of polypeptides (Dobson, 2004). 
 
 
1.1.2 Amyloid Fibrils Exhibit Unique Properties 
Generally, amyloid formation is a poorly understood pathway comprising the accumulation 
of monomeric proteins into well ordered fibrillar aggregates. A nucleation dependent 
pathway is suggested in the Landsbury model (Rochet and Lansbury, 2000). The in vitro 
polymerisation process is believed to pass through three distinct phases (Lomakin et al., 
1997). First, a stable β-sheet enriched nucleus is formed in the lag phase. Subsequently, in 
the growth phase the nucleus rapidly extends to higher oligomers and fibrils by self-
assembly. The fibril formation is finally completed in the stationary phase. Characteristic 
of amyloid fibrils in this phase is the cross-β structure (Figure 1-2 A). 
 
 
 
 
 
 
Figure 1-2: The amyloid cross-β 
structure. (A) The cross-β structure 
with β-strands perpendicular and β-
sheets parallel to the main fibril axis 
(arrow). Dashed lines indicate 
hydrogen bonds. (B) Schematic fibril 
diffraction pattern that shows 
characteristic diffraction lines (adapted 
from Makin and Serpell, 2005). 
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X-ray fibril diffraction experiments identified β-strands perpendicular to the main fibril 
axis and β-sheets parallel to this axis. The two sets of diffraction lines of the obtained 
“cross” pattern (Figure 1-2 B) correspond to interstrand (~ 4.7 Å meridian) and stacking 
distances (~ 10 Å equator) in the β-sheets (Wormell, 1954; Sunde et al., 1997).  
The β-strands of a β-sheet can be arranged parallel or antiparallel to each other. In amyloid 
fibrils the parallel organisation is most common (Shewmaker et al., 2009; Toyama and 
Weissman, 2011) and the β-strands are coordinated in register or in a β-solenoid. In 
parallel in register β-sheets identical β-strands are aligned on top of each other. Two or 
more β-sheets face each other forming a β-sandwich pattern which is continued by stacking 
interactions. The alternative motif is the β-solenoid, which is formed by repeating units of 
coils. Each coil consists of 2 - 4 β-strands and is elongated by an axial rise of 4.8 Å 
(Kajava and Steven, 2006). These coils are aligned on top of each other to form the 
corresponding β-sheets. β-solenoids are further distinguished in β-rolls and β-helices. 
Similar to the β-sandwich, β-rolls are made of two sheets forming an interface. The core of 
a β-helix consists of more than two β-sheets. An overview of the possible β-sheet 
architectures is given in Figure 1-3 (adapted from Toyama and Weissman, 2011). 
 
 
Figure 1-3:  β-sheet architectures that proteins can adopt. (A) β-strands can be arranged antiparallel, 
parallel in-register or in a β-solenoid. These forms can be distinguished by the distances between single 
residues/probes (red rectangle, see text above). (B) Top view of the β-solenoid forms β-roll and β-helix 
(adapted from Toyama and Weissman, 2011).  
 
Moreover, a β-sheet motif, called a “dry steric zipper”, with an unusually high density was 
postulated as a basic principle of the cross-β structure (Nelson et al., 2005; Sawaya et al., 
2007). These tight interfaces are mediated by van der Waals linkages and contain no water 
molecules (Figure 1-4 A). 
Amyloids were identified as long, unbranched fibrous structures with a diameter of 
5 - 15 nm and several micrometers in length (Figure 1-4 B) by transmission electron 
microscopy (TEM) and atomic force microscopy (AFM). The fibrils consist of several 
protofilaments that surround a main axis in a helical manner and interact with each other 
via amino acid side chains illustrated in Figure 1-4 C (Jimenez et al., 1999; Jimenez et al., 
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2002; Makin and Serpell, 2005; Zhang et al., 2009). Amyloids are often characterised by 
structural polymorphism regarding the number of filaments per fibril, degree of twisting 
and the diameter or mass per fibril length (Fandrich et al., 2009).  
Furthermore, most amyloid fibrils can be visualised indirectly due to their affinity for 
amyloid specific dyes (Hawe et al., 2008). In the presence of these specific aggregates, 
Thioflavin T (ThT) reveals a strong fluorescence emission around 480 – 490 nm and the 
binding of Congo Red results in a green birefringence in cross-polarised light (Figure 
1-4 D).  
 
 
Figure 1-4:  Properties of amyloid fibrils. (A) Atomistic structure of microcrystals of the peptide 
GNNQQNY indicating the “dry steric zipper” (Nelson et al., 2005). Each β-strand represents one peptide 
molecule. (B) Transmission electron micrograph (TEM) of fibrils formed by islet amyloid polypeptide. 
(Makin and Serpell, 2005). (C) Model of interprotofilament interactions of Aβ1-42 amyloid fibrils obtained by 
cryo electron microscopy (cryo EM) (Zhang et al., 2009). The atomic model (pdb entry 2BEG) fits into the 
cryo EM density map. (D) Electron micrograph of amyloid deposits in presence of Congo Red in cross-
polarised light (Thompson et al., 2000). 
 
In comparison to other proteins and unspecific aggregates, amyloids are extremely stable. 
Many fibrils are resistant against 1 % (w/v) SDS (Brown et al., 1990; Collinson et al., 
1999) and are often only soluble in hexafluoroisopropanol, 90 % (v/v) formic acid or 
highly concentrated solutions of urea or guanidine hydrochloride (Chiba et al., 2003; 
Collinson et al., 1999; Nichols et al., 2005; Wang et al., 2007). Due to their compact 
structure, amyloids are protected against proteolytic degradation (Collinson et al., 1999; 
Meyer et al., 2000). 
 
 
1.1.3 The Toxicity of Amyloid Fibril Formation 
In the past, the formation of amyloid fibrils has only been associated with fatal protein 
misfolding diseases as the long list of amyloid proteins related to amyloidoses in Table 1-1 
shows (reviewed by Chiti and Dobson, 2006; Herczenik and Gebbink, 2008). Amyloidoses 
describe disease patterns of large abnormal deposits of amyloid fibrils in organs and/or 
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tissues featuring cell death and the loss of function of the affected organ/tissue. The 
dysfunction can be inherited or acquired, systemic or localised. Neurodegenerative 
diseases as for example Alzheimer’s disease or the spongiform encephalopathies are 
amyloidoses of the nervous system and correspond to the progressive loss of structure and 
function of neurons. Amyloidoses, which do not affect the nervous system, are 
nonneuropathic diseases subdivided into systemic and localised amyloidoses. While 
localised amyloidoses are limited to only one organ or tissue, systemic amyloidoses 
correspond to amyloid deposits in more than one organ or system.  
 
Table 1-1:  Amyloidoses - human disease associated with amyloid fibril formation (reviewed by Chiti 
and Dobson, 2006; Herczenik and Gebbink, 2008). 
Disease Associated proteins Native structure  Affected tissue  
Neurodegenerative diseases 
Alzheimer´s disease Amyloid β, tau Unfolded Brain 
Spongiform 
encephalopathies Prion protein 
Unfolded N-term. 
α-helical C-term.  
Brain, peripheral 
nervous system 
Parkinson´s disease α-Synuclein Unfolded Brain 
Lewy-body dementia α-Synuclein Unfolded Brain 
Huntington´s disease Huntingtin  Largely unfolded Brain 
Amyotrophic lateral 
sclerosis Superoxide dismutase I All-β, Ig like Brain 
Familiar amyloidic 
polyneuropathy Transthyretin All-β, prealbumin like 
Peripheral nervous 
system 
Nonneuropathic systemic amyloidoses 
Primary systemic 
amyloidosis 
Immunoglobulin light 
chain All-β, Ig like Most tissues 
Secondary (reactive) 
systemic amyloidosis Serum amyloid A All-α, unknown fold Most tissues 
Senile systemic 
amyloidosis Transthyretin All-β, prealbumin like Microvasculature 
Hemodialysis-related 
amyloidosis β2-Microglobulin All-β, Ig like Osteoarticular tissues 
Nonneuropathic localised amyloidoses 
Type II diabetes Amylin (islet amyloid polypeptide IAPP) Unfolded Pancreas (islet) 
Injection localised 
amyloidosis Insulin All-α, insulin-like Skin, muscles 
Cataract Crystallin All-β, crystalline-like Eye 
Familial subepithelial 
corneal amyloidosis Lactoferrin 
α+ β, periplasmic-
binding protein like Cornea 
 
Even though all diseases are associated with large amyloid deposits, there is a controversy 
about the pathogenic agent (Golde et al., 2006). Initially, only the aggregated 
proteins/peptides were believed to be the toxic form of the protein leading to apoptosis 
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(amyloid hypothesis, Yankner et al., 1990). Today, oligomeric and protofibril 
intermediates of the fibrillisation pathway as well as off-pathway oligomers are believed to 
be the toxic agent (Baskakov et al., 2002; Hardy and Selkoe, 2002; Kayed et al., 2003). 
These oligomers are reported to permeate the membrane and to form ion channels (Kourie 
and Henry, 2002; Lashuel, 2005). The membrane disruption is suggested to be a key player 
in the pathogenesis of amyloidoses (Lashuel, 2005; Quist et al., 2005). It leads to an 
uncontrolled ion transport (especially Ca2+), which disturbs the ion equilibrium between 
cytoplasm, mitochondria and endoplasmatic reticulum. Finally, the dysfunction in 
homeostasis causes apoptosis. The propensity to form ion-permeable pores via nonfibrillar 
oligomers has been shown for several amyloid forming proteins: Aβ (Hirakura et al., 1999; 
Lashuel et al., 2002a), amylin (Hirakura et al., 2000; Mirzabekov et al., 1996), serum 
amyloid A (Hirakura et al., 2002), α-synuclein (Lashuel et al., 2002b; Volles and 
Lansbury, 2002; Volles et al., 2001) and even prion proteins (Kourie, 2002; Kourie et al., 
2001). Nevertheless, comprehension of initiation and progress of neurodegeneration and 
cytotoxicity still remains limited. 
 
 
1.1.4 Amyloid Fibrils as Functional Fold 
Recently, an increasing number of proteins has been shown to form amyloid fibrils, which 
are nontoxic and can be related to normal cellular functions presented in Table 1-2 
(reviewed by Chiti and Dobson, 2006; Fowler et al., 2007; Gebbink et al., 2005; 
Greenwald and Riek, 2010; Otzen and Nielsen, 2008). A wide range of organisms, 
comprising species from bacteria to mammals, takes advantage of the intrinsic propensity 
of proteins to form highly stable amyloid fibrils.  
 
Table 1-2:  Proteins that form functional amyloid fibrils (reviewed by Chiti and Dobson, 2006; 
Fowler et al., 2007; Greenwald and Riek, 2010; Otzen and Nielsen, 2008). 
Protein Species Function  
Bacterial amyloids 
Curli, Tafi E. coli and other  Enterobacteriaceae 
Adhesion, cell invasion, biofilm 
formation, binding to host proteins 
FapC Pseudomonas Biofilm formation 
Chaplins Streptomycetes coelicolor and other Streptomyces 
Assisting aerial hyphae formation via 
modulation of water surface tension 
Microcin E492 Klebselia pneumonia Bacteriocin, membrane pore-forming, 
amyloid form inactive 
Harpins Xanthomonas and other plant pathogenic bacteria 
Destabilisation of plant membranes, 
induction of cell death 
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Protein Species Function  
MTP Mycobacterium tuberculosis Adherence factor 
Eukaryotic amyloids 
Pmel17 Mammals Scaffolding and Sequestration of toxic intermediates during melanin synthesis 
Peptide hormones Mammals Sorting, storage and release of hormones 
Chorion proteins Insects and fish Structure-bearing and protection of 
oocytes and developing embryo 
Spidroins Nephila clavipes (spider) Structure-bearing, formation of spider 
silk 
Hydrophobins Most fungi Modulation of surface attachment and 
aerial hyphae formation 
Prion proteins 
ECTO-NOX Mammals [NADP(H)] oxidation and protein disulfide-thiol interchange 
CPEB Aplysia (sea slug) Memory storage, leading to long term     
synaptic changes 
HET-s Podospora anserina  Regulation of heterokaryon formation 
Sup35 Saccharomyces cerevisiae Regulation of translation termination, prion form inactive 
Ure2p Saccharomyces cerevisiae Regulation of nitrogen catabolism, prion form inactive 
Rnq1p Saccharomyces cerevisiae Enhancing the inducibility of other prions 
Swi1p Saccharomyces cerevisiae Chromatin remodelling 
Mot3 Saccharomyces cerevisiae Regulation of transcription of cell wall 
remodelling genes, prion form inactive 
 
Based on their plastic properties, functional amyloids are involved in a large variety of 
processes such as biofilm formation, protection, adhesion and invasion, as well as the 
development of aerial structures, regulation of melanin synthesis and hormone release, 
molecular memories and information transfer by protein-based genetic elements.  
Functional amyloids are biologically optimised and their formation seems to be highly 
regulated (reviewed by Greenwald and Riek, 2010). Sophisticated mechanisms allow the 
directed assembly into uniform fibrils, lacking cytotoxic oligomeric or protofibrillar 
intermediates (chapter 1.1.3). Currently known, these mechanisms of aggregation control 
comprise: chaperone assisted protein remodelling, enzymatic modifications, fibrillisation 
in specialised enclosed vesicles, nucleator dependent assembly and “gatekeeper” residues.  
In yeast a chaperone network controls propagation of fibril formation and their 
degradation. The chaperones enable prion functionality and prevent amyloid/prion 
associated toxicity (Allen et al., 2005; Gokhale et al., 2005; Uptain and Lindquist, 2002). 
Similarly, a complex network of proteins is involved in curli biogenesis comprising six 
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different proteins (Barnhart and Chapman, 2006). The polymerisation into fibrils is 
nucleator dependent (Hammar et al., 1996) and controlled by “gatekeeper” residues (Wang 
et al., 2010). Due to “gatekeeper” residues distinct segments of the protein are less 
aggregation prone (Rousseau et al., 2006). Thus, these residues avoid uncontrolled self-
assembly, mislocalisation of the fibrils and cytotoxicity (Wang et al., 2010). In the case of 
Pmel17 a proteolytic activation and stepwise modification is necessary (Berson et al., 
2001; Hoashi et al., 2005). In addition, the fibrillisation of Pmel17 is localised to special 
vesicles in the melanosomes and depends on the pH (Berson et al., 2001).  
First and foremost, functional amyloids are widespread in bacteria. Recent studies show 
that amyloid adhesins are abundant in natural biofilms, in which at least 5 - 40 % of the 
prokaryotes produced amyloids, depending on their habitat (Larsen et al., 2007). The curli 
fibrils of E. coli (Vidal et al., 1998), Tafi fibrils of Salmonella (Austin et al., 1998), TasA 
fibrils of Bacillus subtilis (Romero et al., 2010) and FapC fibrils of Pseudomonas 
(Dueholm et al., 2010) have clearly been identified as such bacterial adhesins. For example 
curli of E. coli form a loose fibrillar network on the surface of the bacteria and are a major 
component of the bacterial extracellular matrix. They assist biofilm formation, adhesion to 
host cells and inert surfaces, host cell invasion and the binding to host proteins (reviewed 
by Barnhart and Chapman, 2006). Functional amyloids and prions are also abundant in 
fungi and yeast (reviewed by Gebbink et al., 2005; Wickner et al., 2007). Analysis of the 
heterokaryon incompatibility in Podospora anserina identified the first functional prion – 
the HET-s prion (Coustou et al., 1997). The systems of HET-s and curli are presented in 
detail in chapters 1.2 (HET-s) and 1.3 (curli). 
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1.2 HET-s – A Prion Controls Heterokaryon Incompatibility 
HET-s is one of the protein-based genetic elements in fungi (Wickner et al., 2008b). After 
solving the genetic puzzle of the filamentous ascomycetes Podospora anserina (Rizet, 
1952), Begueret and co-workers reported HET-s as the first prion that displays a normal 
cellular function (Coustou et al., 1997). HET-s is involved in a controlled cell death called 
heterokaryon incompatibility, which is suggested to prevent unlimited spread of fungal 
viruses between fusing colonies. 
 
 
1.2.1 The Phenomenon of Heterokaryon Incompatibility 
Heterokaryon incompatibility is an 
ubiquitous phenomenon in filamentous 
fungi (Glass and Dementhon, 2006). 
Fungal hyphae fuse when two colonies 
grow together. The result is a fusion cell 
(heterokaryon) with nuclei and cytoplasm 
of both parental colonies. This 
heterokaryon formation is genetically 
controlled and can be aborted by a 
programmed cell death. Only strains with 
certain identical loci can undergo hyphal 
fusion (Glass et al., 2000; Saupe, 2000). 
In Podospora anserina this mechanism 
(Figure 1-5) is based on the het locus with 
the genes het-s and het-S (Rizet, 1952; 
Turcq et al., 1991). The encoded proteins 
HET-s and HET-S are isoforms. They are 
made of 289 amino acids and only differ in 
13 residues. HET-s is a prion protein that 
forms amyloid fibrils resulting in a 
conversion of the non-prion phenotype 
[HET-s*] to the prion phenotype [HET-s] 
 
Figure 1-5: The Het-s/HET-S incompatibility. (A) 
The HET-s protein can exist in a soluble inactive 
form in [HET-s*] strains and in the prion form in 
[HET-s] strains. Interaction of the HET-s prion with 
HET-S leads to cell death. (B) Schematic 
representation of possible cell fusion events during 
interaction of strains differing in genotype and 
phenotype (adapted from Saupe, 2011; for 
explanation see text) 
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(Coustou et al., 1997; Maddelein et al., 2002). In the [HET-S] phenotype the HET-S 
protein is soluble and not amyloidogenic.  
[HET-s*] strains are compatible with [HET-S] strains and cell fusion enables heterokaryon 
formation. The fusion of [HET-s*] and [HET-s] strains also leads to heterokaryon 
formation. Subsequently to the fusion, the [HET-s*] phenotype converts into [HET-s] via 
prion transmission and self-propagation. The fusion of a [HET-s] strain with a [HET-S] 
strain does not result in heterokaryon formation and finally the fusion cell dies. These 
corresponding phenotypes are incompatible. The dead cells act as a barrier between the 
growing colonies. In other words, the incompatibility is triggered by the interaction of 
HET-S with the prion form of HET-s (Greenwald et al., 2010; Saupe, 2011). 
 
 
1.2.2 Structure-Function Relationship of HET-s and HET-S 
Podospora anserina heterokaryon incompatibility is driven by HET-s and HET-S – two 
proteins that share high sequence identity but differ especially in their ability to form 
amyloid fibrils (Greenwald et al., 2010). Both proteins differ only in 13 amino acids 
(Figure 1-6 A), but only HET-s is able to form self-perpetuating amyloid fibrils in the 
prion state (Coustou et al., 1997; Dos Reis et al., 2002; Maddelein et al., 2002). HET-s is a 
two-domain protein that consists of an N-terminal globular domain (residues ~ 1 – 227) 
and a C-terminal prion forming domain (pfd, residues 218 – 289) illustrated in Figure 
1-6 B (Balguerie et al., 2003). The N-terminal domain dictates the incompatibility type 
HET-s or HET-S and two amino acid differences at positions 23 and 33 are sufficient to 
cause incompatibility (Deleu et al., 1993). In the prion state the pfd assembles into well 
ordered aggregates (Balguerie et al., 2003; Dos Reis et al., 2002).  
Structural data are available for both domains and enable insights in the structure-function 
relationship of HET-s and HET-S. The crystal structures of the globular domain of both 
proteins revealed a HeLo domain with an α-helical fold of 8 – 9 helices with a short two-
stranded β-sheet presented in Figure 1-6 C (Greenwald et al., 2010; Idnurm and Howlett, 
2003). This HeLo domain was identified to form dimers. HET-s and HET-S differ in the 
thermodynamic stability of their HeLo domain and HET-s constructs are 
thermodynamically more stable (Greenwald et al., 2010). 
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Figure 1-6: Domain organisation and structure of HET-s/HET-S. (A) Sequence alignment of HET-s 
and HET-S. Differing amino acids are highlighted in green. (B) Domain organisation of HET-s/HET-S. 
(C) Ribbon diagram of the HET-S HeLo domain (pdb entry 2VWO) (Greenwald et al., 2010). (D) Side view 
of three stacked HET-s218-289 molecules (pdb entry 2KJ3) (Van Melckebeke et al., 2010; Wasmer et al., 
2008). Strands shown in the same colour correspond to one molecule. (E) Schematic representation of the 
two layers of the amyloid core formed by HET-s218-289. 
 
The first structural characterisation of the HET-s pfd via hydrogen/deuterium exchange 
NMR and solid state NMR spectroscopy (see chapters 1.4.4 and 1.4.5) identified four 
protected segments assigned to β-strands (Ritter et al., 2005; Siemer et al., 2005; Siemer et 
al., 2006b). Subsequently, a structure with atomistic resolution was solved by solid state 
NMR and revealed further insights into the pfd structure shown in Figure 1-6 D (Van 
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Melckebeke et al., 2010; Wasmer et al., 2008). Thus, HET-s218-289 forms a left-handed 
β-solenoid structure with a hydrophobic triangular core and two windings per monomer. 
Each winding is made of four short β-strands (β1a/β1b and β2a/β2b, β3a/β3b and β4a/β4b) 
shown in Figure 1-6 E. In each case two β-strands (a/b) are connected by sharp β-arcs and 
correspond to one previously assigned β-strand. While β2b and β4b point outwards, the 
first three strands of every turn contribute to the triangular core. The two β-strand segments 
are connected by a 15 residue flexible loop (Siemer et al., 2006a). The topology of the core 
region is characterised by hydrophobic residues facing inside and polar residues facing 
outside. Furthermore, the structure is stabilised by three salt bridges and two asparagine 
ladders (Van Melckebeke et al., 2010; Wasmer et al., 2008). Former proline mutagenesis 
studies already indicated that this in vitro structure is highly similar to the prion structure 
formed in vivo (Ritter et al., 2005). 
Continuative studies allowed the proposal of a model (Figure 1-7) for the HET-s/HET-S 
incompatibility and induction of toxicity. This model is based on the local unfolding of the 
globular HeLo domain during the assembly of the pfd (Wasmer et al., 2009b), the tendency 
to form dimers of this globular domain as well as the proven interactions of HET-S with 
HET-s fibrils in vivo (Greenwald et al., 2010). HET-S is suggested to interact with the 
HET-s fibril, which forces the HET-S pfd into the β-solenoid fold. Thereby the globular 
HeLo domain unfolds, followed by the formation of an aggregation prone dimer of the 
HeLo domain. These interactions are believed to block further fibril growth and to activate 
the toxicity of HET-S (Greenwald et al., 2010; Saupe, 2011).  
 
 
Figure 1-7:  Proposed model of HET-s/HET-S incompatibility. The HET-s fibril is shown alternating in 
light and dark grey. Soluble HET-S is shown coloured (rainbow – HeLo domain, black – random coil pfd). 
(A) A soluble HET-S monomer reaches the HET-s fibril. (B) Via interaction of HET-S with the fibril edge 
the terminal α-helices of the HeLo domain unfold to allow the prion fold. (C) Via binding a second HET-S 
molecule the HeLo domains form a dimer. (D) Oligomerisation of the HeLo domain enables un/refolding and 
thus aggregation of the HeLo domain blocking further growth of the fibril (original figure from Greenwald et 
al., 2010). 
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1.2.3 A HET-s Homologue Capable for Species Barrier Breaching 
The analysis of the available fungal genomes (National Center for Biotechnology 
Information and Broad Fungal Genome Initiative) revealed several Fusarium species that 
feature HET-s homologous proteins with a putative prion forming domain (Wasmer et al., 
2010). In comparison to PaHET-s, the homologue of Fusarium graminearum FgHET-s 
exhibits highest sequence similarity. Both proteins show 50 % identity and 58 % homology 
overall illustrated in Figure 1-8. The protein segments, which correspond to the pfd, are 
identical at 37 % and homologous at 46 % of the sequence.  
 
 
Figure 1-8:  Sequence alignment of HET-s from P. anserina and F. graminearum. Primary structure of 
PaHET-s is compared to FgHET-s. Conserved residues are highlighted in green, homologous residues in 
yellow. In the consensus sequence conserved residues are shown in red, $ indicates anyone of I or V, % 
anyone of F or Y, # anyone of D, E, N or Q. For the prion forming domain the β-strands of the β-solenoid 
structure of PaHET-s218-289 Wasmer et al., 2008 are shown on the top of the alignment. Analysis was done 
with the program MultAlin (Corpet, 1988). 
 
Saupe and co-workers identified this homologue to be capable for cross-seeding in spite of 
extensive sequence divergence (Wasmer et al., 2010). In vitro FgHET-s218-289 fibrils 
nucleate the amyloid fibril formation of PaHET-s218-289 and vice versa indicating species 
barrier breaching. These results are quite astonishing. So far prions were obtained to 
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transmit only rarely or not at all between different species, a phenomenon called species 
barrier (Prusiner, 1998; Wickner et al., 2009). In prion transmission preformed amyloid 
fibrils act as structural template (Chien et al., 2004; Cohen and Prusiner, 1998). The 
soluble protein adopts the same conformation as the template fibrils. Transmission and 
cross-seeding presuppose protein sequences and structures that are highly similar 
(Prusiner, 1998). An amino acid sequence dependent host range controls the prion 
transmission. But in the case of the cross-seeding between PaHET-s218-289 and 
FgHET-s218-289 the sequence identity (37 %) is comparatively very low. Certainly, 
amyloids have been shown to form different polymorphic forms and much different 
structures already due to single point mutations (Tycko et al., 2009). Only globular, 
soluble proteins were assumed to adopt the same structure corresponding to a certain 
homology level (Chothia and Lesk, 1986; Ginalski, 2006). Thus, the question about the 
background of the observed cross-seeding effect between the two homologues arose. 
Obviously, the structure elucidation of the FgHET-s prion for comparison with PaHET-s is 
required to answer this question. 
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1.3 Curli Fibrils and Their Major Subunit CsgA 
Curli amyloid fibrils are the main component of a 
complex extracellular matrix formed by many 
enterobacteria like E. coli and Salmonella (Figure 1-9). 
Initially curli fibrils were found in E. coli strains that 
caused bovine mastitis in the late 1980s (Olsén et al., 
1989). Recent studies identified curli as key player in 
adhesion to abiotic and biotic surfaces, host invasion, 
binding to host proteins and biofilm formation 
(reviewed by Barnhart and Chapman, 2006).  
In E. coli curli fibril formation six different proteins are involved. These proteins are 
encoded by the two operons csgBA and csgDEFG (Hammar et al., 1995). The homologous 
fibrils in Salmonella are called Tafi (thin aggregative fimbrae) and the operons are agfBA 
and agfDEFG (Collinson et al., 1996; Romling et al., 1998a). The encoded proteins are 
highly conserved among the two species (Romling et al., 1998a). The following section 
will describe the fibrils of both species and will be referred to as curli. 
 
 
1.3.1 Curli Biogenesis Is Highly Controlled 
Curli fibrils are built up of two highly homologous proteins – the major curli subunit CsgA 
and the nucleator protein CsgB. Fibril formation requires four additional proteins CsgC, 
CsgE, CsgF and CsgG, which interact in a sophisticated mechanism (Figure 1-10).  
The operons csgBA and csgDEFG encode the corresponding curli specific genes. Curli 
gene expression is stringently regulated and responsive to many environmental cues 
(Gerstel and Romling, 2003). CsgD is the transcription factor and promotes the 
transcription of csgBA (Hammar et al., 1995). Thus, the regulation of csgD expression also 
influences curli gene expression. Regularly, curli gene expression is enhanced by a growth 
temperature below 30 °C (Arnqvist et al., 1992; Olsén et al., 1989). However, high 
expression levels of curli specific genes were obtained in clinical E. coli strains at 37 °C 
(Bian et al., 2000), and mutations in the csgD promoter region can lead to curli gene 
expression without any temperature dependence (Romling et al., 1998b; Uhlich et al., 
2001). Furthermore, growth media without salt (Romling et al., 1998b), limitation of 
nutrients like nitrogen, phosphate and iron (Gerstel and Romling, 2001; Romling et al., 
 
Figure 1-9:   Curli on the surface of 
E. coli cells. Electron micrograph of 
curliated bacteria. (Chapman et al., 
2002). 
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1998b) and microaerophilic conditions (Gerstel and Romling, 2001; Romling et al., 1998a) 
are able to promote curli gene expression.  
The curli specific gene products CsgA, CsgB, CsgE, CsgF and CsgG carry an N-terminal 
Sec sequence that enables the proteins to cross the inner membrane via a Sec system. CsgG 
mediates the secretion of CsgA and CsgB out of the cell (Loferer et al., 1997; Robinson et 
al., 2006) This outer membrane lipoprotein forms oligomeric ring-shaped complexes, 
similar to other outer membrane channel-forming proteins (Brok et al., 1999; Thanassi and 
Hultgren, 2000; Thanassi et al., 1998). CsgE and CsgF can interact with the membrane 
pore and are suggested to act as chaperones during curli biogenesis (Robinson et al., 2006). 
While CsgE is believed to avoid premature CsgA assembly in the periplasm (Nenninger et 
al., 2011), CsgF is also secreted to the extracellular space, where it facilitates the 
cell-association and protease resistance of CsgB (Nenninger et al., 2009). 
 
Figure 1-10:  Curli biogenesis. The two curli gene operons are shown at the bottom. CsgD enhances the 
transcription of csgBA. All other gene products carry a sec signal sequence to enter the periplasm via the Sec 
pathway. CsgG is an outer membrane pore mediating the secretion of CsgA and CsgB. Outside the cell CsgB 
nucleates CsgA into well ordered fibrils. CsgE and CsgF interact with CsgG and facilitate curli assembly in a 
chaperone like manner (adapted from Barnhart and Chapman, 2006; Nenninger et al., 2009). 
 
After secretion of CsgA and CsgB, CsgB nucleates the polymerisation of soluble CsgA 
monomers into long unbranched fibrils resulting in a loose network of curli fibrils 
(Chapman et al., 2002; Hammar et al., 1996). Furthermore, the three internal repeats of the 
fivefold repetitive core of CsgA display nonconsensus residues (Wang et al., 2010). These 
“gatekeeper” residues are aspartates and glycines, which reduce the aggregation grade of 
the distinct CsgA segments. Thus, these residues avoid uncontrolled self-assembly, 
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mislocalisation of the curli fibrils and cytotoxicity (Rousseau et al., 2006; Wang et al., 
2010). Recent studies identified the operon csgBA in Salmonella to encode a third protein – 
CsgC (Gibson et al., 2007). Currently, the role of CsgC in curli biogenesis is unclear, but 
loss of CsgC leads to aberrant fibril formation. 
 
 
1.3.2 The Manifold Roles of Curli  
Curliated bacteria benefit from the surrounding fibrillar network in many different ways. 
Next to cellulose and other polysaccharides, curli are the main component of the 
extracellular matrix formed by many enterobacteria (Zogaj et al., 2003). This matrix 
protects the embedded cells and is an important requirement to form biofilms (Hall-
Stoodley et al., 2004; Van Houdt and Michiels, 2005). Biofilms are aggregates of 
microorganisms, in which the single cells benefit from an increased resistance to 
environmental stress. In addition, biofilms provide mechanical stability and metabolisable 
substrates. Since curli also allow the bacteria to adhere to Teflon and stainless steel, 
biofilm formation is often a problem in food industry and hospital settings (Austin et al., 
1998).  
Furthermore, curli can bind to the extracellular matrix proteins fibronectin (Collinson et 
al., 1993; Olsén et al., 1989) and laminin (Olsén et al., 1993), as well as to MHC class I, 
which presents antigens on the cell surface (Olsén et al., 1998). Thus, curli support the 
attachment and invasion of host cells (reviewed by Barnhart and Chapman, 2006). In 
addition, these surface fibrils interact with other intracellular host proteins enhancing 
bacterial spreading throughout the host (Bian et al., 2000). Curli can attach to plasminogen 
and the tissue type plasminogen activator. This attachment enables the activation of 
plasmin leading to the degradation of soft tissue. Thus, the bacteria can access to deeper 
tissue layers (Sjobring et al., 1994). Interactions with the contact-phase proteins 
H-kininogen, fibrinogen and factor XII retard clotting and also enhance the dissemination 
of the curliated bacteria (Ben Nasr et al., 1996; Herwald et al., 1998; Olsén et al., 2002). 
As pathogen-associated molecular pattern (PAMP), curli are recognised by Toll-like 
receptors inducing the innate immune system via proinflammatory cytokines (Froy, 2005; 
Kai-Larsen et al., 2010; Tükel et al., 2010). In summary, curli play an important role in a 
number of mechanisms of pathogens. Thus, detailed insights in the structure-function 
relationship of curli would enhance the understanding of bacterial pathogenesis.  
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1.3.3 The Major Curli Subunit CsgA 
Curli fibrils consist of the elongator protein CsgA, which is the major curli subunit, and the 
nucleator protein CsgB. Both proteins share 30 % sequence identity and 40 % homology 
(Hammar et al., 1995). In vivo CsgA assembles into well ordered amyloid fibrils only in 
the presence of CsgB (Hammar et al., 1996; Hammer et al., 2007). In contrast to the in 
vivo assembly, in vitro formation of curli-like fibrils does not require CsgB (Chapman et 
al., 2002; Wang et al., 2007). 
The amino acid sequence of CsgA 
comprises a signal peptide for protein 
export (residues 1 – 20), 22 flexible 
amino acids (residues 21 – 43) at the 
mature N-terminus and an amyloid core 
(residues 44 – 151), which is made of 
five imperfect repeats (Figure 1-11). 
Hence, mature CsgA comprises both, a 
protease-susceptible and a protease-
resistant domain (Collinson et al., 
1999). The amyloid core is 
characterised by intramolecular highly conserved residues. Every repeated unit shows the 
consensus sequence of Sx5QxGxGNxAx3Qx1-5 and consists of 19 – 23 amino acids 
(Collinson et al., 1999; Hammar et al., 1996). The conserved glutamine and asparagine 
residues are suggested to form a hydrogen bonding network that stabilises the fibrils of 
CsgA (Collinson et al., 1999). Chemically synthesised peptides of the units 1, 3 and 5 are 
also amyloidogenic (Wang et al., 2007). Recombinantly expressed and in vitro 
polymerised mature CsgA shows all the characteristics of amyloid fibrils. CsgA fibrils are 
resistant to proteases and SDS and show a β-sheet rich fold (Chapman et al., 2002; 
Shewmaker et al., 2009; Wang et al., 2007). In the presence of polymerised CsgA, ThT 
shows an increased fluorescence signal, allowing the visualisation of the fibrillisation 
kinetics (Wang et al., 2007).  
A first study on the structure of CsgA with solid state NMR spectroscopy indicated that the 
amyloid core is not made of a parallel in-register β-sheet structure (Shewmaker et al., 
2009). The authors concluded that a β-helix like structure would be likely, but the obtained 
data were not sufficient to identify this structure. 
 
 
Figure 1-11: Domain structure of CsgA. Mature CsgA 
consists of a flexible N-terminus and an amyloid core 
made of five imperfect repeats with a characteristic 
consensus sequence (x is any amino acid). 
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1.4 Techniques to Study Amyloid Structures 
The three-dimensional structure of every protein dictates its function. Thus, protein 
structure elucidation is indispensable in order to understand the corresponding functions. 
Amyloid fibrils form filamentous structures, which are inherently difficult to study. 
Conventional methods for protein structure-function analysis and thermodynamic 
characterisation are usually not feasible for amyloids. Amyloids do not form crystals at all, 
which are required for X-ray crystallography. Multi-subunit proteins in the megadalton 
range such as amyloids are too large for solution NMR spectroscopy. Recent research 
enhanced the known techniques for structure analysis to overcome the challenging 
properties of amyloids (reviewed by Chiti and Dobson, 2006; Toyama and Weissman, 
2011), as for example hydrogen/deuterium (H/D) exchange NMR. 
 
 
1.4.1 Low Resolution Techniques 
For a long time only imaging techniques like TEM and AFM, as well as X-ray fibril 
diffraction analysis revealed insights into amyloid structures as illustrated in chapter 1.1.2 
(Harper et al., 1997; Sunde et al., 1997). Fourier transform infrared (FT-IR) and circular 
dichroism (CD) spectra are helpful to verify a β-sheet rich fold by specific absorption 
bands, as well as the detection of the folding kinetics (Berthomieu and Hienerwadel, 2009; 
Ranjbar and Gill, 2009). Moreover, FT-IR spectra identify amyloid specific β-sheets by a 
characteristic wave number of the amide I band at 1625 – 1610 cm-1, compared to soluble 
proteins with a wave number ≥ 1630 cm-1 (Zandomeneghi et al., 2004). Extrinsic dyes like 
ThT and CR (chapter 1.1.2) are sensitive tools to probe folding intermediates, surface 
hydrophobicity and aggregation or fibrillisation of proteins (Hawe et al., 2008). As most 
fibrils bind to these specific dyes, they can be used to demonstrate the tertiary and 
quaternary structure of the amyloid fold as well. 
Initially, these methods were complemented by techniques like proteolytic digestion 
(Kheterpal et al., 2001) and mutagenesis studies with the β-breaker proline (Chiba et al., 
2003; Williams et al., 2004; Wood et al., 1995) to identify stable regions. An alternative 
mutagenesis approach has been established by using the introduction of single cysteine 
residues. The thiol group of a cysteine residue can be linked to paramagnetic spin labels for 
electron paramagnetic resonance (EPR) measurements (Chen et al., 2007; Der-Sarkissian 
et al., 2003; Torok et al., 2002) and extrinsic fluorescence dyes (Krishnan and Lindquist, 
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2005; Ohhashi et al., 2010; Ritter et al., 2005). The success of the mutagenesis analysis 
depends on the correct folding of the overall structure of the modified proteins compared to 
the wild type form. In general, corresponding experiments provide information about the 
presence or absence of regular secondary structure elements at a defined residue, the 
topology of β-sheets, as well as inter- and intramolecular contacts within the fibril.  
 
 
1.4.2 High Resolution Techniques 
Further developments in biophysical methods facilitate a closer insight into amyloid 
structures by cryo electron microscopy, X-ray crystallography, as well as NMR 
spectroscopy techniques as H/D exchange NMR or solid state NMR. 
Cryo electron microscopy (cryo EM) is an advanced form of electron microscopy at 
cryogenic temperatures. Electrons that transmit through the sample are detected 
(Henderson, 2004). Cryo EM enables the analysis of amyloids under physiological 
conditions without staining or fixation, which is necessary in conventional EM. The 
observed electron densities indicate the helical twist of the protofilaments and the cross-β 
structure of amyloids (Jimenez et al., 1999; Jimenez et al., 2002; Meinhardt et al., 2009; 
Sachse et al., 2008; Schmidt et al., 2009; Zhang et al., 2009).  
Eisenberg and co-workers were able to use X-ray crystallography to analyse microcrystals 
of peptide fragments forming amyloid-like structures. In several studies they revealed 
atomistic details congruent to existing structural models of amyloids (Nelson et al., 2005; 
Sawaya et al., 2007; Wiltzius et al., 2009; Wiltzius et al., 2008). Thus, the β-sheet stacking 
interface “dry steric zipper” was postulated by Eisenberg as a basic principle of the 
cross-β structure illustrated in chapter 1.1.2 (Nelson et al., 2005; Sawaya et al., 2007).  
Since the analysed peptides are only up to seven residues, the wealth of data needs to be 
confirmed by techniques probing the full-length protein. 
 
 
1.4.3 Theoretical Background of NMR Spectroscopy 
Another approach to reveal atomistic resolution of the protein structure is based on nuclear 
magnetic resonance (NMR) spectroscopy. NMR spectroscopy is widely used for the 
structure elucidation of small molecules, but it can also be applied for structure 
determination and structure-function relationship analysis of proteins under physiological 
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conditions (Wüthrich, 1990). In addition to conventional structure determination of 
proteins, NMR enables for example the investigation of folding intermediates (Hofmann et 
al., 2008; Schulenburg et al., 2009), chemical properties of functional groups (Gardiennet 
et al., 2005; Shammas et al., 2007), intermolecular interactions (Debnath et al., 2011; 
Drechsler et al., 2011), hydrogen bonding (Assadi-Porter et al., 2003; Liwang and Bax, 
1997) as well as structural investigation of amyloids and membrane proteins (Hoshino et 
al., 2002; Linser et al., 2011; Tycko, 2011). 
All these NMR applications are based on the phenomenon of nuclear magnetic resonance 
of certain nuclei. Most nuclei have an intrinsic angular momentum P. This angular 
momentum depends on the nuclear quantum number I shown in Equation 1-1. 
 
Equation 1-1:    h = Planck constant 
 
The nuclei have an intrinsic angular momentum P, whenever I ≠ 0. Placed in an external 
magnetic field B0, the intrinsic angular momentum P is orientated along B0. The energy 
level of the nucleus is split in 2I+1 energy states shown in Figure 1-12 (Zeeman effect, 
Zeeman, 1897).  
 
 
Figure 1-12: Zeeman effect of a nucleus with 
I = ½. The energy level of a nucleus with I = ½ 
splits into two energy states (2I+1).   
 
The application of a radio frequency pulse B1, whose energy is equal to ∆E of the split 
energy states of the nucleus, leads to the saturation of the higher energy level. The 
relaxation of the higher energy level can be detected. Depending on the chemical 
environment, the magnetic field B0 on a nucleus is shielded by the B0-induced magnetic 
field of the neighbouring nuclei and their electrons. The result is the local magnetic field 
Beff. Higher shielding effects result in a decreased Beff. For a constant B0 the resonance 
frequency decreases. Different nuclei are distinguished by their resonance frequencies, 
which are influenced by the chemical environment. The different resonance frequencies are 
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given in the chemical shift δ in ppm. The resonance frequency of the nuclei νsample is 
divided by the resonance frequency ν0 referred to a reference signal νref for example 
tetramethylsilane (TMS) as illustrated in Equation 1-2. 
 
Equation 1-2:  
 
Important nuclei in NMR spectroscopy are nuclei with I=1/2 1H, 13C, 15N, 19F, 31P. The 
natural abundance of 13C and 15N nuclei is relative low compared to 1H isotopes. For this 
reason, proteins chosen for NMR experiments have to be labelled with these isotopes. 
The NMR technique has been further developed to multi-dimensional (2D, 3D) NMR 
experiments to overcome the overlap of signals in 1D NMR spectra. These NMR 
experiments are necessary to solve the complex structure of proteins. Multi-dimensional 
data sets are generated from series of one-dimensional experiments and cross-signals 
(cross-peaks) are analysed. Accordingly [15N, 1H] correlation spectra for example reveal 
only cross-peaks of NH-groups, because the corresponding experiments detect exclusively 
the scalar couplings between H- and N-nuclei.  
 
 
1.4.4 The H/D Exchange NMR Experiment 
H/D exchange [15N, 1H] NMR spectroscopy in combination with a sequence specific 
assignment of resonances is a powerful tool to identify structured regions in proteins at 
single residue resolution (Englander, 2000; Li and Woodward, 1999). This experiment is 
based on the different hydrogen exchange rates of backbone amides that depend on their 
conformation. Deuterium is not detectable in the [15N, 1H] NMR spectrum.  
Hydrogen exchange occurs every time between the protons of a protein and the 
surrounding solvent (Englander et al., 1997; Hvidt and Linderstrøm-Lang, 1954). 
Influenced by the chemical environment, the exchange is retarded (Bai et al., 1993). 
Backbone amides, which are involved in hydrogen bonds, are less accessible to the solvent. 
The hydrogen exchange reaction is slowed down. Backbone amides, which are not 
involved in hydrogen bonding, exchange faster. Recording NMR spectra provides 
information about the protonation of backbone amides and their exchange behaviour. Since 
secondary structure elements are formed by hydrogen bonding, this exchange behaviour 
allows to the distinction between ordered and disordered regions of a protein.  
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Amyloids are not feasible for conventional NMR experiments as they form megadalton 
complexes. However, dissolving them in aprotic dimethyl sulfoxide (DMSO) enables the 
analysis of unfolded monomers of amyloid proteins after H/D exchange experiments as 
reported by Goto and co-workers (Hirota-Nakaoka et al., 2003; Hoshino et al., 2002). The 
H/D exchange NMR experiment of amyloids (Figure 1-13) includes three distinct steps 
(Hoshino et al., 2002):   
A) Incubation of the amyloid fibrils in D2O buffer 
  B) Monomerisation of the fibrils with DMSO 
  C) NMR analysis. 
At first the amyloid fibrils are incubated in D2O buffer to enable H/D exchange between 
the protein and the solvent. The reaction is quenched at appropriate time intervals by 
removing the solvent. Secondly, the fibrils are monomerised in DMSO. Furthermore, the 
aprotic DMSO conserves the hydrogen/deuterium pattern present in the fibril at a specific 
incubation time. Finally, [15N, 1H] correlation spectra are recorded and analysed regarding 
the presence and absence of resonances. In a spectrum of fibrils that were incubated in 
water each resonance corresponds to one backbone amide of the protein. 
Hydrogen/deuterium exchange results in a spectrum with significantly reduced or absent 
resonances. The backbone amides corresponding to the absent resonances have undergone 
a fast exchange and deuterium is not detectable in such NMR spectroscopy.  
Furthermore the H/D exchange NMR technique has been improved in different ways 
(Luhrs et al., 2005; Ritter et al., 2005). One improvement is the measurement of series of 
[15N, 1H] correlation spectra in order to correct the resonance intensities for exchange in 
DMSO. Remaining traces of D2O are able to mask the resonance intensities due to further 
exchange in DMSO. For this reason, a rapid mixing with DMSO and preadjusted NMR 
settings (together less than 1 min) are of great importance. The acquisition of one spectrum 
was reduced to less than 5 min. Another aspect is the analysis of NMR spectra after 
different incubation intervals in D2O. These data enable the accurate examination of 
exchange rates of each assigned backbone amide. Finally, the exchange rates provide 
additional information about the homogeneity and regularity within the fibrils (Luhrs et al., 
2005; Ritter et al., 2005).  
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Figure 1-13: Schematic description of the H/D exchange NMR experiment. (A) H/D exchange within the 
fibril. Reaction is started by solvent exchange to D2O. Hydrogens involved in hydrogen-bonds forming 
secondary structure are protected, contrary hydrogens of flexible backbone amides are easily substituted by 
solvents deuterons. (B) Monomerisation and unfolding of the amyloid fibrils using DMSO. Original positions 
of β-strands are highlighted in the same colour as in (A). Dissolving the fibrils in aprotic DMSO conserves 
the proton/deuteron pattern. (C) Detection of H/D exchange via NMR recording [15N, 1H] correlation spectra. 
Obtained NMR spectra differ in their peak intensities.  
 
In summary, H/D exchange NMR spectroscopy is a unique tool to study stability and 
thermodynamic behaviour of proteins and their variants. This approach was already 
successful applied to a number of systems to map the amyloid cores of HET-s (Ritter et al., 
2005), Sup35 (Toyama et al., 2007), Aβ (Luhrs et al., 2005), β2-microglobulin (Hoshino et 
al., 2002), α-synuclein (Vilar et al., 2008) and SH3 domain fibrils (Carulla et al., 2005). 
Alternatively, H/D exchange experiments have been evaluated by mass spectrometry 
HD-MS (Kheterpal et al., 2006). The higher mass of deuterium also enables the detection 
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of the exchange by mass spectrometry. H/D exchange and quenching the reaction are 
followed by the digestion of the protein into smaller peptides. Subsequently the digested 
peptides are separated and analysed by mass spectrometry (Kheterpal et al., 2006). One 
advantage of HD-MS experiments is the requirement of less protein material. One major 
drawback is the missing ability to digest the protein into small peptides suitable for precise 
analysis and the artifactual exchange during this digestion. As many amyloids are only 
soluble in hexafluoroisopropanol, formic acid or DMSO, it is difficult to find a solvent 
suitable for monomerisation and adjacent digestion by a protease. For the prion forming 
domain of HET-s from Podospora anserina H/D exchange experiments were analysed and 
compared for both techniques illustrated in Figure 1-14 (Nazabal and Schmitter, 2006; 
Ritter et al., 2005). The comparison indicated obvious differences in the resolution of the 
techniques. 
 
 
Figure 1-14: H/D exchange analysis of HET-s218-289. (A) NMR analysis identified four protected regions 
assigned to β-strands (Ritter et al., 2005). Bars indicate hydrogen exchange rates kex (h-1), blue arrows 
indicate β-strands. Slow exchange rates correspond to backbone amides, which are involved in hydrogen 
bonding. Black asterisks mark residues, which could not be analysed. (B) MS analysis determined the 
percentage (%) of deuterium incorporation along the HET-s218-289 sequence (Nazabal and Schmitter, 2006). 
Less deuterium incorporation indicates protected backbone amides. 
 
 
1.4.5 Solid State NMR Spectroscopy 
In contrast to solution NMR spectroscopy, solid state NMR (ssNMR) experiments allow 
direct structural elucidation of solid material. The NMR samples in ssNMR experiments 
are rotated at high frequency at 54.74 ° to the magnetic field, called magic angle spinning 
(Andrew, 1981; Hennel and Klinowski, 2005), in order to increase the resolution and 
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decrease anisotropy and dipole dipole couplings effects (Heise, 2008). This technique 
provides information about polypeptide mobility, interresidue distances and residue-
specific positions of secondary structure elements (Heise, 2008; Tycko, 2000, 2006, 2011). 
Furthermore, solid state NMR experiments enable protein structure elucidation at atomic 
resolution. In the early 2000s Oschkinat and co-workers could solve the first complete 
protein structure by ssNMR (Castellani et al., 2002). Tycko and co-workers were the first, 
who applied ssNMR to amyloids with their work on the amyloid β peptide Aβ1-40 
(Antzutkin et al., 2000; Balbach et al., 2002; Petkova et al., 2002; Petkova et al., 2006). In 
addition to Aβ1-40, this technique was successfully applied to determine the β-sheet 
architecture for example of Sup35 (Shewmaker et al., 2006), α-synuclein (Heise et al., 
2005), Rnq1p (Wickner et al., 2008a) and Ure2p fibrils (Baxa et al., 2007). Unfortunately 
uniformly labelled proteins often lead to crowded spectra with overlapping peaks. This fact 
leads to imprecise assignments and absent distance information. Nevertheless, with HET-s 
the first amyloid structure could recently be solved, discussed in chapter 1.2.2 (Wasmer et 
al., 2008).   
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2 Aims and Scope 
 
 
The HET-s prion of Podospora anserina and the curli system of E. coli are two of the most 
studied systems that form functional amyloids (reviewed by Barnhart and Chapman, 2006; 
Saupe, 2011). They constitute a group of unique systems that allows the analysis of how 
proteins fibrillise without forming toxic intermediates resulting in a physiologically 
valuable fold. In order to understand this phenomenon with regard to distinct functions, 
structural information is essential. 
Remarkable results acquired Saupe and co-workers in cross-seeding experiments of two 
HET-s homologues: In spite of the low sequence identity, FgHET-s is capable to nucleate 
PaHET-s fibrillisation and vice versa. In order to analyse the origin of the unexpected 
HET-s cross-seeding phenomenon, one aim of this work was to investigate the structural 
relationship of the homologous prion domains. Therefore, FgHET-s218-289 should be 
subjected to H/D exchange NMR spectroscopy to investigate the structural regularity, 
homogeneity and stability of the fibrils in comparison to PaHET-s. Since the structure of 
the PaHET-s prion domain was already well characterized, H/D exchange NMR should be 
probed for its capability to compare the topology of the homologues without a complete 
solid state NMR analysis for both proteins. For the meaningful determination of residue-
specific H/D exchange rates, FgHET-s218-289 had to be recombinantly produced and 
specifically fibrillised, the sequence-specific backbone-resonance assignment was to be 
established. 
The curli fibrils of Enterobacteria were shown to facilitate manifold functions in bacterial 
pathogens. Since CsgA is the major curli subunit, its structure-function relationship is of 
high interest. As there was no residue-specific information about structural elements of 
CsgA, another aim of this thesis was the structural characterisation of CsgA from E. coli 
following two strategies: the analysis of specific fibrils as well as the analysis of amyloid-
like folding intermediates. In order to investigate the topology, as well as homogeneity and 
stability of EcCsgA fibrils, H/D exchange NMR experiments and fluorescence labelling 
were intended. For this purpose, new protein variants, protein production, specific 
fibrillisation and fluorescence labelling as well as the backbone-resonance assignment had 
to be arranged. In vivo the fibrillisation of CsgA is nucleator dependent. Therefore, 
heteronucleated EcCsgA fibrils should be probed by H/D exchange NMR to evaluate the 
influence of the nucleator EcCsgB on the structure, homogeneity and stability of EcCsgA. 
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In order to analyse amyloid like folding intermediates of EcCsgA, stable soluble analogues 
of EcCsgA oligomers are required. Therefore, appropriate expression constructs, as well as 
the recombinant production of corresponding proteins and purification protocols had to be 
established. Probably stable soluble protein constructs should be analysed with regard to 
their secondary/tertiary structure and capability for structural analysis. 
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3 Material and Methods 
 
 
3.1 Standard Materials 
3.1.1 Chemicals, Enzymes, Antibodies and Kits 
If not stated otherwise, all chemicals that were used in this work were of “pro analysis” 
grade. Chemicals were purchased from the companies Amersham Biosciences, Fluka, 
Merck, Millipore, Omnilab, Qiagen, Roche, Roth, Sigma and Stratagene. 
Enzymes (Table 3-1), antibodies (Table 3-2 and Table 3-3) and kits (Table 3-4) were 
used as described by the corresponding company. 
 
Table 3-1: Enzymes used in this work. 
Enzyme Source Specification 
Hen white-egg lysozyme Fluka Glycoside hydrolase 
DNAse Merck Endodeoxyribonuclease 
Proteinase K EuroClone Serine peptidase 
Shrimp Alkaline Phosphatase Roche Phosphate hydrolase 
Platinum Pfx Polymerase Invitrogen DNA polymerase 
Pfu Turbo Polymerase Stratagene DNA Polymerase 
T4 DNA Ligase New England Biolabs DNA Ligase 
BamHI, DpnI, HindIII, NotI, SacI, 
SapI, TatI, XbaI 
New England Biolabs, 
Fermentas Restriction endonucleases 
 
Table 3-2:  Primary antibodies used in this work. 
Name AB species Antigen Dilution Source 
anti-His6 Mouse Hexa-His 1:1500 Novagen 
 
Table 3-3:  Secondary antibodies used in this work. 
Name AB  
species 
A/R 
species Conjugate Dilution Source 
Anti Mouse IgG (H+L) 
AP Conjugate Goat Mouse 
Alkaline 
phosphatase 1:7500 Promega 
Anti Mouse IgG (H+L) 
HRP Conjugate  Goat Mouse 
Horse radish 
peroxidase 1:2000 Dianova 
 
Table 3-4:  Kits used in this work. 
Kit Source Usage 
QIAprep Spin Miniprep Kit Qiagen Plasmid purification  
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Kit Source Usage 
QIAquick PCR Purification Kit Qiagen Purification of PCR products, 
removal of nucleotides 
QIAquick Gel Extraction Kit Qiagen DNA extraction from gel slices 
QuikChange Site-Directed 
Mutagenesis Kit Qiagen 
Selective modification of  
plasmid DNA by mutation 
BugBuster Kit Protein Extraction 
Reagent Novagen 
Protein extraction after  
expression test 
BCIP/NBT Color Development 
Substrate Promega 
Detection of AP conjugated 
antibodies 
Lumi-Light Western Blotting  
Substrate Roche 
Detection of HRP conjugated 
antibodies by ECL 
 
3.1.2 Molecular Weight Standards 
Following molecular weight standards were used (Table 3-5).  
 
Table 3-5: Molecular weight standards used in this work. 
Name Source Type 
Smart Ladder Eurogentec Agarose gel DNA marker 
Unstained Protein Molecular weight 
marker Fermentas SDS-PAGE protein marker 
PageRulerTM Unstained Protein  
ladder Fermentas SDS-PAGE protein marker 
PageRulerTM Prestained Protein ladder Fermentas SDS-PAGE protein marker 
 
3.1.3 Bacterial Strains 
Following bacterial strains were used (Table 3-6). 
 
Table 3-6:  Bacterial strains used in this work. 
E. coli strain Genotype Source 
BL21 (DE3) F
–
 ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 
gene 1 ind1 sam7 nin5]) Stratagene 
DL39 F– Lam–acpC13 fnr-25rph-1 ilve12 tyrB507 LeMaster and Richards, 1988 
DH5α F
–
 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZ∆M15 ∆(lacZYA-argF)U169, hsdR17(rK- mK+), λ– Invitrogen 
T7 Express 
fhuA2 lacZ::T7 gene1 [lon] ompT gal sulA11 R(mcr-
73::miniTn10--TetS)2 [dcm] R(zgb-210::Tn10--TetS) endA1 
∆(mcrC-mrr)114::IS10 
NEB 
TUNER (DE3) F
-
 lacY ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI 
lacUV5-T7 gene 1 ind1 sam7 nin5]) Novagene 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac Stratagene 
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3.1.4 Plasmids 
Following recombinant plasmids were used in this work (Table 3-7). Plasmid derivatives 
of pET-11d, pET-15b, pETRO, pRSET-A mT and pBar100 carried an ampicillin resistance 
gene. pET-24a and pETM-10 carried a kanamycin resistance gene. In addition to the 
ampicillin resistance, pBar100 plasmids carried a chloramphenicol resistance gene too. 
 
Table 3-7: Recombinant plasmids used. 
Plasmid Features Source 
pRSET-A mT  
(Zahn et al., 1996) 
N-terminal hexa histidine tag, engineered thrombin 
cleavage site 
T. Lührs; HZI, 
Braunschweig 
pBar100 
(Schmoldt et al., 2005) 
pMT416 derivative encoding barnase peptide 
fusion constructs 
M. Daneschdar/H. 
Kolmar; TU 
Darmstadt 
pET-11d CsgA21-151 pET-11d derivative encoding E. coli CsgA21-151 
A. Eberth; HZI, 
Braunschweig 
pET-11d CsgA21-151 V23C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 E44C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 L45C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 N46C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 S55C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 L57C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 A58C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 L59C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 D80C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 V81C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 S88C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 S89C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 S100C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 A125C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 V126C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 S134C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 V135C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 N136C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 T147C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 A148C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA21-151 H149C Site directed mutagenesis of pET-11d CsgA21-151 this work 
pET-11d CsgA40-151 pET-11d derivative encoding E. coli CsgA40-151 this work 
pRSET-A mT CsgA CM pRSET-A mT derivative encoding fusion protein R5c-CsgA-R1c this work 
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Plasmid Features Source 
pET-15b CsgA CM pET-15b derivative encoding fusion protein R5c-CsgA-R1c this work 
pET-15b CsgA CM 
V25K/L161K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
N26K/N162K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
T37K/L173K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
A38K/A174K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
V25K/N26K/L161K/N162K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
T37K/A38K/L173K/A174K Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
V25P/L161P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
T28P/Y164P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
N35P/S171P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
A38P/A174P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
V25P/N35P/L161P/S171P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
T28P/A38P/Y164P/A174P Site directed mutagenesis of pET-15b CsgA CM this work 
pETRO CsgA CM pETRO derivative encoding fusion protein R5c-CsgA-R1c this work
1)
 
pRSET-A mT CsgA CD pRSET-A mT derivative encoding fusion protein R5c-(CsgA)2-R1c this work 
pET-15b CsgA CD pET-15b derivative encoding fusion protein R5c-(CsgA)2-R1c this work 
pET-15b CsgA CM 
V25K/L274K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
N26K/N275K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
T37K/L286K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
A38K/A287K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
V25K/N26K/L274K/N275K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
T37K/A38K/L286K/A287K Site directed mutagenesis of pET-15b CsgA CD this work 
pET-15b CsgA CM 
V25P/L274P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
T28P/Y277P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
N35P/S284P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
A38P/A287P Site directed mutagenesis of pET-15b CsgA CM this work 
pET-15b CsgA CM 
V25P/N35P/L274P/S284P Site directed mutagenesis of pET-15b CsgA CM this work 
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Plasmid Features Source 
pET-15b CsgA CM 
T28P/A38P/Y277P/A287P Site directed mutagenesis of pET-15b CsgA CM this work 
pETRO CsgA CD pETRO derivative encoding fusion protein R5c-(CsgA)2-R1c this work
1)
 
pET-11d Sumo-CsgA-Sumo pET-11d derivative encoding fusion protein Sumo-CsgA-Sumo this work 
pET-11d Bar-(CsgA)2-Bar pET-11d derivative encoding fusion protein Bar-(CsgA)2-Bar this work 
pET-11d Sumo-(CsgA)2-
Sumo 
pET-11d derivative encoding fusion protein 
Sumo-(CsgA)2-Sumo this work 
pET-24a FgHET-s218-289 
pET-24a derivative encoding F. graminearum  
HET-s218-289 
C. Wasmer; ETH 
Zürich 
1)
 The original pETRO vector was established by T. Lührs/S. Loss (HZI, Braunschweig) and kindly provided 
by them. 
Sequences of encoded proteins (excepting variants due to site directed mutagenesis) are given in the 
Appendix. 
 
3.1.5 Oligonucleotides 
Oligonucleotides (Table 3-8) were used as primers for site-directed mutagenesis and PCR. 
They were purchased from MWG. 
 
Table 3-8:  Oligonucleotides used. Recognition sites for restriction enzymes are underlined and point 
mutations/codon exchanges are marked in red. For QuikChange site-directed mutagenesis only forward 
primers are listed.  
Name Sequence (5´ → 3´) Restriction site/ Mutation/Tag 
Cloning and sub-cloning 
csgA⋅∆N39 fwd TCATGCCATGGGCCCAAATTCTGAGC NcoI 
csgA⋅∆N39 rev GGCTTTGTTAGCAGCCGGATCCTTAG BamHI 
csgA⋅fwd GTAATGGATCCAATAGCGGCCCAAAT BamHI 
csgA⋅rev CTCAGAAGCTTTTAGTACTGATGAGCG HindIII 
csgA⋅SacI GGCCCAAATTCTGAGCTCAACATTTACCAGTACGGT SacI 
csgA⋅R5c 
GTTCCGCGTGGATCCAATAGCGGCCCAAATAGCAG
CGTTAACGTTACCCAGGTGGGTTTCGGCAATAATG
CCACAGCCCACCAATATTCTGGTGATAACTCTGAG
CTCAACATT 
BamHI, SacI 
csgA⋅R1c 
CCAACAGTACTCTGGCGACAATAGCGAATTGAATA
TCTATCAATATGGCGGTGGCAATAGCGCCCTGGCA
CTTCAGACCTAAAAGCTTGATCCG 
TatI, HindIII 
csgA⋅∆TatI GACCGCTCATCAGTATTCCGGCGACAACAGC ∆TatI 
csgA⋅R1R1c fwd TTAGAGTACTCCGGTGATAACTCT TatI 
csgA⋅R1R1c rev GGATCAAGCTTTTAGGTCTGAAGT HindIII 
pRSET⋅∆TatI TCAGAATGACTTGGTTGAGTATTCACCAGTCACAGAAAAAGC ∆TatI 
bar⋅N fwd TCATGCCATGGGCGCACAGGTTATCAACAC NcoI 
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Name Sequence (5´ → 3´) Restriction site/ Mutation/Tag 
bar⋅N rev AATGTTGAGCTCAGAATTTGGGCCGCTTCTGATTTTTGTAAAGGTC SacI 
csgA⋅fus fwd TCATGCCATGGGCAGCGGCCCAAATTCTGAG NcoI, SacI 
csgA⋅fus rev CGCGGATCCTTAGTGATGGTGATGGTGATGGCTCATGGAAGAGCTGTACTGATGAGCGGTCG BamHI, SapI 
bar⋅C fwd CTTGCTCTTCCATGAGCGCACAGGTTATCAACAC SapI 
bar⋅C rev CGCGGATCCTTAGTGATGGTGATGGTGATGTCTGATTTTTGTAAAGGTC BamHI, H6 
sumo⋅N fwd TCATGCCATGGGTCATCACCATCATCATCACGGGTCCCTACAGGAC NcoI, H6 
sumo⋅N rev AATGTTGAGCTCAGAATTTGGGCCGCTCCTGCCAGGCATGC SacI 
sumo⋅C fwd GAAGCTCTTCCATGAGCGGGTCCCTACAGGAC SapI 
sumo⋅C rev CGCGGATCCTTACCTGCCAGGCATGCCACCAAT BamHI 
csgAd⋅fwd TTAGAGTACTCTGGTGACAACTCTGAGCTGAACATTTACCAGTACGGTG TatI, ∆SacI 
csgAd⋅rev GGATCAAGCTTGCTCATGGAAGAGCTATACTGATGAGCGGTCG HindIII, SapI 
pET11d⋅∆ 
SapI AGGAAGCGGAAGGGCGCCTGATGCG ∆SapI 
Mutagenesis to create Cys variants of EcCsgA 
csgA⋅V23C ATATACCATGGGTGTTTGTCCTCAGTACGGCGGCG V23C 
csgA⋅E44C GTAATAATAGCGGCCCAAATTCTTGCCTGAACATTT ACCAGTACGGTGG E44C 
csgA⋅L45C AGCGGCCCAAATTCTGAGTGCAACATTTACCAGTA CGGTGG L45C 
csgA⋅N46C CCCAAATTCTGAGCTGTGCATTTACCAGTACGGTGGC N46C 
csgA⋅S55C GGTGGCGGTAACTGTGCACTTGCTCTGC S55C 
csgA⋅L57C GGCGGTAACTCTGCATGTGCTCTGCAAACTGATGC L57C 
csgA⋅A58C GGTGGCGGTAACTCTGCACTTTGTCTGCAAACTGATGCCCGTAAC A58C 
csgA⋅L59C GGTAACTCTGCACTTGCTTGCCAAACTGATGCCCGTAACTC L59C 
csgA⋅D80C CGGCGGTAATGGTGCATGTGTTGGTCAGGGCTCA D80C 
csgA⋅V81C CGGTAATGGTGCAGATTGTGGTCAGGGCTCAGATG V81C 
csgA⋅S88C CAGGGCTCAGATGACTGCTCAATCGATCTGACC S88C 
csgA⋅S89C GGCTCAGATGACAGCTGTATCGATCTGACCCAACGT S89C 
csgA⋅S100C CGTGGCTTCGGTAACTGCGCTACTCTTGATCAG S100C 
csgA⋅A125C GTGGTGGCAACGGTGCTTGCGTTGACCAGACTGCATC A125C 
csgA⋅V126C TGGCAACGGTGCTGCATGTGACCAGACTGCATCTA V126C 
csgA⋅S134C ACTGCATCTAACTCCTGCGTCAACGTGACTCAGG S134C 
csgA⋅V135C CTGCATCTAACTCCTCCTGCAACGTGACTCAGGTTGG V135C 
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Name Sequence (5´ → 3´) Restriction site/ Mutation/Tag 
csgA⋅N136C CTGCATCTAACTCCTCCGTCTGCGTGACTCAGGTTGGCTTTGG N136C 
csgA⋅T147C TGGCTTTGGTAACAACGCGTGCGCTCATCAGTACCATCACC T147C 
csgA⋅A148C GCTTTGGTAACAACGCGACCTGTCATCAGTACCATCACCATC A148C 
csgA⋅H149C GGTAACAACGCGACCGCTTGTCAGTACCATCACCATCACC H149C 
Mutagenesis to create Lys and Pro variants of CsgA CM and CsgA CD 
V25K GCGGCCCAAATAGCAGCAAGAACGTTACCCAGGTGGG V25K 
N26K CCCAAATAGCAGCGTTAAAGTTACCCAGGTGGGTT N26K 
T37K GTTTCGGCAATAATGCCAAAGCCCACCAATATTCTGG T37K 
A38K GGGTTTCGGCAATAATGCCACAAAGCACCAATATTCTGGTGATAACT A38K 
L161K 
L274K 
TATTCTGGCGACAATAGCGAAAAGAATATCTATCA
ATATGGCGGTG 
L161K 
L274K 
N162K 
N275K 
GGCGACAATAGCGAATTGAAAATCTATCAATATGG
CGGT 
N162K 
N275K 
L173K 
L286K CGGTGGCAATAGCGCCAAGGCACTTCAGACCTAAA 
L173K 
L286K 
A174K 
A287K 
GGTGGCAATAGCGCCCTGAAACTTCAGACCTAAAA
GCTT 
A174K 
A287K 
V25K/N26K TAGCGGCCCAAATAGCAGCAAGAAAGTTACCCAGGTGGGTTTCG V25K/N26K 
T37K/A38K CAGGTGGGTTTCGGCAATAATGCCAAAAAGCACCAATATTCTGGTGATAACTCT T37K/A38K 
L161K/N162K 
L274K/N275K 
TATTCTGGCGACAATAGCGAAAAGAAAATCTATCA
ATATGGCGGTGGC 
L161K/N162K 
L274K/N275K 
L173K/A174K 
L266K/A287K 
TCAATATGGCGGTGGCAATAGCGCCAAGAAACTTC
AGACCTAAAAGCTT 
L173K/A174K 
L266K/A287K 
V25P CGGCCCAAATAGCAGCCCGAACGTTACCCAGGTGG V25P 
T28P AGCAGCGTTAACGTTCCGCAGGTGGGTTTCGGC T28P 
N35P GGTGGGTTTCGGCAATCCGGCCACAGCCCACCAAT N35P 
A38P GTTTCGGCAATAATGCCACACCGCACCAATATTCTGGTGATAA A38P 
L161P, L274P TATTCTGGCGACAATAGCGAACCGAATATCTATCAATATGGCGGT L161P, L274P 
Y164P, Y277P GACAATAGCGAATTGAATATCCCGCAATATGGCGGTGGCAATAGC Y164P,Y277P 
S171P, S284P AATATGGCGGTGGCAATCCGGCCCTGGCACTTCAGA S171P,S284P 
A174P, A287P GGCAATAGCGCCCTGCCGCTTCAGACCTAAAAG A174P, A287P 
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3.2 Media and Buffer 
The media and buffer, which were used in this study, are summarised in Table 3-9 and 
Table 3-10. All media were sterilised by autoclaving (121 °C, 2 bar, 20 min, Top7000PST, 
Sauter) and heat-sensitive additives were sterile filtered (pore width 0.2 µM). Antibiotics 
were added after media cooling below 50 °C. Depending on plasmid and bacterial strain 
the following antibiotics were used: ampicillin (100 µg/mL), chloramphenicol (34 µg/mL) 
and kanamycin (30 µg/mL).  
 
Table 3-9:  Media used for bacterial culture. 
Medium Composition 
Lysogeny Broth (LB) 1 % (w/v) tryptone, 0.7 % (w/v) NaCl, 0.5 % (w/v) yeast extract, 
adjusted to pH 7.5 with NaOH 
LB-Agar LB, 1.5 % (w/v) agar-agar 
Terrific Broth (TB) 1.2 % (w/v) tryptone, 2.4 % (w/v) yeast extract, 0.4 % (v/v) glycerol, 0.1 x TB salts 
TB salts 0.17 M KH2PO4, 0.72 M K2HPO4 
Minimal Medium (M9) 0.2 x M9 salts, 19 mM NH4Cl, 0.4 % (w/v) glucose, 1 mM MgSO4, 0.0002 x trace metal mix, 0.01 x MEM vitamin solution (SigmaAldrich) 
M9 salts 240 mM Na2HPO4, 110 mM KH2PO4, 1 % (w/v) NaCl 
Trace metal mix 50 mM FeCl3, 20 mM CaCl2, 10 mM MnSO4, 10 mM ZnSO4, 2 mM CoCl2, 2 mM CuCl2, 2 mM NiCl2, 2 mM Na2MoO4, 2 mM H3BO3 
Muchmore Medium 
(MMM9) 
(Muchmore et al., 1989) 
0.05 % (w/v) Ala, 0.04 % (w/v) Arg, 0.04 % (w/v) Asp,  
0.005 % (w/v) cystine, 0.04 % (w/v) Gln, 0.065 % (w/v) Glu,  
0.055 % (w/v) Gly, 0.01 % (w/v) His, 0.023 % (w/v) Ile,  
0.023 % (w/v) Leu, 0.042 % (w/v) Lys ⋅ HCl, 0.025 % (w/v) Met, 
0.013 % (w/v) Phe, 0.01 % (w/v) Pro, 0.21 % (w/v) Ser,  
0.023 % (w/v) Thr, 0.023 % (w/v) Val 
0.05 % (w/v) adenine, 0.065 % (w/v) guanosine,  
0.02 % (w/v) thymine, 0.05 % (w/v) uracil, 0.02 % (w/v) cytosine, 
18.3 mM NaAc, 0.15 % (w/v) succinic acid, 9.3 mM NH4Cl, 21.3 mM 
NaOH, 77 mM KH2PO4, 0.05 x supplementary solution, 
adjusted to pH 7.5 with NaOH 
Supplementary solution 
40 % (w/v) glucose, 80 mM MgSO4, 0.2 mM FeCl3, 0.27 mM CaCl2,  
0.14 mM ZnSO4, 0.24 mM MnSO4, 0.1 % (w/v) Trp, 3.3 mM thiamine, 
8.1 mM niacin, 80 µM biotin 
  
Table 3-10:  Solution and buffers used in this work. 
Solution/Buffer Composition 
AP buffer 100 mM Tris/HCl pH 9.5, 100 mM NaCl, 5 mM MgCl2 
Blocking solution TBST, 5 % (w/v) skimmed milk powder 
Coomassie staining solution 30 % (v/v) ethanol, 10 % (v/v) acetic acid, 0.25 % (w/v) Coomassie R-250 
Coomassie destaining solution 40 % (v/v) ethanol, 10 % (v/v) acetic acid 
Congo red stock solution 0.2 % (w/v) congo red, 1 % (w/v) NaCl, 80 % (v/v) ethanol, 0.001 % (w/v) NaOH 
6 x DNA loading buffer 10 mM Tris/HCl pH 7.4, 25 mM EDTA, 30 % (v/v) glycerol, 
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Solution/Buffer Composition 
0.4 % (w/v) OrangeG 
IB wash buffer A (EcCsgA) 50 mM Tris/HCl pH 8, 1.5 M NaCl,  1 % (w/v) N-Lauroylsarcosine 
IB wash buffer B (FgHET-s) 50 mM Tris/HCl pH 8, 1.5 M NaCl,  1 % (v/v) Triton X-100 
4 x Lower buffer  1.5 M Tris/HCl pH 8.8 
Lysis buffer I 50 mM Tris/HCl pH 8, 150 mM NaCl 
Lysis buffer II 
50 mM Tris/HCl pH 7.5, 150 mM NaCl, 5 % (v/v) glycerol, 
0.1 % (v/v) Triton X-100, 0.01 % (w/v) SDS,  
0.05 % (w/v) N-Lauroylsarcosine 
Native buffer A (EcCsgA) 50 mM KPi pH 7.2 
Native buffer B (FgHET-s) 50 mM Tris/HCl pH 8, 150 mM NaCl 
Ponceau S staining solution 2 % (w/v) Ponceau S, 30 % (w/v) TCA, 30% (w/v) 
sulfosalicylic acid 
Proteolysis buffer 125 mM Tris/HCl pH 7.5, 0.8 M urea 
Y x SDS sample buffer 0.1 M Tris/HCl pH 6.8, 2 % (w/v) SDS, 0.2 % (w/v) Bromphenol blue, 20 % (v/v) glycerol, 5 mM DTT 
SDS separating gel (15 %) 
7.5 mL Rotiphorese Gel 30 (Carl Roth), 3.8 mL 4 x lower 
buffer, 0.15 mL 10 % (w/v) SDS, 3.55 mL MilliQ, 
0.02 mL TEMED, 0.03 mL 25 % (w/v) APS 
SDS separating gel (12 %) 
6 mL Rotiphorese Gel 30 (Carl Roth), 3.8 mL 4 x lower 
buffer, 0.15 mL 10 % (w/v) SDS, 5 mL MilliQ, 
0.02 mL TEMED, 0.05 mL 25 % (w/v) APS 
SDS stacking gel (5 %) 
0.8 mL Rotiphorese Gel 30 (Carl Roth), 1.3 mL 4 x upper 
buffer, 3 mL MilliQ, 7.5 µL TEMED, 
12.5 µL 25 % (w/v) APS 
Solubilisation buffer A (EcCsgA) 100 mM KPi pH 7.2, 150 mM NaCl, 8 M GdnHCl 
Solubilisation buffer B (FgHET-s) 50 mM Tris/HCl pH 8, 500 mM NaCl, 6 M GdnHCl, 5 mM imidazole 
1 x TAE buffer 40 mM Tris, 20 mM sodium acetate, 1 mM EDTA, adjusted to pH 8.2 with acetic acid 
1 x TBST 20 mM Tris/HCl pH 8, 150 mM NaCl, 0.05 % (v/v) Tween-20 
Transfer buffer for Western Blotting 20 mM Tris pH 8, 192 mM glycine, 15 % (v/v) Methanol 
4 x Upper buffer 0.5 M Tris/HCl pH 6.8, 0.4 % (w/v) SDS 
Urea/SDS 8 M urea, 2 % (w/v) SDS 
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3.3 Microbiological and Molecular Biological Methods 
Molecular biology methods, which were applied in this study, were adapted from standard 
procedures (Ausubel et al., 2007; Coligan, 2003; Sambrook and Russell, 2000) and are not 
described in detail unless essential modifications were made. 
 
3.3.1 General Conditions of Bacterial Culture 
In order to cultivate bacteria for gene expression and plasmid amplification, cells were 
always freshly transformed with plasmid DNA by heat shock or electroporation. 
Subsequently, the transformed cells were incubated overnight on agar plates that contained 
an antibiotic, which corresponded to the used plasmid. For liquid cultures an appropriate 
volume of culture medium was inoculated with a single colony. These cultures were 
incubated in baffled flasks under shaking (120 – 180 rpm, depending on number of baffles 
and ventilation). All bacterial cultures were grown at 20 - 37 °C.  
Plasmids were extracted from DH5α and XL1-Blue cells. BL21(DE3), DL39, T7 Express 
and TUNER(DE3) cells were subjected to bacterial culture for recombinant gene 
expression. 
 
3.3.2 DNA Analytical Methods 
Agarose gel electrophoresis was performed to analyse and purify DNA samples after PCR, 
modification by restriction enzymes and mutagenesis. The gels were prepared from 0.8 or 
2 % (w/v) agarose in TAE buffer and supplemented with 5 ‰ (v/v) ethidium bromide. 
DNA samples were mixed with 6 x DNA loading buffer. The gels were run in TAE buffer 
with 5 V/cm for 60 min and documented under UV illumination at 254 nm. The yield and 
purity of isolated bacterial plasmid DNA, PCR products and modified DNA during cloning 
were checked spectrophotometrically by absorption at 260 and 280 nm. The DNA 
concentration was calculated from A260, assuming that A260 = 1 is equivalent to 50 µg/mL 
DNA. With a ratio of A260/A280 of 1.8 – 2 DNA was supposed to be pure. 
 
3.3.3 Molecular Cloning 
During this work certain protein variants were analysed and several cloning steps were 
necessary to establish the different constructs. The enzymes, bacterial strains, plasmids and 
oligonucleotides, which were employed to this purpose, are summarised in Table 3-1, 
Table 3-6, Table 3-7 and Table 3-8. If not stated otherwise, all reactions were carried out 
as described in the protocols of the manufacturers’ instructions. 
In general, genes of interest were amplified by PCR using the Platinum Pfx Polymerase 
and the amplificates were purified by agarose gel electrophoresis and adjacent agarose gel 
extraction. Afterwards the obtained polynucleotides as well as the recipient plasmids were 
digested with the corresponding restriction enzymes. Linearised plasmids were 
dephosphorylated by Shrimp Alkaline Phosphatase to avoid self-ligation. In order to 
remove the modifying enzymes and remaining nucleotides, the PCR amplificates and the 
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linearised plasmids were applied to the PCR purification kit. In preparation of ligation, 
plasmid- and target-DNA were mixed in a molar ratio of 1:5 and heated to 90 °C for 5 min. 
This mixture was cooled down and incubated with T4 DNA Ligase at 16 °C overnight and 
finally 2 µL of the reaction volume were utilised for transformation.  
In order to modify plasmid-DNA selectively, QuikChange Site-Directed Mutagenesis was 
performed using the Pfu Turbo Polymerase. 
All constructs were confirmed by sequencing in the department of Genome Analytics 
(HZI, Braunschweig) using a 3100-Avant genetic analyser (ABI Prism) or by the 
companies GATC (Konstanz) and MWG (Ebersberg). 
 
3.3.4 Generation of Plasmid Constructs to Obtain Fusion Proteins 
A schematic representation of gene constructs encoding CsgA fusion proteins is shown in 
Figure 3-1. 
Gene constructs that encode CsgA fusion proteins with additional edge strands (CsgA CM 
and CsgA CD) were cloned into the pRSET-A mT vector (Zahn et al., 1996) after 
removing the TatI recognition site in the plasmid backbone (pRSET.∆TatI). First csgA38-151 
was amplified using the primer pair csgA.N fwd, csgA.C rev and cloned into the given 
vector by BamHI and HindIII. A silent mutation was introduced via csgA.SacI generating a 
SacI recognition site. In order to fuse additional edge strands, the ss-oligonucleotide pairs 
of csgA.R1c and csgA.R5c were annealed by heating to 95 °C (1 °C/min, start 20 °C) and 
cloned into pRSET-A mT CsgA38-151 using BamHI, SacI and TatI and HindIII respectively. 
Thus, pRSET-A mT R5c-csgA38-151-R1c was generated, named pRSET-A CsgA CM.  
To generate a gene construct, which encodes CsgA CD, csgA38-151-R1c was again 
amplified using the primer pair csgA.R1R1c fwd, csgA.R1R1c rev and 
pRSET-A mT R5c-csgA38-151-R1c as template after removing the TatI recognition site by a 
silent mutation (csgA.∆TatI). The obtained PCR product was introduced in a 
pRSET-A CsgA CM vector with an intact TatI recognition site in the csgA gene using TatI 
and HindIII resulting in pRSET-A CsgA CD. Using XbaI and HindIII, the CsgA CM and 
CsgCD constructs were also cloned into the vectors pET-15b and pETRO (established and 
provided by T. Lührs/S.Loss; HZI, Braunschweig).  
The oligonucleotides of csgA.R1c and csgA.R5c were designed in that way that their 
sequence differs from the original DNA sequence but is still encoding for the same amino 
acids. This fact allowed specific modifications of R1c and R5c by QuikChange 
Mutagenesis. 
Gene constructs that encode barnase- and sumo-fusion proteins of CsgA were established 
using the pET-11d vector as follows: csgA38-151 was amplified using 
pRSET-A mT CsgA CM as template and the primer pair csgA.fus fwd, csgA.fus rev. The 
obtained PCR product was cloned into pET-11d via NcoI and BamHI. For N- and 
C-terminal fusion of barnase the corresponding gene was amplified based on pBar100 via 
bar .N fwd, bar .N rev and bar .C fwd, bar .C rev respectively and introduced into the 
obtained pET-11d derivative using NcoI, SacI and SapI, BamHI, respectively. Cloning of 
sumo constructs was done accordingly using 0912068_new_3Sumostar_for_Ch_pMA as 
template (Geneart construct, kindly provided by J. van den Heuvel, HZI, Braunschweig). 
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To generate fusion constructs, which include a duplicate of the five CsgA repeats, first a 
“dimer” had to be created. Therefore intermediates of establishing pRSET-A CsgA CD 
could be used. pRSET-A mT CsgA CM lacking TatI in csgA was used to amplify a csgA 
construct flanked by TatI and SapI, HindIII recognition site respectively (csgAd.fwd, 
csgAd.rev). The obtained product was cloned into pRSET-A mT R5c-csgA38-151-R1c by 
TatI and HindIII resulting in a duplicate of the five CsgA repeats, which was accordingly 
introduced into pET-11d bar-csgA-bar and pET-11d sumo-csgA-sumo by SacI and SapI. 
 
 
Figure 3-1: Cloning sites for gene constructs encoding CsgA fusion proteins. CsgA CM und CsgA CD 
present EcCsgA constructs with additional edge strands (R1c and R5c shown in light blue), Bar-(CsgA)n-Bar 
and Sumo-(CsgA)n-Sumo present CsgA constructs fused to barnase (green) or sumo (yellow). CsgA 
repeating units (R1 – R5) are shown in blue, DNA restrictions sites, protease cleavage sites and affinity tags 
are highlighted. The coding sequences are shown in 5´ → 3´ direction.  
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3.4 Protein Production and Purification 
3.4.1 Test Expression 
Small scale test expressions were performed to establish the recombinant expression of 
novel gene constructs. Thus, 20 mL liquid medium were inoculated with a single colony 
and cultures were grown to an OD600 of 0.6 – 0.8 at 37 °C. Optimal IPTG concentration, 
expression time and expression temperature were verified by varying these parameters. At 
several time points after induction samples were taken by V (µL) = 300/OD600. These 
samples were further analysed for soluble and insoluble expressions products using the 
Bug-Buster Kit followed by SDS PAGE. Previous to SDS PAGE, insoluble fractions 
were solubilised with 8 M urea or 98 % (v/v) formic acid. Formic acid was removed using 
a speed vac at 60 °C for 1 h and the pellets were dissolved in SDS sample buffer as 
described in chapter 3.5.4. 
 
3.4.2 Recombinant Protein Synthesis 
According to recombinant expression, bacteria were cultivated as described in chapter 
3.3.1. The main culture was always inoculated with an appropriate volume of a pre-culture, 
which was grown overnight at 37 °C, to reach a start OD600 of 0.1. This main culture was 
grown to exponential phase (OD600 0.6 – 0.8) at 37 °C and shifted to optimal expression 
temperature. Gene expression was induced by adding IPTG to a final concentration of 
0.25 – 1 mM. Cells were harvested after 2 – 8 h induction by centrifugation (6000 g, 
10 min, 4 °C) and stored at -20 °C until further processing. The expression conditions are 
summarised in Table 3-11. 
 
Table 3-11:   Expression conditions. 
Gene product Host  [IPTG]  Induction  temperature Induction time  
EcCsgA, CsgA CM, 
CsgA CD  T7 Express/DL39 1 mM 37 °C 2 h 
CsgA – barnase/sumo 
fusion proteins BL21 (DE3) 0.25 mM 20 °C 4 h 
FgHET-s218-289 
BL21 (DE3), 
TUNER(DE3) 1 mM 37 °C 8 h 
 
3.4.3 Production of Isotope Labelled Protein 
To obtain uniform isotope labelled protein, gene expression was carried out in 
M9 medium, which was enriched with an isotope labelled carbon and nitrogen source. Pre-
cultures were grown in LB (EcCsgA) or in M9 (FgHET-s) and transferred into the M9 
main culture. In case of EcCsgA, the pre-culture was harvested by centrifugation (6000 g, 
10 min, 4 °C) and re-suspended in M9 medium. 2 L main culture were incubated until 
reaching an OD600 of 1.0, spun down as described and transferred again in 0.5 L fresh M9 
enriched with 15NH4Cl as well as 13C-glucose for double labelling followed by induction 
with 1 mM IPTG (Marley et al., 2001). To gain isotope labelled FgHET-s the M9 pre-
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culture was directly used to inoculate the main culture of M9 supplemented with 15NH4Cl 
and 13C-glucose. Main culture was grown and induced as shown in chapter 3.4.2 avoiding 
centrifugation steps in between. 
Growing host bacteria on a defined medium, which is supplemented with appropriate 
isotope labelled amino acids, leads to protein labelling at specific residues (Muchmore et 
al., 1989). In order to obtain EcCsgA21-151 that is 15N and 13C labelled at positions of 
aspartatic acid, asparagine, glycine and phenylalanine an auxotrophic E. coli strain DL39 
was used as expression host (LeMaster and Richards, 1988). Pre- and main cultures were 
grown in MMM9, whereas the main culture was enriched with the corresponding labelled 
amino acids and the remaining amino acids in unlabelled form. 
 
3.4.4 Cell Lysis 
Cell pellets were thawed on ice and 1 g cells was suspended in 5 mL lysis buffer I 
supplemented with 1 mg lysozyme per 1 g cell pellet. After incubation for 1 h at 4 °C cells 
were disrupted by sonication for 10 min on ice (1 s pulse, 5 s delay, sonotrode TT13/F2, 
Bandelin/Sonopuls). The additional incubation in presence of 5 µg/mL DNase and 5 mM 
MgSO4 for 30 min at 4 °C ensured DNA degradation. In case of Bar-CsgA-Bar and 
Sumo-CsgA-Sumo fusion proteins, lysis occurred chemically without sonication. 
Therefore, 1 g of cells was suspended in 5 mL of lysis buffer II enriched with lysozyme 
and DNase/MgSO4 as described above. The cell suspension was incubated for 1 h at 4 °C.  
Finally soluble and insoluble components were separated by centrifugation (37000 g, 
45 min, 4 °C). Except for Bar-CsgA-Bar and Sumo-CsgA-Sumo fusion proteins all 
proteins were obtained in the insoluble fraction as inclusion bodies. 
 
3.4.5 Purification under Denaturing Conditions and Fibrillisation 
Since most of the proteins, which were analysed during this study, were obtained as 
inclusion bodies after expression and cell lysis, they were purified under denaturing 
conditions comprising different conditions summarised in Table 3-12 and illustrated 
below. The composition of the corresponding buffers is listed in Table 3-10. 
 
 
Table 3-12:   Purification under denaturing conditions. 
Protein IB purification  Solubilisation  IMAC Desalting 
EcCsgA21-151, 
EcCsgA40-151, 
EcCsgA21-151 XnC 
- 
8 M GdnHCl 
→ Sol. buffer A Ni-Sepharose Sephadex G25 
CsgA CM  N-Lauroylsarcosine 
→ IB wash buffer A  
8 M GdnHCl 
→ Sol. buffer A Ni-Sepharose Sephadex G25 
Bar-(CsgA)2-Bar 
Sumo-(CsgA)2-
Sumo, CsgA CD 
N-Lauroylsarcosine 
→ IB wash buffer A 
Formic acid, 8 M 
GdnHCl 
→ Formic acid and 
sol. buffer A 
Ni-Sepharose Sephadex G25 
EcCsgB21-151 - 
8 M GdnHCl 
 → Sol. buffer A Ni-Sepharose Sephadex G25 
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Protein IB purification  Solubilisation  IMAC Desalting 
FgHET-s218-289 
Triton X-100 
→ IB wash buffer B 
6 M GdnHCl 
→ Sol. buffer B Ni-NTA 
Lyophilisation and  
Sephadex G25 
 
Purification and Solubilisation of Inclusion Bodies 
Inclusion bodies (IB) of EcCsgA oligomeric variants and FgHET-s were purified and 
solubilised adapted from a protocol of Rudolph (Rudolph et al., 1997). At first, the IBs 
were suspended in the corresponding IB wash buffer, which contained Triton X-100 or 
N-Lauroylsarcosin as detergent. The IB suspension was incubated under mild agitation for 
1 h at 4 °C and following spun (37000 g, 30 min, 4° C). To remove further impurities, 
dissolving in lysis buffer and centrifugation were repeated twice. IBs were solubilised by 
re-suspending the pellet of the last centrifugation step in the appropriate solubilisation 
buffer and further incubation at 4 °C under gentle agitation. EcCsgA variants and 
EcCsgB21-151 had to be incubated for 48 h, FgHET-s for 2 h followed by sonication for 10 
min on ice (1 s pulse, 5 s delay, sonotrode TT13/F2, Bandelin/Sonopuls). CsgA CD fusion 
proteins had to be dissolved in 98 % (v/v) formic acid first. Next, the acid was diluted 1/10 
by adding solubilisation buffer and pH was adjusted to 7.2 with NaOH. This suspension 
was incubated for 48 h too. Insoluble material was removed by centrifugation (37000g, 
30 min, 4 °C) and solubilised proteins were purified further. 
 
Affinity Chromatography 
All proteins in this study carried a hexa histidine-tag and were applied to IMAC. The 
protein solutions were mixed either with equilibrated Ni-Sepharose or Ni-NTA matrix 
(Qiagen, 1 mL per 1 L bacterial culture) and incubated for 1 h at 4 °C to ensure binding to 
the matrix. Subsequently, the solid phase was packed into a column and immobilized 
proteins were washed threefold with 25 CVs per step (5, 10 and 20 mM imidazole in the 
corresponding solubilisation buffer). Finally proteins were eluted with 300 mM (3 x 5 CV) 
and 500 mM (5 CV) imidazole. Amount and purity of protein solutions were determined 
by SDS-PAGE (see chapters 3.5.3 and 3.5.4). Elution fractions of high yield and purity 
were combined. 
 
Buffer Exchange and Fibrillisation 
To allow fibril formation, the processed protein samples were transferred to native buffer 
lacking any denaturing agent and incubated accordingly. 
 
EcCsgA Variants: 
After IMAC the proteinaceous sample were desalted using Sephadex G-25 medium in a 
Nap-5 or PD-10 column or a self-packed column (GE Healthcare) as follows: 
The samples were spun down (20800 g, 10 min, RT), directly loaded on an equilibrated 
Nap-5 or PD-10 desalting column (GE Healthcare) and desalted as described in the 
manufactures protocol and summarised in Table 3-13. Proteins were eluted with native 
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buffer A and fibrillised in presence of 2.5 % (w/w) preformed EcCsgA21-151 fibrils or 
10 % (w/w) preformed EcCsgB21-151 fibrils serving as seed.  
 
Table 3-13: Buffer exchange using Nap5 and PD10 columns (GE Healthcare). 
Column 1st equilibration  sample volume 2nd equilibration elution 
Nap5 10 mL water,  10 mL buffer 500 µL - 2 x 400 µL 
PD-10 50 mL water,  50 mL buffer 0.5 – 1.5 mL ad 2.5 mL buffer 4 x 850 µL 
 
Furthermore a self-packed column (Sephadex G-25 medium, 10/40, column 
volume ~ 30 mL) was used on an ÄKTA-FPLC system to desalt samples. 2 – 3 mL were 
spun down (20800 g, 10 min, RT) and loaded on the equilibrated column. The proteins 
were eluted with 1.5 column volumes of native buffer A with a flow rate of 1.5 mL/min.  
In the case of cysteine variants, proteins were firstly reduced for 30 min in presence of 
20 mM DTT and afterwards processed as described above. The elution buffer contained 
5 mM DTT. 
Later experiments revealed that a filtration step of the solubilised and processed samples is 
necessary to obtain concentration dependent lag phases during fibril formation. Thus, 
proteinaceous samples were filtered before buffer exchange at room temperature by 
ultracentrifugation (4000 g, RT) using Vivaspin concentrators (MWCO 30000 - 50000). 
Finally, the permeate was processed further as described above. 
 
EcCsgB21-151 
Samples of EcCsgB21-151 were desalted as described above for the EcCsgA variants. To 
avoid the premature aggregation of EcCsgB21-151, 50 mM KPi pH 3 was used for the 
desalting procedure. After the elution, the pH was adjusted by adding NaOH and the 
samples were incubated for fibrillisation. 
 
FgHET-s218-289:  
From IMAC derived and combined elution fractions of FgHET-s218-289 were dialysed 
(SnakeSkin membrane, 3500 MWCO, Thermo Scientific) twice for 4 h and overnight at 
4 °C against 100fold volume of 0.1 % (v/v) acetic acid. Afterwards the protein solution 
was frozen in liquid nitrogen and lyophilised in order to concentrate the protein sample. 
The obtained dry powder was dissolved in 0.5 – 1.5 mL of 50 mM Tris/HCl pH 8, 
150 mM NaCl, 6 M GdnHCl. Buffer exchange to native buffer B was performed by 
desalting using Nap-5 columns as described above (Table 3-13). The eluted protein was 
incubated at room temperature under gentle shaking. 
 
Preparation of Seeds 
To ensure specific fibrillisation, protein samples of EcCsgA variants were supplemented 
with preformed fibrils as seeds. These fibrils were incubated up to four weeks (at least one 
week) at room temperature and prepared accordingly: Fibrils were sedimented (20800 g, 
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5 min, RT) and resuspended in native buffer A. The centrifugation and resuspension steps 
were repeated twice. Finally, the fibrils were sonicated for 10 min in an ultrasonic bath and 
added to freshly desalted protein samples.  
 
3.4.6 Purification under Native Conditions 
Bar-CsgA-Bar and Sumo-CsgA-Sumo were partly obtained in the soluble fraction after 
cell lysis and could be purified under native conditions. Thus, the soluble cell lysate was 
directly loaded onto Ni-Sepharose and processed as described above. Retained proteins 
were washed stepwise with 5, 10 and 20 mM imidazole in 50 mM Tris/HCl pH 7.5, 
150 mM NaCl, 5 % (v/v) glycerol and eluted with 300 mM and 500 mM imidazole. 
Elution fractions were analysed via SDS-PAGE and accordingly combined. The proteins 
were concentrated by ultracentrifugation (4000 g, 4 °C) using Vivaspin concentrators 
(MWCO 10000) up to 2 mg/mL. Finally, size exclusion chromatography was performed 
using a Superdex 16/60 prep grade column (GE Healthcare). 2 mL of a concentrated 
protein sample were loaded onto the equilibrated column and eluted with 50 mM Tris/HCl 
pH 7.5, 150 mM NaCl. Pooled samples were stored at 4 °C. 
 
 
3.5 Protein Analytical Methods 
3.5.1 Physico-Chemical Parameters of the Studied Proteins 
The physico-chemical parameters of the studied proteins are summed up in Table 3-14 and 
were calculated using the programs PROTPARAM (www.expasy.org). 
 
Table 3-14:  Physico chemical parameters of the studied proteins. 
Protein Position  H6 
Number of  
amino acids 
MW  
(kDa) pI ε280 (M
-1
 cm-1) 
EcCsgA21-151 C-term. 138 14.05 5.73 11460 
EcCsgA21-151 XnC C-term. 138 ~ 14 5.73 11460 
EcCsgA40-151 C-term. 119 12.38 5.59 9970 
CsgA CM N-term. 177 18.25 5.56 14440 
CsgA CD N-term. 290 29.77 4.88 24410 
Bar-CsgA-Bar C-term. 347 37.63 6.55 63830 
Bar-(CsgA)2-Bar C-term. 459 48.98 5.71 72310 
Sumo-CsgA-Sumo N-term. 334 36.54 4.88 12950 
Sumo-(CsgA)2-Sumo N-term. 446 47.89 4.75 21430 
EcCsgB22-151 C-term. 137 14.65 9.3 8940 
FgHET-s218-289 C-term. 79 9.04 8.26 6990 
X is any amino acid, n corresponding residue number. 
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3.5.2 Photometric Quantification of Protein Concentration 
According to Lambert Beer law, the concentration of purified protein solutions was 
determined by detecting the absorption at 280 nm A280 against buffer. The molar extinction 
coefficient ε280 (Table 3-14) for each protein was calculated in silico (chapter 3.5.1). 
Under denaturing conditions A280 was measured in spectroscopic pure guanidine 
hydrochloride. Under native conditions absorption was detected immediately after 
desalting avoiding fibrillisation. 
 
3.5.3 NaDOC/TCA Precipitation 
In preparation for SDS-polyacrylamide gel electrophoresis proteins from guanidine 
hydrochloride containing solutions had to be precipitated by sodium deoxycholate and 
trichloracetic acid (Arnold and Ulbrich-Hofmann, 1999; Bensadoun and Weinstein, 1976). 
Corresponding samples were diluted 1:10 in 0.1 % (w/v) NaDOC and mixed with TCA to 
a final concentration of 10 % (w/v). After incubation for 30 min at 4 °C the samples were 
spun down (20800 g, 30 min, 4 °C). The obtained pellets were washed twice by adding 
500 µL chilled acetone, which was removed after centrifugation (20800 g, 10 min) and the 
pellets were air-dried to remove retained acetone. Dried pellets were dissolved in 
20 µL SDS sample buffer and applied on a SDS gel. 
 
3.5.4 SDS-Polyacrylamide Gel Electrophoresis 
In order to analyse amount, purity and molecular weight of protein solutions, discontinuous 
SDS-polyacrylamide gel (SDS PAGE) electrophoresis was performed under denaturing 
and reducing conditions (Laemmli, 1970). Therefore, proteinaceous samples were mixed 
with an excess of SDS-sample buffer, boiled for 5 – 10 min at 95 °C and run on a suitable 
gel. The gels consisted of a 5 % (w/v) acrylamide stacking gel and a 12 or 15 % (w/v) 
acrylamide separating gel. Corresponding to the separating gel the PAGE was performed at 
40 mA per gel for 28 and 33 min respectively. Furthermore commercial 
NuPAGE Novex 4-12% Bis-Tris Midi Gels (Invitrogen, 1.0 mm x 26 well) were run as 
described in the manufacturers’ manual. If not stated, otherwise always 10 µL were loaded 
per lane. Finally, gels were stained with Coomassie R-250 and destained with 
corresponding solutions by boiling and shaking. 
 
 
3.5.5 Transfer of Proteins to Membranes (Western Blot) and Immunodetection 
For immunodetection or N-terminal sequencing experiments protein samples in 
SDS-polyacrylamid gels were immobilised on polyvinylidene difluoride (PVDF) 
membranes (Immobilon P, Millipore). First, the membrane was activated in 100 % 
methanol (~ 10 s) and washed with transfer buffer. Freshly run gels were equilibrated in 
transfer buffer as well (15 min). Following, the gel was placed onto the membrane, and 
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both placed between two layers of soaked Whatman paper onto the anode of a semi-dry 
blot apparatus. The transfer was carried out for 40 min at 15 V.  
After western blotting unspecific binding sites on the PVDF membrane were saturated for 
1 h in blocking solution and washed in TBST (5 min). Antibodies were diluted in 
TBST/0.5 % (v/v) blocking solution. The membrane was incubated with the primary 
antibody (Table 3-2 in chapter 3.1.1) overnight and after washing with TBST (3 x 5 min) 
additionally incubated for 2 h with the secondary antibody (Table 3-3 in chapter 3.1.1). 
Finally, the membrane was washed (TBST, 3 x 5 min) and immobilised proteins were 
detected by BCIP/NBT (Promega) or Enhanced Chemiluminescence (ECL, LumiLight, 
Roche). 
 
3.5.6 N-Terminal Sequencing 
Proteins, which were transferred to a membrane as described in chapter 3.5.5, were excised 
after visualising with Ponceau S staining solution and sequenced by automated Edman 
degradation (Edman and Begg, 1967). N-terminal sequencing was carried out by Rita 
Getzlaff or Beate Jaschok-Kentner (HZI, Braunschweig) using a 494A HT Protein 
Sequencer (Applied Biosystems). 
 
3.5.7 Mass Spectrometry 
MALDI-TOF-MS was used to verify the mass and intactness of recombinant produced 
proteins. Mass shifts were analysed to confirm site-directed amino acid exchange as well 
as the incorporation of thiol-active probes. The fibrils (approximately 25 - 50 µg) were 
dissolved in 98 % (v/v) FA, loaded onto a prespotted anchor chip (PAC) target with an 
α-cyano-4-hydroxycinnamic acid matrix and dried at RT. To avoid N-formylation the FA 
containing solutions were processed as fast as possible. The molecular masses were 
determined in the positive-ion mode on a Bruker Ultraflex time-of-flight mass 
spectrometer (Bruker Daltonics GmbH). All experiments were performed by Manfred 
Nimtz, Anja Meier and Undine Felgenträger (HZI, Braunschweig).  
 
 
3.6 Protein Structure Analysis 
3.6.1 Secondary Structure Analysis 
CD experiments and FT-IR spectroscopy experiments were performed to probe the 
secondary structure content of a protein. In CD experiments the differential absorption of 
left and right circular polarised light by chiral molecules is recorded. FT-IR is based on 
measuring molecular bond vibrational frequencies. Thus, both techniques provide 
information about the content of β-sheets, α-helices and loops of a protein structure. 
 
 
 
MATERIAL AND METHODS 
 
58  
Circular Dichroism 
In preparation of CD experiments, protein samples were first transferred to a CD suitable 
buffer (50 mM KPi pH 7.2 or water) by dialysis of soluble proteins or washing of specific 
aggregates. If not stated otherwise, protein concentration was adjusted to 1 mM peptide 
bonds and samples were applied to cuvettes with a path length of 1 mm (Hellma). Spectra 
were taken using a spectropolarimeter JASCO J-810 and accumulated (5 – 20 spectra). 
Measurements were performed in far UV (190 – 260 nm) range in stepwise scanning mode 
with a resolution of 0.2 – 0.5 nm at 4 °C (soluble proteins) or 20 °C (fibrils). 
 
Fourier Transform Infrared Spectroscopy 
FT-IR spectroscopy was carried out using a Bruker Tensor 27 system (Bruker Optics) 
equipped with a BioATR cell (ZnSe single crystal), a mid-IR source (4000 – 400 cm-1) and 
a KBr beamsplitter. The protein samples were applied as fine suspension with a protein 
concentration of 1 – 2 mg/mL. In preparation of the FT-IR experiments, fibrils were 
washed three times with water by repeating centrifugation (20800 g, 5 min, RT) and re-
suspension steps. Finally fibrils were re-suspended and sonicated for 10 min in an 
ultrasonic bath. Measurements were carried out in absorbance mode using following 
conditions: sample and background scan time was 200 scans, optical filter was open and 
aperture was set to 6 mm, detector setting was given by LN-MCT Photovoltaic and preamp 
gain A. 
 
3.6.2 Probing the Amyloid fold as Tertiary/Quaternary Structure  
The specific aggregation into the amyloid fold was confirmed by different imaging, 
staining and biochemical methods.  
Since specific aggregates of amyloid fibrils are obtained as long, unbranched fibrous 
structures, electron microscopy allows to differ between unspecific and specific 
aggregates.  
Most amyloids can be stained by the amyloid dyes CR and ThT. The binding of CR is 
detected as green birefringence under cross-polarised light. The interaction of ThT with 
amyloid fibrils results in an increased and robust ThT fluorescence at 485 nm. 
Furthermore, the use of limited proteolysis was used to identify stable folded protein 
domains. Thus, this technique was also used to probe amyloids stability. 
 
Electron Microscopy 
In order to analyse fibrils by electron microscopy, appropriate samples were deposited on a 
carbon-coated grid and stained negatively by a method adapted from Valentine et al., 1968.  
Appropriate samples were negatively stained with 4% (w/v) aqueous uranyl acetate using 
300 mesh nickel grids (Plano). To coat these grids, thin carbon support films, 
approximately 10 nm thick, were prepared. Carbon was sublimated from a carbon thread 
on to freshly cleaved mica (SCD500, Bal-Tec). Finally, the negatively stained samples 
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were examined in a Zeiss 910 transmission electron microscope (Zeiss) with an 
acceleration voltage of 80 kV and at calibrated magnifications. Images were recorded 
digitally with a Slow-Scan CCD-Camera (ProScan, 1024x1024) with ITEM-Software 
(Olympus Soft Imaging Solutions). All experiments were performed by Manfred Rohde 
and Heinrich Lühnsdorf (HZI, Braunschweig) 
 
Congo Red Labelling and Birefringence 
In order to stain specific amyloid aggregates with congo (Westermark et al., 1999), 20 µL 
of fibril suspension were air-dried on a glass slide and adjacent incubated with 10 µM 
congo red (CR stock solution diluted in water) until the dye was also dried. Excess of CR 
was washed away by rinsing with 70 % (v/v) ethanol. Typical birefringence was detected 
under cross polarised light using a microscope with two polarisation filters.  
 
Thioflavin-T Fluorescence Studies 
If not stated otherwise, fluorescence measurements were carried out under stirring using a 
Fluoro-Max4 spectrometer (Horiba Jobin Yvon) and corresponding fluorescence cells with 
a light path of 10 x 4 mm (Hellma). Steady-state and time-resolved Thioflavin-T 
fluorescence studies were carried out to detect protein structural changes (fibril formation) 
over time.  
For steady-state experiments protein solutions (2 – 50 µM) were mixed with a two-fold 
molar excess of ThT and incubated for 30 min to allow dye binding. Samples were excited 
at 442 nm (band width 5 nm) and emission was followed from 465 to 600 nm (band width 
5 nm). The ThT fluorescence was correlated to the intrinsic fluorescence of the protein 
(excitation 280 nm, emission 340 nm). 
In time-resolved ThT studies 200 µL of fresh desalted CsgA variants (2 – 16 µM) were 
applied to a 96 well plate (Corning, Flat Bottom, Non-Binding Surface, Non-Sterile, Black 
Polystyrene) and subsequently incubated in presence of 20 µM ThT. ThT fluorescence 
intensity was obtained at 485 nm after excitation at 442 nm every 10 min using a           
Tecan-Platereader. The measurements were performed at 25 °C. For both, excitation and 
emission, a band width of 5 nm was used and multiple readings were obtained per well 
(4 x 4, border 1000 µM). The homogeneity of the samples was ensured by shaking the 
plate before every measurement for 2 s (amplitude 2 mm). The gain (100 – 150) and the 
z-position (~ 20000 µm) were adjusted manually before starting the assay using preformed 
fibrils. 
 
Limited Proteolysis 
In order to compare the stability of different CsgA variants, the obtained aggregates were 
applied to limited proteolysis. First EcCsgA fibrils were washed twice by re-suspending in 
proteolysis buffer and centrifugation (20800 g, 5 min, RT). 35 µg fibrils were incubated at 
room temperature with proteinase K in different ratios (1:5 – 1:1000 (w/v)). Proteolytic 
digestion was stopped by adding the 4-fold volume of 98 % (v/v) FA and the acid was 
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removed using a speed vac at 60 °C for 1 h. Remained pellets were dissolved in 
20 µL urea/SDS solution and analysed via SDS-PAGE. 
 
3.6.3 Analysis of Side-Chain Solvent Accessibility and Inter- and Intramolecular 
Contacts 
 
Due to their natural properties, β-sheets are always characterised by a specific architecture. 
The side-chains of neighbouring amino acids in a β-strand face to opposite directions. 
Thus, amyloid fibrils are characterised by solvent accessible and not accessible side chains. 
Depending on the arrangement of the β-strands within the fibril, amyloid structures feature 
specific intra- and intermolecular contacts. As cysteine residues can be labelled with thiol-
reactive agents, they are sensitive probes for solvent accessibility and inter- and 
intramolecular contacts (Javitch et al., 2002). These thiol-reactive probes comprise for 
example sodium iodacetate (IAA), iodacetamide (IAM), and the fluorescence dyes 
AlexaFluor488 C5 maleimide (AF488) and N-(1-pyrene)maleimide (PM) summarised in 
Table 3-15 (Molecular Probes, Invitrogen; Hansen and Winther, 2009).  
 
Table 3-15:   Thiol-reactive agents and their properties. 
Agent Molecular mass (g mol-1) 
Absorption  
(nm) 
Emission  
(nm) Detection 
IAA 186 - - Mass spectrometry 
IAM 185 - - Mass spectrometry 
AF488 643 ~ 495 ~ 520 Mass spectrometry, Fluorescence spectroscopy 
PM 297 ~ 345 450 – 500 nm  (excimer) 
Mass spectrometry 
(labelling), Fluorescence 
spectroscopy (excimer) 
 
Since these agents bind covalently to the thiol groups, the labelling efficiency can be 
determined by mass or in case of fluorescence dyes by an increased fluorescence signal. 
Furthermore pyrene-labelling can lead to the formation of excimers that are detected by a 
strong red shift in fluorescence (Lehrer, 1997). This excimer formation only occurs when 
two cysteine bound pyrene molecules lie within 4 – 10 Å. Thus, inter- and intramolecular 
contacts can be analysed. 
 
Specific Thiol-Labelling 
In order to analyse the β-strand topology as well as inter- and intramolecular contacts 
within EcCsgA fibrils, IAA, IAM, AF488 and PM (Molecular Probes, Invitrogen) were 
applied to appropriate EcCsgA21-151 cysteine variants. To optimise the labelling strategy, 
several different labelling conditions (Table App-1) were checked. Two main strategies 
were followed: labelling of fibrils under native conditions (post assembly) and labelling of 
monomeric, unfolded protein under denaturing conditions (pre assembly).  
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One post assembly labelling strategy was identified as optimal and used solely: The 
appropriate cysteine variants were fibrillised as described (chapter 3.4.5). Prior desalting, 
proteins were supplemented with 10 % (w/w) solubilised EcCsgA21-151 wt to enable 
co-aggregation into the wt fold. To seed the fibrillisation, 2.5 % (w/w) prefomed wt fibrils 
were added. After two days incubation under mild agitation, the observed fibrils were 
subjected to labelling experiments adapted to former protocols (Krishnan and Lindquist, 
2005; Ritter et al., 2005). In preparation of labelling, the fibrils were washed twice with 
labelling buffer (50 mM Tris/HCl pH 8, 150 mM NaCl, 0.1 mM TCEP) by repetitive 
centrifugation (20800 g, 5 min, RT) and resuspension. 20 - 100 µM of two days old fibrils 
were incubated in presence of an appropriate thiol-reactive agent for 30 min (2.5 molar 
excess AF488) and 3 h (20x IAA, 20x IAM, 10x PM) respectively. The sample volume 
was around 250 - 500 µl. The labelling reaction was quenched by centrifugation (20800 g, 
5 min, RT) and three washing steps comprising repetitive re-suspension in 
50 mM KPi pH 7.2 and centrifugation (20800 g, 5 min, RT). In the first washing step the 
buffer was supplemented with 5 mM DTT. 
 
Detection of Specific Thiol-Labelling 
The chemical labelling of thiol groups was detected via mass spectrometry and 
fluorescence spectroscopy respectively. 
In case of mass spectrometry analysis, fibrils were harvested by centrifugation as described 
above and solubilised in 98 % (v/v) FA. After solubilisation the samples were processed as 
fast as possible to avoid N-formylation as described in chapter 3.5.7.  
To analyse the linkage to AF488 and excimer formation of PM, the fibrils were re-
suspended in 1 mL 50 mM KPi pH 7.2 and applied to a Fluoro-Max spectrometer (Horiba 
Jobin Yvon) in a fluorescence cell with a light path of 10 x 4 mm (Hellma). AF488 
fluorescence was detected at 516 nm (1 nm band width) after excitation at 493 nm (1 nm 
band width). The observed values were normalised to the intrinsic fluorescence (excitation 
280 nm, emission 340 nm). PM excimer fluorescence was analysed in a range of 360 to 
600 nm (2 nm band width) after excitation at 343 nm (3 nm band width). An emission 
maximum around 450 – 500 nm was characteristic for excimer fluorescence (Lehrer, 
1995). 
 
3.6.4 NMR spectroscopy 
General Measurement Conditions 
All NMR experiments were carried out at 25 °C using a Bruker Avance III 600 
spectrometer equipped with four radio-frequency channels and a 5 mm Z-axis gradient 
triple-resonance cryo-probehead. The offset that represses the water signal and the pulse 
length were optimised for every individual dataset.  
Amyloid fibrils were collected by centrifugation (20800 g, 4 min, RT) and solubilised in ~ 
500 µL aprotic DMSO (perdeuterated, d6-DMSO) containing up to 0.1 % (v/v) TFA 
(deuterated, d1-TFA), and the samples were placed in a 5 mm NMR tube (Norrel). For 1D- 
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and 2D-experiments ~ 20 mg wet pellet of fibrils was processed, for 3D-experiments up to 
35 mg were used.  
Under native conditions 50 mM KPi pH 6 was used as buffer and complemented with 
10 % (v/v) D2O prior measurements. The protein concentration was ~ 50 µM. 
All experiments and most important parameters are summed up in Table 3-16, sample 
preparation is shown in Table 3-17. The spectra were processed and analysed using the 
programs PROSA (Guntert et al., 1992) and CARA (Keller, 2004). 
 
Table 3-16:  NMR experiments carried out in this work and their parameters. SW: sweep width 
(spectral width), TD: time domain (number of obtained data points), NS: number of scans 
Experiment Obtained correlation SW (Hz) TD NS pulse programme 
1D-experiments 
1D-1H 1H 8417.5 2048 128 zgpr 
2D-experiments 
fHMQC 
(Luhrs et al., 2005; 
Ritter et al., 2005) 
1H(i), 15N(i) 4807.7 1338.3 
1024 
128 2 
fhmqc, time optimised 
HMQC (modified from 
Bax et al., 1983) 
ctHSQC 1H(i), 15N(i) 4807.7 1338.3 
2048 
192 2 
NHSQC-ct 
(Mori et al., 1995) 
3D-experiments 
NOESY-HSQC 
 
1H(i)         1H(j), 15N(j) 
7812.5 
1338.3 
7803.7 
4096 
128 
320 
8 noesy.ct-hsqc.G (Marion et al., 1989) 
HNH-NOESY 
 
1H(i)         1H(j), 15N(j) 
8417.5 
8403.4 
1338.3 
2048 
384 
72 
8 HNH_noesy (Marion et al., 1989) 
HNCA 
1HN(i), 15N(i), 13Cα(i), 
13Cα(i-1) 
8417.5 
1338.3 
4830.6 
4096 
62 
196 
16 
hncapwg3d 
(Grzesiek and Bax, 
1992) 
HN(CO)CA 1HN(i), 15N(i), 13Cα(i-1) 
8417.5 
1338.3 
4830.4 
4096 
62 
196 
16 
hncocapwg3d 
(Grzesiek and Bax, 
1992) 
HNCACB 
1HN(i), 15N(i), 13Cα(i), 
13Cα(i-1), 13Cβ(i), 
13Cβ(i-1) 
8417.5 
1338.3 
11312.2 
2048 
64 
192 
32 
hncacbgp3d 
(Wittekind and 
Mueller, 1993) 
 
Table 3-17: Sample preparation for NMR experiments.  
Protein Experiment wet pellet [TFA]  volume  
1D & 2D 20 – 25 mg 
EcCsgA 
3D 35 mg 
0.1 % (v/v) 520 µL 
1D & 2D  ~ 20 mg 
FgHET-s218-289 
3D 20 mg 
0.05 % (v/v) 500 µL 
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Sequence Specific Resonance Backbone Assignment 
13C,15N-labelled fibrils were subjected to triple-resonance-experiments HNCACB 
(Wittekind and Mueller, 1993), HNCA and HN(CO)CA (Bax and Ikura, 1991) as well as 
HNH nuclear Overhauser enhancement spectroscopy (Diercks et al., 1999) experiments to 
achieve the sequence-specific resonance assignment of the backbone HN/N cross-peaks. 
HNCACB, HNCA and HN(CO)CA enabled the correlation of backbone amide proton and 
nitrogen resonances with the corresponding alpha- and beta-carbon resonances. These 
experiments resolve the proton/nitrogen correlations in the same fashion as [15N,1H] 
correlation experiments and the third dimension of the spectra contains 13C-chemical shifts 
of carbon resonances summarised in Table 3-16 and Figure 3-2. 
 
 
Figure 3-2: Magnetisation transfer during the triple-resonance experiments HNCACB, HNCA and 
HN(CO)CA. The nuclei, whose frequencies are detected, are indicated in blue. The nuclei, which only 
transfer the magnetisation, are shown in red. The arrows indicate the magnetisation direction. 
 
Due to different magnetisation transfer pathways, HNCACB spectra display 13C-chemical 
shifts of the Cα and Cβ resonances of the same residue as the backbone amide and the 
preceding residue in one strip. HNCA spectra display Cα shifts of a given residue and the 
predecessor, while HN(CO)CA spectra exploit the Cα shift of the previous residue only. 
Cα- and Cβ-resonances are differentiated by their opposite sign. Resonances of the same 
residue as the backbone amide and the preceding residue are discriminated by their 
intensities. Based on this information, peaks are aligned establishing that the corresponding 
amide pairs are adjacent in the sequence. The Cα- and Cβ-chemical shifts were compared to 
the average of chemical shifts for each amino acid deposited in the BMRB 
(www.bmrb.wisc.edu). This allowed the assignment of the strips onto the protein sequence. 
The assignments were confirmed by HNH nuclear Overhauser enhancement spectroscopy 
experiments. Each strip (3rd dimension) of a NEOSY-HSQC spectrum contains NOEs from 
one backbone amide group to all protons close by. Due to solubilising the fibrils, proteins 
were unstructured and the obtained signals corresponded only to short and medium range 
NOEs enabling the alignment of adjacent backbone amides. 
 
H/D Exchange NMR Experiments 
15N labelled fibrils of EcCsgA and FgHET-s variants were used for H/D exchange studies 
of the backbone amides (Hoshino et al., 2002; Li and Woodward, 1999). 
MATERIAL AND METHODS 
 
64  
To start the exchange reaction, the fibrils were sedimented at 20800 g for 4 min, washed in 
corresponding native buffer comprising D2O as the solvent, sedimented again and re-
suspended in the same buffer for incubation up to 12 weeks at room temperature. Every 
sample contained around 20 – 25 mg wet pellet of fibrils. Hydrogen exchange was 
quenched at suitable intervals (15 min, 1 h, 1 d, ..., 20 w) by sedimenting the fibrils 
(20800 g, 4 min, RT) and freezing the pellet in liquid nitrogen.  
A series of up to 80 two-dimensional [15N,1H] correlation spectra were recorded directly 
after solubilising the fibrils in ~500 µL perdeuterated dimethyldisulphoxide (d6-DMSO) 
containing deuterated trifluoric acid (d1-TFA). The amount of residual D2O was about 4 % 
(wet pellet of fibrils). Residues that display a fast exchange in the fibrils and residues with 
high intrinsic exchange rates in DMSO result in absent peaks in the [15N,1H] correlation 
spectrum. To differentiate them, a second series of two-dimensional spectra were measured 
after addition of 4 % (v/v) H2O.  
Next, the peak volumes within a series of NMR spectra were integrated for each amino 
acid and extrapolated to tDMSO = 0 min. The extrapolated peak volume displayed the 
resonance intensities corresponding to the incubation time of fibrils in D2O (Equation 3-1). 
To determine the specific exchange rates these intensities were fitted monoexponential to 
the exchange time (Equation 3-1).  
 
 
 
Equation 3-1:  Exponential decay. It gives peak volume at certain time, I0 peak volume at t = 0, I∞ at t∞, kex 
exchange rate and t certain time. 
 
The data were analysed by using the programs PROSA (Guntert et al., 1992) and CARA 
(Keller, 2004), and a special written program in Visual basic in combination with 
Microsoft Excel (Luhrs et al., 2005). 
 
 
RESULTS 
 
65 
4 Results 
 
 
4.1 Choice of Experimental Strategy 
As outlined in the introduction (chapter 1.1) and in the aims and scope (chapter 2), the 
two functional amyloids FgHET-s218-289 and the major curli subunit EcCsgA were 
addressed for structural analysis.  
Since amyloids form filamentous structures that are inherently difficult to study, 
conventional methods for protein-structure analyses are usually not feasible. During this 
study two strategies (Figure 4-1) were followed to investigate the structure of amyloids 
and amyloid-like intermediates. Thus, fibrils of FgHET-s218-289 and EcCsgA variants, as 
well as probable soluble monomeric analogues of EcCsgA oligomers were addressed to 
study. 
 
 
Figure 4-1: Experimental strategy. 
 
The recent developments in biophysical methods facilitate closer insights into fibrillar 
structures. X-ray crystallography, as well as H/D exchange NMR and solid state NMR 
spectroscopy enable sequence specific structural information of amyloids (reviewed by 
Chiti and Dobson, 2006; Toyama and Weissman, 2011). As illustrated in chapter 1.4.2, 
X-ray crystallography is only suitable for the analysis of short peptide fragments forming 
amyloid-like crystals. But H/D exchange NMR and solid state NMR spectroscopy facilitate 
the structural investigation of wt full-length amyloid fibrils (chapter 1.4.4, 1.4.5 and 
citations therein).  
H/D exchange NMR spectroscopy was chosen as main technique in this study to analyse 
the fibril topology of FgHET-s218-289 and EcCsgA even though solid state NMR 
spectroscopy has the potential for the amyloid structure elucidation at atomic resolution. 
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To gain atomic insights into protein structures by solid state NMR spectroscopy, numerous 
experiments and distance measurements are necessary. Although with PaHET-s218-289 the 
first amyloid structure was recently solved by solid state NMR experiments (Wasmer et al., 
2008), for most proteins uniformly labelled experiments are often less helpful due to peak 
overlapping. The crowded spectra hinder precise assignments and distance measurements. 
H/D exchange NMR spectroscopy is a powerful tool to identify structured regions in 
amyloids at single residue resolution. Furthermore, the determination of H/D exchange 
rates provides information about the stability of amyloids as well as the homogeneity and 
regularity within the fibrils (Luhrs et al., 2005; Ritter et al., 2005; Vilar et al., 2008). Thus, 
H/D exchange NMR spectroscopy is highly suitable to compare homologous proteins and 
their variants. In combination with other techniques like fluorescence labelling studies, 
H/D exchange NMR provides valuable insights into the fibril topology and was chosen for 
the current questions about the fibril topology of FgHET-s218-289 and EcCsgA. 
In order to obtain soluble monomeric analogues of EcCsgA oligomers that are suitable to 
study their stable soluble structure, the aggregation tendency of the amyloidogenic EcCsgA 
was to be blocked. Due to their natural properties, β-sheets are always characterised by 
edge strands, which exhibit free hydrogen bond donors or acceptors. Thus, these 
aggregation-prone β-strands can always template the interaction with any other β-strands 
by hydrogen bonding. Natural soluble β-sheet proteins are protected by different features 
against these interactions. Due to the missing improvement of the β-sheet structure in 
general, this natural strategy is termed negative design. The strategy comprises a) covering 
edge strands with a loop of a helical or nonrepetitive structure, b) inward rolling of one 
sheet, c) the introduction of a local twist and a local outward protrusion by a β bulge and/or 
a proline and d) an inward pointing charged side chain (Richardson and Richardson, 2002; 
Cherny et al., 2005; Soto et al., 1998; Wang and Hecht, 2002). Since proline and charged 
residues are easily introduced by site-directed mutagenesis, the strategies of implementing 
a local twist by proline and inward pointing charged side chains were to be checked for 
EcCsgA. Furthermore, the N- and C-terminal fusion of small well folding proteins was 
chosen to cover EcCsgA edge strands against β-sheet interactions. Potentially, soluble and 
stable folded proteins are suitable for conventional structural analysis.  
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4.2 Structural Characterisation of the FgHET-s Prion Domain 
In order to explain the observed cross-seeding between two HET-s homologues, 
FgHET-s218-289 was subjected to H/D exchange NMR experiments to compare its structure 
with PaHET-s. This analysis was done as part of a structure-function study of the HET-s 
homologues in collaboration with the labs of Beat Meier (ETH Zürich) and Sven Saupe 
(Université de Bordeaux). Christian Wasmer (ETH Zürich) kindly provided the 
recombinant plasmid encoding FgHET-s218-289. 
 
 
4.2.1 Protein Production and Purification 
The HET-s prion forming domain of Fusarium graminearum FgHET-s218-289 was purified 
as C-terminal histidine-tagged protein after overexpression in E. coli BL21 (DE3) cells as 
described in chapter 3.4.5 and illustrated in Figure 4-2. 
 
 
Figure 4-2:  Purification and aggregation of FgHET-s218-289. (A) 15 % SDS-PAGE (Coomassie staining) 
of FgHET-s218-289 production, isolation by IMAC and desalting. (B) FgHET-s218-289 aggregates obtained after 
1 d incubation. 
 
At first, cultivation and cell harvest were followed by cell lysis and IB purification via 
several resuspension and centrifugation steps. After solubilisation the protein solution was 
subjected to Ni-NTA to perform IMAC under denaturing conditions. Protein containing 
fractions were pooled, dialysed against 1 % (v/v) acetic acid and afterwards lyophilised to 
concentrate the protein sample. The dry powder was re-suspended in 6 M GdnHCl and the 
protein solution was desalted using Sephadex G25. Desalting resulted in monomeric 
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FgHET-s218-289, which started immediately to aggregate similar to PaHET-s218-289 
(Balguerie et al., 2003; Ritter et al., 2005).  
Thus, FgHET-s218-289 was purified up to homogeneity and polymerised.  The aggregation 
was completed within a few hours. 
 
 
4.2.2 Recombinant FgHET-s218-289 Forms Amyloid Fibrils in Vitro 
Prior to the structural investigation, FgHET-s218-289 was demonstrated to fibrillise 
specifically. To ensure the analysis of amyloid fibrils, the observed aggregates were 
characterised by CD, CR binding, ThT fluorescence and EM as shown in Figure 4-3.  
Far-UV-CD spectra of soluble and insoluble material showed a typical shift of the 
ellipticity (Ranjbar and Gill, 2009). This shift from a minimum at 200 nm to a minimum at 
218 nm and a maximum below 200 nm indicated the conversion from the random coil 
conformation to a β-sheet rich fold similar to what has been shown for PaHET-s218-289 
(Balguerie et al., 2003).  
CR binding resulted in green birefringence under cross polarised light as expected for 
amyloids (Hawe et al., 2008).  
In contrast to PaHET-s218-289 (Sabate et al., 2007), ThT mixing experiments with 
FgHET-s218-289 aggregates at neutral pH resulted in a strong ThT fluorescence. ThT is 
suggested to bind to channels within the β-sheets of the amyloid fibrils. Since ThT is 
positively charged, basic residues hamper the ThT binding (Krebs et al., 2005). In the 
bundles of PaHET-s218-289 fibrils all channels feature at least one positively charged, basic 
residue that probably inhibits ThT binding (Wasmer et al., 2008). In comparison to 
PaHET-s218-289, FgHET-s218-289 features a different charge distribution as indicated above 
in the sequence alignment in Figure 1-6. In case of a similar fold, the channels within 
FgHET-s218-289 fibrils would possess less basic residues. This charge distribution probably 
enables an increased ThT binding.  
Finally, bundles of laterally associated fibrils were obtained by EM similar to 
PaHET-s218-289 (Balguerie et al., 2003).  
In summary, the biophysical characterisation of the observed aggregates verified specific 
amyloid fibril formation by FgHET-s218-289 in vitro. Thus, the aggregates were capable for 
specific H/D exchange NMR experiments. 
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Figure 4-3: Biophysical characterisation of FgHET-s218-289. (A) Far-UV-CD spectra of soluble 
FgHET-s218-289 in 50 mM Tris/HCl pH 8, 150 mM NaCl directly after desalting (black) and aggregates after 
3 d incubation (red). 20 spectra were accumulated using a cuvette with 1 mm path length. (B) Micrograph of 
FgHET-s218-289 fibrils in presence of 10 µM aqueous CR showing green birefringence under cross polarised 
light. (C) ThT fluorescence in presence of FgHET-s218-289 (red) compared to buffer (black, 50 mM Tris/HCl 
pH 8, 150 mM NaCl). 40 µM ThT were excited at λex = 442 nm in presence and absence of 20 µM protein. 
(D) Electron micrograph of FgHET-s218-289 aggregates.  
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4.2.3 Sequence-Specific Secondary Structure Analysis 
For the structural comparison of the two cross-seeding HET-s homologues, regularly 
structured segments in FgHET-s218-289 fibrils were specified. This analysis included the 
sequence-specific backbone-resonance assignment of FgHET-s218-289 and appropriate 
H/D exchange NMR experiments of specific FgHET-s218-289 fibrils. 
 
Sequence-Specific Backbone-Resonance Assignment  
In order to analyse the H/D exchange behaviour of each backbone amide, the sequence 
specific resonance assignments of the backbone amides were obtained by triple-resonance 
HNCACB experiments (Wittekind and Mueller, 1993) and HNH nuclear Overhauser 
enhancement spectroscopy (Diercks et al., 1999) using uniform 13C,15N labelled 
FgHET-s218-289. Based on corresponding 13C chemical shifts and NOE signals each 
backbone amide was assigned to one cross-peak with the exception of R252 (Figure 4-4). 
 
 
Figure 4-4: Backbone NH-assignments of FgHET-s218-289. Fast HMQC spectrum of uniformly 15N labelled 
FgHET-s218-289 (20 mg wet pellet of fibrils) in d6-DMSO containing 0.1 % (v/v) d1-TFA. Sequence-specific 
chemical shift assignments are indicated next to the resonance. 
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H/D Exchange NMR and Location of β-sheets 
Solvent-protected protons of secondary structural elements were identified by hydrogen 
exchange NMR experiments similar to former studies of amyloid fibrils (Luhrs et al., 
2005; Ritter et al., 2005). As described in chapter 3.6.4, 15N labelled FgHET-s218-289 fibrils 
were incubated in D2O buffer up to 12 weeks and H/D exchange was quenched at suitable 
time points (0 h, 1 h, 24 h, 72 h, 1 w, 2 w, 4 w, 12 w). Subsequently, series of two-
dimensional [15N,1H] correlation spectra were recorded by performing fast HMQC 
experiments. In general, the [15N,1H] fHMQC experiments resulted in spectra with broad, 
intense peaks after a short acquisition time (~ 2.5 min), which favours a high time 
resolution and kinetic analyses as outlined in chapter 1.4.4. Due to less overlap of the 
cross-peaks in the [15N,1H] fHMQC spectra of labelled FgHET-s218-289, the broad peaks 
were unambiguously evaluated. Thus, the observed spectra enabled an accurate analysis of 
the backbone resonances as illustrated below. 
The hydrogen exchange of FgHET-s218-289 resulted in NMR spectra with different 
resonance intensities depending on the incubation time in D2O buffer. After 4 weeks, the 
intensity of about 40 % of the resonances had disappeared. This suggested that the 
corresponding amides have undergone exchange with solvent deuterons, which are not 
visible in the [15N,1H] NMR spectrum (Figure 4-5). 
 
 
Figure 4-5: H/D exchange of FgHET-s218-189. Fast HMQC spectra of uniformly 15N labelled FgHET-s218-289 
(~20 mg wet pellet of fibrils) in d6-DMSO containing 0.05 % (v/v) d1-TFA corresponding to fully protonated 
(start) and partially hydrogen exchanged (1 h, 24 h, 4 w) FgHET-s218-189 fibrils. 
 
Subsequently to the addition of H2O, a second series of [15N,1H] NMR spectra revealed 
that there are no artefacts of disappearing resonances due to ultra fast H/D exchange in 
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DMSO. Fast intrinsic exchange in DMSO was still detectable due to the high time 
resolution of the series of fHMQC experiments (Figure 4-6 A).  
 
 
Figure 4-6: Determination of exchange rates. (A) Intrinsic H/D exchange in DMSO of E223 and S227 
backbone amides indicated by the changes of peak volumes after monomerising FgHET-s218-289 fibrils in 
DMSO/TFA and final addition of H2O respectively. Red curves show the monoexponential fits of the raw 
data. (B) Monoexponential fit of peak volumes at tDMSO = 0 min to tex for selected backbone amides. (C) Fast 
HMQC spectra of  uniformly 15N labelled FgHET-s218-289 (~20 mg wet pellet of fibrils) in d6-DMSO 
containing 0.05 % (v/v) d1-TFA corresponding to fully protonated (0h) and partially hydrogen 
exchanged (1 d) FgHET-s218-189 fibrils indicated strong overlap in the shown region. 
 
Thus, the absent resonances related to backbone amides, which were rapidly substituted by 
deuterons during incubation of the fibrils in D2O buffer and not by remained traces of D2O 
while recording the NMR spectra. Hence, the peak volumes at tDMSO = 0 min were 
determined for all assigned resonances and used to calculate accurate exchange rates 
(Figure 4-6 B). Due to strong overlap with resonances, which corresponded to protected 
backbone amides, residue V254 was excluded from further analysis (Figure 4-6 C). 
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The resulting exchange rates are shown in Figure 4-7. All residues revealed a monophasic 
exchange behaviour indicating a well defined and homogeneous structure of the fibrils. 
The backbone amides of the five amino-terminal residues, the seven carboxy-terminal 
residues and residues 246-258 exchanged quickly (≥ 1.5 h-1). They are only weak or not 
protected against the solvent. Therefore, these residues seem to be conformationally 
disordered. Four segments were identified displaying slow exchange rates in the range of 
10-2 h-1 to 10-5 h-1 similar to PaHET-s218-289 (Ritter et al., 2005) and Aβ1-42 fibrils (Luhrs et 
al., 2005). These slow exchange rates demonstrate the extraordinary stability and 
compactness of the studied fibrils. Comprised residues E223-E234, A237-F245, 
R259-T270 and S273-G282 are protected and thus considered to be involved in hydrogen 
bonds. Since circular dichroism spectra of the FgHET-s218-289 fibrils confirmed a β-sheet 
rich fold, the four protected segments were identified to form β-strands. The corresponding 
residues are located in the same regions as described for PaHET-s218-289 (Ritter et al., 2005; 
Wasmer et al., 2008). In contrast to PaHET-s218-289, FgHET-s218-289 features six more 
protected backbones comprising E223-H225 and R259-K261. 
 
 
Figure 4-7: H/D exchange data for FgHET-s218-289 compared to PaHET-s218-289 and secondary 
structure prediction for FgHET-s218-289. Red bars show the exchange rates of FgHET-s218-289 kex (h-1) and 
blue arrows indicate β-strands. Grey bars indicate rates of PaHET-s218-289 (Ritter et al., 2005). The shown 
amino acid sequence corresponds to that of FgHET-s218-289. Residues marked with an asterisk were excluded 
from the analysis due to missing assignment and overlap respectively.  
 
The residues G235 and S236 as well as N271 and Q272 exchanged fast – indicating 
β-turns, which connect the segments 1-2 and 3-4 respectively. The 2nd, 3rd and 4th segments 
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were characterised by outstanding residues: N243, R265 and N279, which displayed a fast 
exchange rate in a protected region representing a structural disturbance such as a β-arc. 
E229, N243, R265 and N279 are located at positions, which were identified as less defined 
in PaHET-s218-289 due to forming β-arcs (Wasmer et al., 2008). In contrast to N243, R365 
and N279, E229, positioned at a β-arc too, was highly protected against H/D exchange 
within FgHET-s218-289 fibrils. The expected partner R265 revealed fast H/D exchange 
indicating different hydrogen bonding patterns in the β-arcs at these positions. A similar 
H/D exchange behaviour was observed in PaHET-s218-289 at β-arc positions N243 and 
N279. N279 was fully protected, while N243 revealed relative fast H/D exchange (Ritter et 
al., 2005).  
Similar to the residues of the β-turns and β-arcs, protected amide backbones of segment 
1 and 3 as well as 2 and 4 are separated by 36 residues supporting a repetitive structural 
pattern. 
Despite little differences, the H/D exchange NMR analysis of FgHET-s218-289 revealed a 
structural pattern that is highly similar to that of its homologues PaHET-s218-289. The 
comparison with complementary data of PaHET-s218-289 enabled already further insights 
into the topology of FgHET-s218-289 fibrils as discussed in chapter 5.1. 
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4.3 Structural Characterisation of EcCsgA Fibrils 
4.3.1 Starting Point of EcCsgA Structure Elucidation 
At the beginning of this study an initial H/D exchange analysis of mature EcCsgA 
(residues 21-151) revealed overcrowded low resolution fHMQC spectra (Alexander 
Eberth, unpublished). The strong overlap of numerous cross-peaks hampered the initial 
peak picking and the sequence specific backbone assignment. Moreover, the strong 
overlapping effect inhibited the precise determination of the resonance intensities after 
numerous incubation times in D2O. Thus, the exchange rates were masked and this fact 
disabled an accurate H/D exchange analysis. For that reason a strategy was developed to 
improve the spectra and the resonance assignment of EcCsgA comprising an optimised sample 
preparation to avoid heterogeneity, the application of another NMR experiment, new EcCsgA 
constructs and selective labelling. Based on the developed concept, H/D exchange experiments 
were successfully performed and analysed. Furthermore the topology analysis comprised 
fluorescence labelling studies to elucidate solvent accessible side chains, as well as intra- and 
intermolecular contacts.  
 
 
4.3.2 Sequence Analysis and Design of New EcCsgA Constructs 
In order to obtain CsgA variants that are suitable for an enhanced structural analysis via 
H/D exchange NMR spectroscopy and fluorescence labelling studies, appropriate gene 
constructs were designed.  
As shown in Figure 4-8, the mature form of EcCsgA consists of a glycine-rich, flexible 
N-terminal region and five repeating units with the consensus sequence 
Sx5QxGxGNxAx3Qx1-5, x is any amino acid (Collinson et al., 1999; Hammar et al., 1996). 
The repetitive sequence and especially the glycine/asparagine patches led to a strong 
overlap in NMR spectra and were found to be a drawback in the resonance assignment and 
the H/D exchange NMR analysis. As the repeating units are supposed to form the amyloid 
core (Collinson et al., 1999), at first a truncated EcCsgA variant EcCsgA40-151 was 
designed. The corresponding gene csgA40-151 was cloned into a pET-11d vector using NcoI 
and BamHI restriction sites.  
In order to elucidate the topology of EcCsgA, cysteine variants of EcCsgA21-151 were 
analysed with thiol-reactive fluorescence dyes (Javitch et al., 2002; Lehrer, 1997). 
Cysteine residues were introduced by site directed mutagenesis and the corresponding 
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oligonucleotides are summarised in Table 3-8. The substitution of intramolecularly 
conserved residues was avoided with the exception of S88C, which constitutes a 
conservative replacement. Even- and odd-numbered residues where chosen for 
mutagenesis and labelling studies in order to identify solvent accessible side chains 
suitable for the investigation of intra- and intermolecular contacts. The corresponding gene 
constructs are listed in Table 3-7.  
 
 
Figure 4-8: Intramolecular alignment of EcCsgA21-151. Comparison of the primary structure of the 
mature N-terminus and the five repeating units. (A) Intramolecularly conserved residues are shown in green, 
homologous residues in yellow. The consensus sequence indicates intramolecularly conserved residues in red 
and residues conserved only among the repeating units in blue. The analysis was done with the program 
MultAlin (Corpet, 1988). (B) Charged residues are highlighted in red or blue, polar uncharged residues are 
shown in green, glycines in grey and unpolar residues are not coloured. Arrows indicate hypothetical 
hydrophobic ladders.  
 
 
4.3.3 Protein Production and Purification 
In contrast to former studies (Wang et al., 2007), EcCsgA variants were purified as 
C-terminal histidine tagged proteins from inclusion bodies after overexpression in 
E. coli T7 Express cells as described in chapter 3.4.5 and summarised in Figure 4-9. After 
cultivation and cell harvest, cells were lysed under native conditions and the insoluble 
material was solubilised subsequently. The solubilisation was followed by IMAC under 
denaturing conditions using Ni-Sepharose. Eluted proteins were combined and finally 
desalted using Sephadex G25. To ensure complete buffer exchange conductivity was 
monitored. Only protein fractions devoid of denaturant were pooled and fibrillised.  
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Figure 4-9: Purification of EcCsgA variants. (A) 4-12 % NuPAGE (Coomassie staining) of production 
and isolation of EcCsgA21-151 and EcCsgA40-151 by IMAC and desalting. (B) Elution profile of desalting 
EcCsgA40-151 via Sephadex G25 (10/40). Elution occurred via 50 mM KPi pH 7.2 with a flow rate of 1.5 
mL/min. The enframed fraction was further characterised. 
 
Thus, EcCsgA variants were purified to homogeneity from bacteria grown in LB as well as 
minimal medium with a yield of 5 - 10 mg per L culture. Aggregation after buffer 
exchange was completed within a few hours and the aggregates were stable against 
0.1 % (w/v) SDS overnight.  
 
 
4.3.4 EcCsgA21-151 and EcCsgA40-151 Have Similar Biophysical Properties 
Both variants EcCsgA21-151 and EcCsgA40-151 readily formed aggregates. FT-IR and 
CD spectroscopy, as well as ThT binding and EM were used to characterise the amyloid 
properties of the variants shown in Figure 4-10.  
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Figure 4-10:  Biophysical characterisation of EcCsgA21-151 and EcCsgA40-151. (A) FT-IR spectra showing 
the amide I band of aggregates (1 mg/mL) formed by EcCsgA21-151 (black) and EcCsgA40-151 (red) after 
4 days incubation. Aggregates were washed with water and applied to a BioATR cell. (B) Far-UV-CD 
spectra of aggregates in ddH2O formed by EcCsgA21-151 (black) and EcCsgA40-151 (red) after 4 days 
incubation. 20 spectra were accumulated using a cuvette with 1 mm path length. (C) Increase in ThT 
fluorescence depending on time and protein concentration. 25 µM ThT were mixed with freshly desalted 
EcCsgA using 2 µM (black), 4 µM (red), 8 µM (green), 12 µM (blue) and 16 µM (grey) protein 
concentration. Fluorescence was measured every 10 min at 485 nm after excitation at 442 nm. (D) Electron 
micrographs of EcCsgA aggregates.  
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FT-IR and CD were used to estimate the secondary structure content of the aggregates. 
Both variants displayed a characteristic signal around 1622 cm-1 in the FT-IR spectra, 
which is characteristic for the β-sheet arrangement in amyloid fibrils (Zandomeneghi et al., 
2004). CD spectra showed a minimum around 218 nm and maximum around 195 nm, 
typical for proteins with a high β-sheet content (Ranjbar and Gill, 2009) corresponding to 
the observations reported for EcCsgA21-151 (Chapman et al., 2002; Shewmaker et al., 2009; 
Wang et al., 2007). Mixing each variant with ThT resulted in a strong ThT fluorescence. 
ThT was also used to monitor the transition of freshly desalted EcCsgA variants from 
monomeric proteins into specific amyloid aggregates (LeVine, 1999). For both variants the 
evolution of the ThT fluorescence showed a distinct lag phase, growth and stationary phase 
in a protein concentration dependent manner. The observation of concentration dependent 
lag times was fully consistent with former studies on EcCsgA (Wang et al., 2007) and 
other amyloidogenic proteins (Lomakin et al., 1997). Electron microscopy revealed 
regular, unbranched fibrils characteristic for amyloid fibrils as curli (Chapman et al., 2002; 
Shewmaker et al., 2009; Wang et al., 2007).  
In summary, the biophysical analysis confirmed specific aggregation of EcCsgA 21-151 and 
EcCsgA40-151 into highly similar amyloid fibrils allowing comparative H/D exchange NMR 
experiments. 
 
 
4.3.5 Strategies to Improve NMR Spectra and the Assignment 
Well resolved and intense NMR spectra are indispensable for a complete resonance 
backbone assignment and a significant H/D exchange NMR analysis. A first analysis of 
EcCsgA21-151 failed due to insufficient resolved NMR spectra. In order to improve the 
NMR spectra and the assignment of EcCsgA, another type of [15N, 1H] correlation 
experiments and new EcCsgA constructs, as well as selective labelling were employed. 
 
ctHSQC Experiments Resulted in Spectra With High Resolution 
[15N, 1H] NMR spectra that display well resolved peaks are essential for accurate 
H/D exchange NMR analysis. As fHMQC experiments of EcCsgA21-151 resulted in spectra 
with high intensity but insufficient resolved peaks, ctHSQC experiments were employed to 
EcCsgA variants. These experiments differ in the evolution of magnetisation as well as the 
evolution period. In ctHSQC a constant 15N evolution period is used instead of the 
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conventional variable evolution period. In the case of EcCsgA21-151, ctHSQC experiments 
resulted in [15N,1H] correlation spectra with high intensity, well separated peaks and less 
peak broadening as shown in Figure 4-11. This enhancement enabled accurate peak 
picking and the precise determination of resonance intensities for separated peaks. 
 
 
Figure 4-11:  fHMQC and ctHSQC spectra of EcCsgA21-151 in comparison. fHMQC and ctHSQC 
spectrum of 20 mg wet pellet of uniformly 15N labelled CsgA21-151 fibrils in d6-DMSO containing 
0.1 % (v/v) d1-TFA.  
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Improved Spectra of New EcCsgA Variants  
In addition to enhanced 2D NMR experiments, new EcCsgA variants and selective labelled 
samples (Figure 4-12) were utilised to promote the EcCsgA assignment. 
 
 
Figure 4-12: ctHSQC spectra of different EcCsgA variants. All spectra were taken from 20 – 25 mg wet 
pellet of appropriate labelled fibrils, which were solubilised in d6-DMSO containing 0.1 % (v/v) d1-TFA. 
(A) EcCsgA21-151. (B) EcCsgA41-151. (C) EcCsgA21-151 S55C. The red circle corresponds to the original 
position of the cross-peak of S55. (D) EcCsgA21-151 specific labelled at positions of Asn, Asp, Gly and Phe. 
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The repetitive sequence and especially the glycine/asparagine patches led to a strong 
overlap in NMR spectra and were found to be a drawback in the resonance assignment and 
the H/D exchange NMR analysis (Alexander Eberth, unpublished). As the repeating units 
are supposed to form the amyloid core (Collinson et al., 1999), the truncated EcCsgA 
variant EcCsgA40-151 was subjected to NMR experiments. The corresponding spectra 
demonstrated less overlap of the cross-peaks due to lacking the resonances of the N22 tag 
illustrated in Figure 4-12 A/B.  
Furthermore, cysteine variants of EcCsgA21-151 were employed. In comparison to 
EcCsgA wt, the peaks of the substituted amino acid and adjacent residues were dislocated 
(Figure 4-12 C). Owing to the dislocation of the peaks, corresponding assignments were 
confirmed. 
Selective labelling studies are common to support sequence specific assignments. In order 
to assign the glycine/asparagine patches, an EcCsgA21-151 sample, which was specifically 
labelled at the positions of glycine, asparagine, aspartatic acid and phenylalanine, was 
produced and analysed in NMR experiments. The resulting spectra displayed solely the 
resonances of the labelled residues shown in Figure 4-12 D.  
 
 
4.3.6 Sequence-Specific Analysis of Secondary Structure Elements 
In order to elucidate the fold of the amyloid fibrils formed by EcCsgA and to study the 
effect of the nucleator protein EcCsgB to this fold, sequence-specific positions of regular 
secondary structure elements in fibrils of EcCsgA21-151 and EcCsgA40-151 as well as 
heteronucleated EcCsgA40-151 fibrils were analysed. These analyses were done analogously 
to the precedent study of FgHET-s218-289 (chapter 4.2.3). In addition to HNCACB and 
NOESY experiments, the sequence-specific backbone-resonance assignment of EcCsgA 
depended on numerous NMR experiments comprising different variants and different 
labelling strategies. In contrast to the H/D exchange NMR analysis of FgHET-s218-289, 
[15N,1H] correlation spectra of EcCsgA variants were recorded by performing ctHSQC 
experiments instead of fHMQC experiments. As described above, ctHSQC experiments 
resulted in intense and well resolved peaks after ~ 5 min acquisition time enabling an 
accurate analysis of single spectra (chapter 4.3.5). Compared to the short acquisition time 
of fHMQC experiments (~ 2.5 min), the acquisition time of ctHSQC experiments is less 
favourable in respect of an appropriate time resolution. Despite the lower time resolution, 
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series of ctHSQC spectra still enabled the correction of the resonance intensities for 
exchange in DMSO and thus reasonable H/D exchange NMR analysis as shown below. 
 
Sequence-Specific Backbone-Resonance Assignment 
Sequence specific resonance assignments of the backbone amides of EcCsgA were finally 
obtained by a combination of NMR experiments recorded on different EcCsgA variants 
employing selective labelling strategies summarised in Table 4-1. 
 
Table 4-1: NMR experiments used for EcCsgA sequence specific backbone resonance assignment.  
EcCsgA variant Labelling 2D experiments 3D experiments 
EcCsgA21-151 uniform fHMQC, ctHSQC HNCACB, HNCA, HNCOCA, HNH NOESY 
EcCsgA21-151 Asp, Asn, Gly, Phe fHMQC, ctHSQC HNCACB 
EcCsgA21-151 XnC uniform ctHSQC - 
EcCsgA40-151 uniform ctHSQC HNCACB, NOESY-HSQC 
X is any amino acid, n corresponding residue number. 
 
Finally 88 % of the backbone amides of EcCsgA21-151 and 95 % of EcCsgA40-151 were 
assigned to the sequence illustrated in Figure 4-13. In addition to the first assignments 
made from EcCsgA21-151 (Alexander Eberth, unpublished), further 17 cross-peaks were 
mapped sequence specifically. The previous assignments of 13 cross-peaks to backbone 
amides were verified. Three repetitive units of the amyloid core were completely assigned. 
Thus, the backbone-resonance assignment of EcCsgA was improved enabling entire H/D 
exchange NMR analysis and an unambiguous evaluation of the repeating units within the 
amyloid core. 
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Figure 4-13: Backbone NH-assignments of EcCsgA. (A) ctHSQC spectrum of uniformly 15N labelled 
CsgA40-151 (20 mg wet pellet of fibrils) in d6-DMSO containing 0.1 % (v/v) d1-TFA. Sequence-specific 
chemical shift assignments are indicated next to the corresponding resonance. (B) Improvement of the 
backbone assignments compared to first assignments. Confirmed assignments are mapped in yellow to the 
sequence, corrected assignments in orange and novel assignments in green.  
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H/D Exchange NMR Analysis of EcCsgA40-151 Fibrils 
Since the amyloid core of EcCsgA comprises the five repeating units (Collinson et al., 
1999) and [15N,1H] correlation spectra of EcCsgA40-151 showed less overlap with 
resonances of the highly flexible N22 tag, the truncated EcCsgA variant EcCsgA40-151 was 
initially chosen for H/D exchange NMR analysis. 15N labelled fibrils were incubated in 
D2O buffer up to 20 weeks (0 h, 15 min, 1 h, 24 h, 72 h, 1 w, 4 w, 20 w) and after four 
weeks incubation, 45 % of the assigned resonances were reduced (Figure 4-14). 
 
Figure 4-14:  H/D exchange of EcCsgA40-151. ctHSQC spectra of uniformly 15N labelled EcCsgA40-151 
(~20 mg wet pellet of fibrils) in d6-DMSO containing 0.1 % (v/v) d1-TFA. The spectra correspond to fully 
protonated (start) and partially hydrogen exchanged (1 d, 4 w) EcCsgA40-151 fibrils. 
 
Due to fast intrinsic H/D exchange in DMSO (Figure 4-15 B), A79 and A124 were 
excluded from further analysis. All other absent resonances were evaluated and the 
corresponding exchange rates were calculated. Nearly all residues displayed a 
monoexponential decay suggesting a well defined and homogeneous structure of the fibrils 
(Figure 4-15 A). Biphasic behaviour with a first fast exchanging and a second slow 
exchanging population was observed for the backbone amides of D67 and L68 (Figure 
4-15 C), which are located in the second repeat, as well as A125 in the fourth and S134, 
G141 and A146 in the fifth repeat. The corresponding resonances are well separated and 
do not overlap with resonances that correspond to fast exchanging backbone amides 
illustrated for D67 and L68 in Figure 4-15 D. Furthermore, a heterogeneous behaviour of 
the intramolecular conserved asparagines N54, N77, N99, N122 and N144 cannot be 
excluded (Figure 4-15 C). The resonances of the backbone amides N54, N77, N122 and 
N144 displayed a strong overlapping. For that reason, they were analysed as one unit. 
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Moreover, this unit overlapped with the resonance of the backbone amide F97, which 
displayed fast exchange with the solvent. The resonance of N77 was separated from the 
other named peaks, but also overlapped with the resonance of a rapidly exchanging 
backbone amide, F142. Potentially, the exchange rates of the asparagines were masked by 
the resonance overlapping shown in Figure 4-15 D.  
 
Figure 4-15: Determination of exchange rates of EcCsgA40-151. (A) Monoexponential fit of peak volumes 
at tDMSO = 0 min to tex corresponding to selected backbone amides. (B) Intrinsic H/D exchange in DMSO of 
L59 and A124 backbone amides. The evolution of peak volumes after monomerising the EcCsgA40-151 fibrils 
in DMSO/TFA and final addition of H2O is shown. Red curves show the monoexponential fits of the raw 
data. (C) Biphasic exchange behaviour of selected backbone amides. The sum of two monoexponential 
equations is shown. (D) ctHSQC spectrum of uniformly 15N labelled EcCsgA40-151 (~20 mg wet pellet of 
fibrils) in d6-DMSO containing 0.1 % (v/v) d1-TFA. The section shows the backbone amides of the 
intramolecularly conserved asparagines, as well as D67 and L68 that display biphasic behaviour in H/D 
exchange. 
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The resulting exchange rates are shown in Figure 4-16. In case of biphasic behaviour, 
nearly all appropriate residues featured a major slow and a minor fast exchanging 
population (Figure App-6-1). The H/D exchange NMR analysis identified two segments 
per repeat that displayed slow exchange rates of 10-5 h -1 to 10-1 h-1. Similar exchange rates 
have been found for the amyloid core of PaHET-s218-289 (Ritter et al., 2005) and Aβ1-42 
fibrils (Luhrs et al., 2005) indicating the high stability and compactness of the fibrils. 
These segments, which comprise the backbone amides of the residues S43-Y50, S55-T61, 
D67-H73, G78-G84, S89-R95, S100-W106, E112-F118, G123-Q128, S134-V140 and 
N145-Y151, were assumed to be involved in hydrogen bonds that protect the 
corresponding backbone amides against hydrogen exchange. As the biophysical 
characterisation of EcCsgA40-151 (chapter 4.3.4) confirmed a β-sheet rich amyloid 
structure, the protected segments were assigned to β-strands that consist of seven to eight 
residues. The conserved serines (S43, S66, S88, S111 and S133) exhibited different 
exchange behaviour and the conserved asparagines (N54, N77, N88, N122 and N144) 
seemed to be masked. Thus, their β-strand incorporation remains elusive. In contrast to the 
protected backbones, the backbone amides of N42, G51, D62-S66, G74, S85-S88, 
G96-G98, N107-N110, G119-G121, T129-S133 and G141-G143 exchanged 
rapidly (k ≥ 1.5 h-1). Since these backbone amides are only weak or not protected against 
H/D exchange with the solvent, they seem to be conformationally disordered. In 
consequence, the corresponding residues were identified to form turn and loop regions that 
connect the distinct β-strands. 
Thus, the H/D exchange analysis of EcCsgA40-151 identified every repeating unit to form 
two β-strands that are connected by a short β-turn. The β-strands of adjacent repeats are 
connected by flexible loops comprising four to five residues. The protected segments 
1, 3, 5, 7, 9 and 2, 4, 6, 8, 10 in each case are separated by 22-23 residues indicating a 
repetitive structural pattern. 
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Figure 4-16:  H/D exchange NMR data of EcCsgA40-151 and secondary structure prediction. Red and 
grey bars indicate exchange rates of EcCsgA40-151 kex (h-1). Grey bars indicate exchange rates of the fast first 
phase in case of biphasic behaviour. Patterned bars present the exchange rates of the intramolecularly 
conserved asparagines. Residues marked with a rectangle were analysed as one unit. Residues marked with 
an asterisk were excluded from the analysis due to fast intrinsic exchange in DMSO (A79, A124) and 
missing assignments. Blue arrows indicate β-strands. The β-strand incorporation of the intramolecularly 
conserved serines and asparagines remained unclear shown in light-blue. 
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H/D Exchange NMR Analysis of EcCsgA21-151 Fibrils 
Since in vivo mature EcCsgA comprises the residues 21 to 151, wt EcCsgA21-151 fibrils 
were subjected to H/D exchange analysis. The mature full-length protein was probed in the 
same context to validate the results of the H/D exchange NMR experiments of 
EcCsgA40-151 fibrils. Do the fibrils feature the same structural pattern and same 
homogeneity? 15N labelled EcCsgA21-151 fibrils were processed in the same manner as 
EcCsgA40-151 and H/D exchange was followed up to one week (0 h, 1 h, 1 d and 1 w) 
illustrated in Figure 4-17. 
 
 
Figure 4-17:  H/D exchange of EcCsgA21-151. ctHSQC spectra of uniformly 15N labelled EcCsgA21-151 
(~20 mg wet pellet of fibrils) in d6-DMSO containing 0.1 % (v/v) d1-TFA. The spectra correspond to fully 
protonated (start) and partially hydrogen exchanged (1 d, 1 w) EcCsgA21-151 fibrils. 
 
In addition to A79 and A124, the resonances of N46 and A58 were excluded from further 
analysis due to fast H/D exchange in DMSO. Thus, H/D exchange rates were determined 
for all assigned residues except N46, A58, A79 and A124. Most of the backbone amides 
featured a monophasic H/D exchange reaction similar to EcCsgA40-151. In comparison to 
the truncated variant, D67, L68, A125 and the asparagines N54, N77, N122 and N144 
demonstrated the same biphasic reaction as in EcCsgA40-151 fibrils. In contrast to the 
analysis of EcCsgA40-151, N99, S134, G141 and A146 revealed less biphasic H/D exchange 
reaction shown for N99 and A146 in Figure 4-18 A. Furthermore, biphasic behaviour was 
observed for the resonances of the backbone amides I70, T71 and G78 that are located in 
the second repeat, I90 in the third repeat, as well as M113, T114, G123 and D127, which 
are located in the fourth repeat (Figure 4-18 B). The corresponding resonances are mostly 
well separated. The resonances of I90, G78 and G123 demonstrated overlap with other 
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resonances illustrated in Figure 4-18 C/D. I90 overlapped with resonances of slow 
exchanging backbone amides, and G78 and G123 overlapped with each other. Since the 
spectra of EcCsgA21-151 featured resonances of the glycine rich N22 tag, overlap with a non 
assigned flexible glycine cannot be excluded. G78, G123 and D127 are amino acids, which 
have been assigned to “gatekeeper” residues before (Wang et al., 2010). Nearly all 
biphasic exchanging residues revealed a major slow and a minor fast exchanging 
population (Figure App-6-1). 
 
 
Figure 4-18: Determination of exchange rates of EcCsgA21-151. (A) Monoexponential fit of peak volumes 
at tDMSO = 0 min to tex corresponding to selected backbone amides. (B) Biphasic exchange behaviour of 
selected backbone amides. The sum of two monoexponential equations is shown. (C) and (D) ctHSQC 
spectra of uniformly 15N labelled EcCsgA21-151 (~20 mg wet pellet of fibrils) in d6-DMSO containing 
0.1 % (v/v) d1-TFA. The respective section shows the backbone amides of I90, G78, G123 and overlapping 
resonances. 
 
Figure 4-19 presents the observed exchange rates for EcCsgA21-151 fibrils in comparison to 
the exchange rates of EcCsgA40-151. The slow exchange rates of EcCsgA21-151 were masked 
due to the short H/D exchange period (≤ 1 w). In most cases, the short exchange period 
prohibited the examination of exchange rates k ≤ 10-2 h-1. Therefore, the exchange rates are 
in a range of 10-2 h-1 to 10 h-1. Supplementary, Figure App-6-2 illustrates the results for 
EcCsgA21-151 solely.  
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Figure 4-19: H/D exchange NMR data of EcCsgA21-151 and secondary structure prediction. Red bars 
indicate exchange rates of EcCsgA21-151 kex (h-1), grey bars indicate exchange rates of EcCsgA40-151 kex (h-1). 
Patterned bars present the exchange rates of the intramolecularly conserved asparagines. Residues marked 
with a rectangle were analysed as one unit. Residues marked with an asterisk were excluded from the 
analysis due to fast intrinsic exchange in DMSO (N46, A58, A79, and A124) and missing assignments. Blue 
arrows indicate β-strands. The β-strand incorporation of the intramolecularly conserved asparagines remained 
unclear shown in light-blue. 
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The H/D exchange analysis of EcCsgA21-151 fibrils revealed ten segments that displayed 
slow exchange rates. Similar to EcCsgA40-151 fibrils, the backbone amides of E44-Y50, 
S55-T61, D67-H73, G78-G84, S88-R95, N99-W105, S111-F118, G123-Q128, S134-V140 
and N145-Y151 were protected against H/D exchange and thus assigned to β-strands. The 
assigned backbone amides of the N22 tag, S43, G51, D62-S66, G74, S85-S87, G96-G98, 
W106-N110, G119-G121, A130-S133 and G141-G143 exchanged rapidly. Thus, they are 
highly flexible.  
In contrast to the H/D exchange analysis of EcCsgA40-151, all intramolecular conserved 
serines rapidly exchanged and were thus excluded from the β-strands. The β-strand 
incorporation of the intramolecular conserved asparagines N54, N77, N99, N122 and N144 
remained still elusive due to the strong overlapping (Figure 4-15 D). However, the 
backbone-resonance of N99 disappeared in a less biphasic manner as before and the slow 
monoexponential exchange rate indicated the affiliation to the corresponding β-strand. In 
consideration of the repetitive structural pattern and the presumed formation of a stacking 
asparagine ladder, the corresponding asparagines should behave uniformly. In that case, 
the biphasic intensity decrease was induced by overlap with a fast exchanging residue and 
not by different exchange behaviour of the asparagines. Thus, a β-strand conformation of 
all appropriate asparagines is conceivable.  
The backbone amides of the intramolecular conserved alanines A101 and A146 exhibited a 
fast exchange in a protected region indicating a structural disturbance at these positions. 
EcCsgA40-151 revealed also less protection or biphasic H/D exchange behaviour at these 
positions. Unfortunately, exchange data are not available for A79 and A124 due to fast 
exchange in DMSO. Even A56 is protected against H/D exchange, a structural disturbance 
like a kink or a β-arc at the positions of the conserved alanines is feasible. The precedent 
H/D exchange analysis of FgHET-s218-289 fibrils also did not reveal fast exchange at all 
β-arc positions (chapter 4.2.3, Figure 4-7). 
In summary, the H/D exchange analysis of EcCsgA21-151 fibrils identified a repetitive 
structural pattern with a two β-strands per repeating unit congruent to the results of 
EcCsgA40-151. In comparison to EcCsgA40-151, the analysis revealed a biphasic exchange 
behaviour at similar positions in most instances. However, the exchange behaviour was 
defined and supported a specific fibrillar structure of both variants. Thus, the analysis is 
fully congruent to the analysis of EcCsgA40-151 fibrils. Furthermore, the exchange data 
indicated that the N22 tag is highly flexible. Hence, the exchange pattern confirms the 
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domain character of mature EcCsgA (21-151), which consists of a flexible protease-
susceptible and a well structured protease-resistant domain (Collinson et al., 1999). 
 
H/D Exchange Analysis of Heteronucleated Fibrils 
In vivo the fibrillisation of CsgA is nucleator dependent. CsgB is indispensible for the 
assembly of monomeric CsgA into appropriate amyloid fibrils (Hammar et al., 1996; 
Hammer et al., 2007).  
In order to investigate the effect of the heteronucleation to the EcCsgA structure and to 
investigate a detailed molecular model of the nucleator dependent assembly, 15N labelled 
EcCsgA40-151 was seeded by 10 % (w/w) unlabelled EcCsgB fibrils and the newly formed 
EcCsgA40-151 fibrils were analysed by H/D exchange NMR. The H/D exchange reaction 
was quenched after 15 min, 1 h, 1 d, 1 w and 4 w. After incubation in D2O buffer for four 
weeks, already 60 % of the assigned resonances of EcCsgA40-151 were significantly reduced 
or absent illustrated in Figure 4-20.  
 
 
Figure 4-20: H/D exchange of EcCsgA40-151 after seeding with EcCsgB. ctHSQC spectra of uniformly 15N 
labelled EcCsgA40-151 (~25 mg wet pellet of fibrils) after seeding with 10 % (v/v) EcCsgB in d6-DMSO 
containing 0.1 % (v/v) d1-TFA. The spectra correspond to fully protonated (start) and partially hydrogen 
exchanged (1 d, 4 w) EcCsgA40-151 fibrils. 
 
In contrast to the precedent analysis of EcCsgA40-151 and EcCsgA21-151, remarkable 30 % of 
the residues revealed an H/D exchange in a biphasic manner indicating heterogeneity. The 
relative exchange behaviour as well as the relative population of EcCsgA40-151 fibrils after 
seeding with 10 % (w/w) EcCsgB fibrils is shown in Figure 4-21. The detailed exchange 
rates are shown in the Appendix in Figure App-6-3.  
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Figure 4-21:  Relative exchange behaviour and population of EcCsgA40-151 after seeding with EcCsgB 
fibrils. Fast exchange is shown in grey, slow exchange in blue. Residues marked with an asterisk were 
excluded from the analysis due to fast exchange in DMSO (A79, A124) and missing assignments. 
 
The backbone amides of the N-terminal residues, as well as the first and fifth repeat 
displayed a homogeneous protection pattern, which is congruent to the analysis of 
EcCsgA40-151 and EcCsgA21-151. Both, first and fifth repeat revealed two protected 
segments per repeat. But in contrast to homonucleated EcCsgA40-151 fibrils, most slow 
exchange rates are in a range of 10-3 h-1 to 10 h-1 indicating less stability. The exchange 
rates of the central repeats (repeat 2, 3 and 4) exhibited a less regular protection pattern. 
Nearly 50 % of the assigned residues in this segment showed biphasic H/D exchange 
behaviour with a fast and a slow exchanging population. Less of these backbone amides 
revealed a major population, which exchanged slowly. In most instances, the major 
population rapidly exchanged. The exchange behaviour of backbone amides, which 
RESULTS 
 
95  
displayed an almost exclusively monoexponential exchange, was congruent to former 
analysis of EcCsgA40-151 and EcCsgA21-151 except, G98, N107, N110 and A130. These 
residues displayed an unexpected slow exchange within weak protected segments. Since 
half of the backbone amides in the central repeats exchanged in a biphasic manner without 
any regularity and even monophasic amides revealed an unexpected exchange rate, the 
structure of the central repeats is very heterogeneous and less regular.  
Recapitulatory, the H/D exchange analysis of EcCsgA40-151 fibrils, which were nucleated 
by 10 % (v/v) EcCsgB fibrils, revealed a homogeneous exchange behaviour for the first 
and fifth repeat and a heterogeneous and less regular structure of the three central repeats. 
Thus, there are distinct differences in comparison to EcCsgA fibrils, which were nucleated 
by preformed EcCsgA21-151 fibrils.  
 
 
4.3.7 Characterisation of the β-Sheet Architecture 
Owing to their natural properties, β-sheets always feature a specific architecture. Every 
amyloid core exhibits solvent accessible and non accessible side-chains. The arrangement 
of the β-strands enables characteristic inter- and intramolecular contacts. In order to 
analyse the topology of β-strands as well as these inter- and intramolecular contacts within 
EcCsgA21-151 fibrils, cysteine variants of EcCsgA21-151 were subjected to thiol-reactive 
probes.  
 
Initial Labelling Experiments 
In labelling experiments appropriate cysteine variants (Table 3-7) were incubated in 
presence of the thiol-reactive probes iodaceteic acid (IAA), iodacetamide (IAM), 
N-(1-pyrene)maleimide (PM) and AlexaFluor488 C5 maleimide (AF488) under numerous 
conditions as described in chapter 3.6.3. Thus, the fibrillisation- and labelling conditions 
of EcCsgA21-151 cysteine variants were optimised. Finally, the variants were co-aggregated 
with 10 % (w/w) wt EcCsgA21-151 and seeded with preformed EcCsgA21-151 fibrils. 
Reducing fibrillisation and labelling conditions emerged as indispensable (Figure 4-22). 
The double variant EcCsgA21-151 E44C/N46C, which was expected to feature two solvent 
accessible cysteines close to each other, was chosen for initial PM-labelling studies. 
PM-labelling can lead to the formation of excimers, which are detected by a strong red 
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shift in fluorescence (Lehrer, 1997). This typical red shift was only observed after 
fibrillisation and labelling under reductive conditions (Figure 4-22). 
  
 
Figure 4-22: Pyrene excimer formation of EcCsgA21-151 E44C/N46C fibrils depending on reductive 
fibrillisation conditions. Approximately 15 µM fibrils after PM labelling were applied to fluorescence 
spectroscopy. Covalent bound pyrene was excited at λex = 342 nm. Protein samples were fibrillised in 
presence and absence of 5 mM TCEP (A) and 5 mM DTT (B).  
 
The reductive conditions avoided disulphide formation and facilitated free accessible thiol 
groups that bound PM. The proximity of the cysteines enabled pyrene excimer formation 
and thus led to a characteristic red shift fluorescence at ~ 455 nm (Lehrer, 1997). In 
preparation of further labelling experiments, cysteine variants were always fibrillised in the 
presence of 5 mM DTT according to the conditions mentioned in chapter 3.6.3. 
After the labelling reaction proteins were applied to mass-spectrometry to confirm the 
specific binding of the thiol-reactive probes. Since the thiol-labelling is covalent, the 
reaction results in a mass shift. Figure 4-23 shows mass spectra of EcCsgA21-151 V23C 
after labelling reactions with IAM, PM and AF488. The residue 23 is located in the 
flexible N terminus and is thus expected to be solvent accessible. Considering N-
formylation (∆m = 28 Da per N-formylation) and a probably missing start methionine 
(∆m = 149.2 Da), an appropriate mass shift was only detected after labelling with PM 
(∆m = 297 Da) and AF488 (∆m = 643 Da). Owing to the missing mass shift, IAM was not 
binding at all neither to fibrillar nor unfolded EcCsgA21-151 cysteine variants. A similar 
behaviour was observed for IAA (data not shown). Thus, IAM and IAA were excluded 
from further analysis.  
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Figure 4-23: MALDI spectra after thiol-labelling of EcCsgA21-151 V23C. Approximately 50 µg 
EcCsgA21-151 V23C were applied to mass analysis after thiol-labelling. Owing to thiol-labelling, protein 
samples were incubated in presence of IAM under native conditions (A) and denaturing conditions (B), PM 
(C) and AF488 (D) under native conditions. Mass of EcCsgA21-151 V23C prior labelling is shown in grey, 
mass of probably labelled protein is shown in blue. Calculated masses are 14049.8 Da for unlabelled protein, 
14234.8 Da for covalent IAM labelling, 14347.1 Da for covalent PM labelling and 14692.8 Da for covalent 
AF488 labelling. The observed masses were masked due to N-formylation and a probably absent start 
methionine. 
 
Side-Chain Solvent Accessibility 
In order to characterise the β-strand topology of EcCsgA fibrils and to identify suitable 
cysteine variants for the analysis of intra- and intermolecular contacts within EcCsgA 
fibrils, appropriate fibrils of EcCsgA21-151 cysteine variants were applied to thiol-labelling 
with N-(1-pyrene)maleimide PM. Fibrils were processed and analysed by mass 
spectrometry as described in chapter 3.6.3. 
Considering N-formylation and a probably missing start methionine, MALDI spectra 
revealed an appropriate mass shift for numerous variants (Figure App-6-4) indicating a 
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specific labelling and thus side-chain solvent accessibility. Illustrated in Figure 4-24, 14 of 
the 17 cysteine variants, which carried a single cysteine residue in the amyloid core region, 
were labelled with PM.  
 
 
Figure 4-24: Solvent accessibility of EcCsgA21-151 single cysteine variants. The relative labelling 
efficiency is shown for appropriate variants. Solvent accessible side-chains are highlighted in green, not 
accessible residues in red. Blue arrows indicate β-strands, which were localised by H/D exchange NMR in 
this study. 
 
The high cross-linking rates of E44C, N46C, L57C, L59C, D80C, S89C, A125C, S134C, 
N136C, T147C and H149C, as well as the low rates of V81C, V135C and A148C are fully 
congruent to the repetitive structural pattern of EcCsgA indicated by H/D exchange 
analysis and the domain character of the protein. The side-chain solvent accessibility of the 
analysed residues is fully congruent to the presumption that amyloids feature solvent 
accessible and non accessible side-chains in a defined manner. Furthermore, the results 
indicated that all β-sheets feature one solvent accessible side. Considering this fact, the 
β-strand topology and the repetitive character of EcCsgA, L45C and V81C behaved 
contrariwise. The corresponding cysteine residues were accessible. Due to the natural 
topology of β-strands it is not possible that three adjacent side-chains feature the same 
orientation. Thus, the accessibility can only be explained by structural differences of the 
cysteine variants. The neighbouring serine residues S88 and S89 were both identified as 
solvent accessible. In conformity with the H/D exchange analyses, S88 is part of a loop 
region leading into the β-strand, which incorporates S89. Considering the geometry of 
turns and loops, both residues can feature solvent accessibility.  
In addition to PM-labelling, side-chain solvent accessibility was also probed by AF488 
labelling for selected cysteine variants. The EcCsgA21-151 variants V23C, E44C, N46C and 
N136C were labelled with AF488 and processed as described in chapter 3.6.3. Congruent 
to the PM labelling, MALDI spectra demonstrated the expected mass shift owing to 
covalent thiol modification illustrated in Figure 4-25.  
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Figure 4-25: MALDI spectra after thiol-labelling of EcCsgA21-151 cysteine variants. Approximately 
50 µg of EcCsgA21-151 cysteine variants were subjected to mass analysis after thiol-labelling.                                
(A) MALDI spectra after PM labelling. (B) MALDI spectra after AF488 labelling. (C) Chemical structures of 
PM and AF488. 
 
V23C, which carries the cysteine residue in the highly flexible N-terminal tail, was 
completely labelled with PM and AF488. In contrast to PM labelling, after AF488 labelling 
unlabelled protein was detected for the variants E44C, N46C and N136C indicating an 
incomplete reaction. These variants bore the cysteine residues in the amyloid domain. 
Despite solvent accessibility, these residues might be even less accessible for thiol-reactive 
probes depending on the size of the chemical compound and the arrangement of the 
protofilaments within the fibril. Since AF488 and PM differ in their size, a different 
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labelling efficiency is conceivable. Furthermore, this fact indicates the high compactness 
of the amyloid fibrils of EcCsgA. 
 
 
4.4 Stable Oligomers – Initial Experiments on Analogues of 
CsgA Oligomers 
 
Since oligomeric intermediates of the fibrillisation pathway are believed to be the toxic 
agent in case of disease related amyloid formation, their structure-function relationship is 
of high interest. In order to obtain soluble analogues of EcCsgA oligomers, three general 
ideas were followed up. The principle was the negative design of natural soluble β-sheet 
proteins to avoid edge-to-edge aggregation (Richardson and Richardson, 2002). Due to the 
natural occurring edge strands, which exhibit free hydrogen bond donors or acceptors, 
β-sheets are always aggregation prone. Natural soluble β-sheet proteins are protected by 
different features against the interaction with any other β-strands.  
The following natural strategies were chosen to inhibit CsgA aggregation: 
 a) Introduction of the β-breaker proline.  
 b) Introduction of an inward pointing charged side chain by lysine.  
c) Covering the edge strands with a loop of a helical or nonrepetitive structure by 
fusing the well folded small proteins barnase and sumo.  
 
 
4.4.1 Design and Expression of CsgA Fusion Constructs 
All constructs in that approach were made from the repetitive core of EcCsgA lacking the 
N22 tag. Following the concept of the negative design by introducing proline or lysine into 
predicted edge strands, additional repeating units were fused. These additional strands 
should act as proper edge strand, thus named caps, and were modified accordingly. 
Therefore and to create duplicates of the core, R5 was extended to the same length of the 
other repeating units. R5 was prolonged by the addition of amino acids that correspond to 
the loop regions of the other repeats. As further fusion partners, an inactive variant of 
barnase from Bacillus amyloliquefaciens (Schmoldt et al., 2005) and sumostar were used. 
All corresponding gene constructs were generated as described in chapter 3.3.4. Encoded 
proteins are shown in Figure 4-26 A. 
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Figure 4-26:  Design of CsgA fusion proteins. (A) CsgA CM und CsgA CD present CsgA constructs with 
additional edge strands (R1c and R5c shown in light blue), Bar-(CsgA)n-Bar and Sumo-(CsgA)n-Sumo 
present CsgA constructs fused to barnase (green) or sumo (yellow). CsgA repeating units (R1 – R5) are 
shown in blue, protease cleavage sites, linker peptides and affinity tags are highlighted. (B) Residues chosen 
for proline/asparagine substitution. Residues substituted by proline or lysine were highlighted in orange, red 
indicates residues, substituted by lysines and yellow indicates residues, substituted by proline. 
 
CsgA CM (capped monomer) and CsgA CD (capped dimer) were further modified via site 
directed mutagenesis. In each case, one to two prolines or lysines were introduced in 
R5 cap, named R5c, and R1 cap, named R1c, of the same protein construct. As the 
positions of inward or outward pointing residues and hydrogen bond donors or acceptors 
were not known at this time point, odd and even numbered residues were chosen for 
modifications of each edge strand (Figure 4-26 B). Since the effect of charged side-chains 
depends on inward-pointing charges, it was important to substitute inward-pointing 
residues with lysine. Proline disfavours further β-strand interactions due to a missing 
hydrogen bond donor and a very strong local twist (Richardson and Richardson, 2002). 
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To enforce the effect of proline and lysine, each edge strand was modified twice in 
addition to single modifications of the strands. Double variants comprised variants with 
one modification in R5c and a modification in R1c at the corresponding position. 
Quadruple variants display in each case two modifications in R5c and R1c. Altogether 24 
proline and lysine variants (Table 3-7) were generated and analysed. Barnase and sumostar 
were fused without further modifications. Short linker peptides were used to avoid 
undesired flexibility and thus a missing masking effect. 
The expression of plasmid constructs, which correspond to EcCsgA fusion proteins, were 
first analysed in order to differ soluble and insoluble expression products. For proline and 
lysine variants of CsgA CM, CsgA CD as well as Bar-(CsgA)2-Bar and 
Sumo-(CsgA)2-Sumo no soluble protein was obtained. In contrast to this insoluble 
expression, Bar-CsgA-Bar and Sumo-CsgA-Sumo were partly soluble. Short induction 
times and a low induction temperature (20 °C) resulted in soluble expression products as 
shown in Figure 4-27. 
 
 
Figure 4-27: Expression test analysis of Bar-CsgA-Bar. 12 % SDS-PAGE (Coomassie staining) according 
to expression test analysis of Bar-CsgA-Bar. E. coli BL21 cells were transformed with 
pET 11d Bar-CsgA-Bar and induced with 250 µM IPTG. Cell growth and induction were quenched at 
suitable time points and cells were further processed using BugBuster reagent. Since EcCsgA fibrils are not 
readily soluble in common denaturants, pellet fractions were solubilised with urea (PU) or formic acid (PFA) 
to characterise the aggregates for EcCsgA amyloidogenic behaviour. Supernatants (S) were directly loaded 
onto the gel. 
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4.4.2 Protein Production and Purification 
Similar to other EcCsgA constructs that were analysed during this study, the fusion 
variants were produced as histidine-tagged proteins.  
Variants of CsgA CM, CsgA CD as well as Bar-(CsgA)2-Bar and Sumo-(CsgA)2-Sumo 
were obtained in inclusion bodies and purified under denaturing conditions according to an 
initial inclusion body purification as illustrated in chapter 3.4.5 and in Figure 4-28.  
After cultivation, cell harvest and lysis, IBs were pre-purified by repetitive steps of re-
suspending in appropriate washing buffers and spinning. The monomeric analogues were 
solubilised as described. IBs of dimeric analogues were extremely stable and thus initially 
solubilised in formic acid before adding the proper solubilisation buffer. Further 
purifications steps were identical to processing EcCsgA21-151 and EcCsgA40-151 
(chapter 4.3.3). 
 
 
Figure 4-28:  Purification of CsgA CM and CsgA CD variants. (A) 15 % SDS-PAGE (Coomassie 
staining) of initial purification of CsgA CM and CsgA CD inclusion bodies. 1st wash includes IB wash buffer 
A, 2nd and 3rd wash include lysis buffer. (B) 4-12 % NuPAGE (Coomassie staining) of CsgA CM and 
CsgA CD according to IMAC. 
 
In contrast to the insoluble expression products, barnase- and sumo-constructs that contain 
only one copy of the EcCsgA amyloid core (Bar-CsgA-Bar and Sumo-CsgA-Sumo) were 
purified natively as described in chapter 3.4.6. The yield of soluble fusion proteins was 
increased by a cell lysis protocol with a combination of lysozyme and suitable detergents 
instead of sonication. After this gentle cell disruption, the soluble proteins were directly 
processed via IMAC under native conditions resulting already in quite pure protein 
fractions (Figure 4-29), which were applied to further experiments. 
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Figure 4-29:  Purification of soluble Bar-CsgA-Bar and Sumo-CsgA-Sumo. 4-12 % NuPAGE 
(Coomassie staining) of production and isolation of Bar-CsgA-Bar and Sumo-CsgA-Sumo. 
 
 
4.4.3 Insoluble Expression Products Behave like EcCsgA wt 
Insoluble expression products of CsgA CM and CsgA CD variants were analysed further in 
order to study their amyloidogenic behaviour. Incubation of the purified proteins in native 
buffer after desalting resulted in protein aggregation. Suitable biophysical methods were 
employed to analyse the amyloid character of these aggregates as illustrated below.  
 
 
Figure 4-30: Biophysical characterisation of CsgA CM N26K/N162K. (A) Far-UV-CD spectra of 
CsgA CM N26K/N162K after desalting (black) with 50 mM KPi pH 7.2 and 3 days incubation (red). 
20 spectra were accumulated using a cuvette with 1 mm path length. (B) ThT fluorescence depending on time 
and protein concentration. 50 µM ThT were mixed with freshly desalted CsgA CM N26K/N162K. 
Fluorescence was measured every 10 min at 485 nm after excitation at 442 nm. 
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Similar to EcCsgA21-151 (chapter 4.3.4), CD spectra of the formed aggregates revealed the 
typical minimum around 218 nm and maximum around 195 nm as well. The CD spectra, 
which were recorded immediately after desalting, revealed a strong minimum around 
200 nm indicating the random coil conformation. Thus, CD spectra of protein samples 
directly after buffer exchange and incubation under native conditions (Figure 4-30 A) 
confirmed the transition into a β-sheet rich fold (Ranjbar and Gill, 2009).  
ThT mixing experiments displayed a strong ThT fluorescence and distinct phases during 
polymerisation illustrated in Figure 4-30 B. The appearance of concentration dependent 
lag phases was congruent to former studies of EcCsgA21-151 and EcCsgA40-151 
(chapter 4.3.4) and other amyloidogenic proteins (Lomakin et al., 1997; Wang et al., 
2010).  
Finally, fibrillar structures were obtained by electron microscopy shown in Figure 4-31. 
 
 
 
 
 
 
 
 
 
 
Figure 4-31:   Electron micrograph of aggregates formed by 
CsgA CM N26K/N162K.  
 
As shown for CsgA CM N26K/N162K, the results of the biophysical characterisation of 
CsgA CM and CsgA CD fusion proteins are consistent with the behaviour of typical 
amyloids outlined in chapter 1.1.2.  
In contrast to the intent of generating soluble analogues of EcCsgA oligomers, both proline 
and lysine variants of CsgA CM and CsgA CD fusion proteins seem to assemble like 
EcCsgA wt into specific amyloid aggregates. 
 
 
4.4.4 Folding Behaviour of Soluble Expression Products 
The fusion proteins Bar-CsgA-Bar and Sumo-CsgA-Sumo were obtained in the soluble 
form and purified under native conditions. Therefore, the question about the stability and 
the folding level especially of the EcCsgA was addressed. In order to analyse the folding 
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behaviour of these fusion variants, the proteins were subjected to size exclusion 
chromatography, solubility tests, CD experiments and 2D-NMR. 
Both proteins feature a molecular mass around ~ 37 kDa (Table 3-14). This suggested 
similar elution profiles in size exclusion chromatography experiments in case of same 
oligomerisation level and a globular fold. Size exclusion chromatography experiments 
were performed as described in chapter 3.4.6 and the results are summarised in Figure 
4-32. The symmetric single peak indicated homogeneous protein samples with only one 
oligomeric species per sample. But the elution profile of both protein variants revealed 
different elution volumes suggesting differences in oligomerisation or fold of the proteins.  
 
 
Figure 4-32: Size exclusion chromatography of Bar-CsgA-Bar and Sumo-CsgA-Sumo. (A) Elution 
profiles of corresponding experiments using Superdex200 (16/60). Elution occurred via 
50 mM Tris/HCl pH 7.5, 150 mM NaCl with a flow rate of 1.5 mL/min. (B) 12 % SDS PAGE (Coomassie 
staining) of protein containing fractions (enframed in A) according to size exclusion chromatography.         
(C) A calibration run of Superdex200 (16/60) was performed using different proteins. 
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Next, the aggregation tendency of these two fusion proteins was checked by solubility 
tests. In low concentrated solutions (~ 0.2 mg/mL), both proteins were soluble up to 
several weeks at 4 °C. In concentrated samples (> 1.5 mg/mL) the variants formed 
aggregates at 4 °C within few hours. Contrary to the specific fibrils of EcCsgA wt, these 
aggregates were readily soluble in 8 M urea and 0.1 % (w/v) SDS. Thus, they seem to be 
unspecific.  
The soluble and aggregated protein fractions were analysed by CD experiments to test their 
secondary structural content (Figure 4-33). In the soluble state, CD spectra of 
Bar-CsgA-Bar revealed a double minimum at 228 and 208 nm and a maximum at 195 nm, 
typical for α-helical proteins (Ranjbar and Gill, 2009). Self-contained barnase features 
21 % α-helical and 22 % β-sheet secondary structures (Baudet and Janin, 1991). CD 
spectra of Sumo-CsgA-Sumo displayed a double minimum at 225 and 205 nm and a 
maximum at 190 nm. Since the minimum at 205 nm is highly developed and CD spectra of 
irregular structured proteins display an intense negative Cotton effect near 200 nm 
(Ranjbar and Gill, 2009), this fact indicates a high random coil content. Separate sumo 
features 16 % α-helical and 25 % β-sheet secondary structures (Sheng and Liao, 2002). 
The CD spectra of the aggregates of both Bar-CsgA-Bar and Sumo-CsgA-Sumo revealed a 
minimum around 218 nm and a maximum around 195 nm, typical for β-sheet rich proteins 
(Ranjbar and Gill, 2009).  
 
 
Figure 4-33: Secondary structure analysis of soluble and aggregated Bar-CsgA-Bar and 
Sumo-CsgA-Sumo. Far-UV-CD spectra of soluble and aggregated fusion proteins in 50 mM KPi pH 7.2. 
20 spectra were accumulated using a cuvette with 1 mm path length. 
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Due to the promising CD spectra of soluble Bar-CsgA-Bar, this fusion protein was further 
investigated by 2D NMR spectroscopy to gain more information about the structural 
organisation. [15N,1H] ctHSQC correlation spectra of 15N labelled Bar-CsgA-Bar were 
recorded accordingly. The obtained spectrum (Figure 4-34) revealed a remarkable number 
of sharp and more intense peaks in the random coil chemical shift region around 8 ppm. 
This fact potentially indicates numerous conformationally disordered residues.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-34:   [15N, 1H] ctHSQC spectrum of 
Bar-CsgA-Bar. Spectra were recorded of 
45 µM 15N labelled Bar-CsgA-Bar in 
50 mM KPi pH 6. 
 
In summary, these data suggested that the fusion proteins Bar-CsgA-Bar and 
Sumo-CsgA-Sumo are soluble and folded to a certain extent, but not quite stable at higher 
concentrations. Especially the CD and NMR data of the soluble proteins indicated a high 
content of irregular structured and flexible residues. These data are congruent to similar 
experiments with the Ure2p prion domain fused to barnase (Baxa et al., 2002). The prion 
domain was unfolded in the soluble state of the corresponding fusion protein. Thus, it is 
conceivable that the EcCsgA moiety is not well folded in the soluble state as well. 
However, since Bar-CsgA-Bar and Sumo-CsgA-Sumo are soluble after expression and the 
formed aggregates are unspecific, the fusion proteins successfully alter the EcCsgA 
amyloidogenic behaviour. 
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5 Discussion 
 
 
5.1 H/D Exchange NMR Is Capable to Explain HET-s Species 
Barrier Breaching  
 
In order to investigate the phenomenon of HET-s species barrier breaching, structural 
analysis of FgHET-s218-289 with H/D exchange NMR spectroscopy was done as part of a 
structure-function analysis of the HET-s homologues in collaboration with Beat Meier lab 
(ETH Zürich) and Sven Saupe lab (Université de Bordeaux). Thus, the following 
discussion takes results of all three groups into account (Wasmer et al., 2010). 
 
 
5.1.1 H/D Exchange Explains Remarkable Cross-Seeding 
The obtained H/D exchange data of the prion forming domain of the HET-s homologues 
from Fusarium graminearum FgHET-s218-289 revealed four highly protected segments per 
molecule suggesting β-sheet elements at the positions E223-E234, A237-F245, E259-T270 
and S273-G282. The corresponding residues are located in the same regions as described 
for PaHET-s218-289 (Ritter et al., 2005) illustrated in Figure 5-1. Thus, both homologues 
seem to feature a very similar hydrogen bonding pattern. 
 
 
Figure 5-1: H/D exchange rates of FgHET-s218-289 and PaHET-s218-289. Red bars show the exchange rates 
of FgHET-s218-289 kex (h-1) and grey bars indicate rates of PaHET-s218-289 (Ritter et al., 2005). 
 
In addition to PaHET-s218-289, FgHET-s218-289 features six more protected residues 
comprising E223-H225 and R259-K261. Since the slow exchange rates of the protected 
segments are monoexponential and in the same range as demonstrated for PaHET-s218-289, 
both homologues demonstrate an extraordinary homogeneity and stability. Fast exchange 
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rates within highly protected regions identified structural disturbances at positions 
G235-S236 and N271-Q272, as well as at the positions N243, R265 and N279 similar to 
PaHET-s218-289 indicating β-turns and β-arcs. In contrast to PaHET-s218-289, residues 236, 
272 and 279 are less protected in FgHET-s218-289, while residue E229 was highly protected. 
These observations denote a different hydrogen bonding pattern at the corresponding 
positions.  
In summary, the H/D exchange analysis of FgHET-s218-289 in comparison with 
PaHET-s218-289 revealed structural similarities and differences of the two homologues. 
Since the results are congruent, the H/D exchange analysis of FgHET-s218-289 identified all 
structure elements in FgHET-s218-289 that constitute the amyloid core of PaHET-s218-289. 
Both homologues feature β-strands and β-turns at similar positions. The protected 
segments 1, 3 and 2, 4 as well as the turn regions are separated in each case by 36 residues 
indicating a repetitive structural character. Thus, the H/D exchange NMR analysis revealed 
that both homologues feature very similar structures despite the low sequence identity. 
And this structural relationship explains the HET-s cross-seeding phenomenon, since 
cross-seeding presupposes structures that are highly similar to act as structural template for 
each other (Prusiner, 1998).  
Furthermore, the comparison of the H/D exchange data enabled already detailed insights in 
the FgHET-s218-289 structure, since the H/D exchange data can be correlated to the high 
resolution solid state NMR data of PaHET-s218-289 (Van Melckebeke et al., 2010; Wasmer 
et al., 2008). PaHET-s218-289 was identified to constitute a β-solenoid structure (Wasmer et 
al., 2008). The two pseudo-repeats of PaHET-s218-289 are suggested to form parallel 
β-sheets (Ritter et al., 2005) and every proposed β-strand is subdivided into two shorter 
fragments (e.g., β1 into β1a and β1b) by β-arcs. Since the H/D exchange NMR analysis of 
the homologues revealed ordered and flexible residues at congruent positions, 
FgHET-s218-289 is capable to arrange β-strands in the same manner. Two asparagine ladders 
(N226/N262 and N243/N279) stabilise the amyloid structure of PaHET-s218-289. These 
residues are conserved among the two homologues enabling two asparagine ladders in 
FgHET-s218-289, too. Evidently, there are additional rigid residues in FgHET-s218-289 that 
comprise residues E223-H225 and R259-K261, which could form a very short β-sheet. 
E223 and R259 are oppositely charged and separated by 36 residues. Thus, they might 
form a salt bridge that stabilises the β-sheet. PaHET-s218-289 features salt bridges at 
positions K229/R265, E234/K270 and R236/E272. The opposite charges of the salt bridge 
between the residues 229 and 265 are rearranged in FgHET-s218-289 (E229/R265) and 
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missing charges at positions 236, 270 and 272 disable salt bridges at E234/T270 and 
S236/Q272. Thus, there are obvious differences in the structural and stabilising elements, 
too. However, both homologues feature adequate, stable structure elements at appropriate 
positions to form a robust and very similar fold despite these differences. The 
FgHET-s218-289 amyloid core is highly suggested to form a β-solenoid structure with two 
windings per molecule and a triangular hydrophobic core illustrated in Figure 5-2.  
 
 
Figure 5-2:  Schematic representation of the two layers of the amyloid core formed by                        
(A) PaHET-s218-289 (structure) and (B) FgHET-s218-289 (model). Charged residues are shown in red or 
blue, polar but uncharged resides are highlighted in green, unpolar residues in white circles. (C) Structure of 
the PaHET-s218-289 fibrils. Side view of five stacked PaHET-s218-289 molecules (Wasmer et al., 2008). 
Strands display in same colour correspond to one molecule, the fibril axis is indicated by an arrow. 
 
Intermolecular hydrogen bonding via the edge strands enables the monomers to assemble 
along the fibril axis as shown for a PaHET-s218-289 pentamer that was calculated from 
NMR restraints (Wasmer et al., 2008). The arrangement of hydrophobic and hydrophilic 
side chains is consistent to that of PaHET-s218-289. The hydrophobic core is formed by one 
polar and eleven non-polar residues. Outside pointing side chains are mostly polar or 
charged tightening the structure model for amyloid fibrils formed by FgHET-s218-289. 
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5.1.2 Solid State NMR Results Are Complementary and Reveal Further 
Structural Details 
In addition to the presented H/D exchange study, solid state NMR experiments were 
performed by Christian Wasmer and Beat Meier (ETH Zürich) to identify residues that are 
involved in the β-sheet structure of FgHET-s218-289. The segments E223-S246 and 
D258-Y281 as well as W287 were specifically assigned. The strong dependence of the 
chemical shifts on the backbone amide conformation and the difference of the observed Cα 
and Cβ secondary chemical shifts ∆δCα - ∆δCβ enabled information about the positions of 
secondary structural elements as well. α-helical and β-sheet conformations are indicated by 
positive and negative values respectively.  
Almost all assigned residues, which displayed slow exchange rates during H/D exchange, 
were allocated to β-strands by solid state NMR illustrated in Figure 5-3.  
 
 
Figure 5-3:  Sequence specific determination of secondary structure elements of FgHET-s218-289 and 
PaHET-s218-289. Upper bars indicate hydrogen exchange rates kex (h-1) of FgHET-s218-289 (red) and 
PaHET-s218-289 (grey). Residues marked with an asterisk were detached from analysis due to missing 
assignment and overlap respectively. Blue arrows indicate assigned β-strands. Lower bars show the 
difference of Cα and Cβ secondary chemical shifts, which were extracted from solid state NMR spectra, for 
residues with both Cα and Cβ resonances assigned (adapted from Wasmer et al., 2010).  
 
Owing to the positive ∆δCα - ∆δCβ value, a structural disturbance at positions N271-S272 
was identified too by the secondary shift deviation. In contrast to former studies of 
PaHET-s218-289, negative ∆δCα - ∆δCβ values were detected for presumable β-arc positions 
E229 and R265, while the H/D exchange data indicated a structural disturbance at position 
265. In spite of slow H/D exchange rates, positive values were detected for the adjacent  
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residues F230 and T266. The position of the 
expected secondary shift deviation is shifted by 
one residue.  
Since there are multiple types of two-residue β-
arcs (Hennetin et al., 2006), FgHET-s218-289 
could feature bl arcs, while ab arcs are present at 
the corresponding positions in PaHET-s218-289. 
These arrangements would show the same side-
chain topology but different backbone angles 
(Figure 5-4) that probably induce differences in 
the secondary chemical shifts (Wishart and Nip, 
1998). 
In summary, solid state NMR and H/D exchange 
experiments complemented each other. The 
H/D exchange NMR analysis was complete and revealed significant information about the 
hydrogen bonding pattern of all FgHET-s218-289 backbone amides, while the solid state 
NMR analysis revealed insights in the backbone conformation of the assigned residues. 
Thus, both techniques identified structural similarities as well as differences of the 
homologous proteins and complementary specified all structure elements to form a highly 
similar amyloid core. 
 
 
5.1.3 The β-Solenoid Fold of HET-s Is Evolutionary Conserved 
The sequence specific secondary structural analysis has shown that the specific aggregates 
formed by FgHET-s218-289 and PaHET-s218-289 are structurally highly similar, although they 
show low sequence identity. It is well known that globular, soluble proteins with a 
homology level around 30 % typically adopt similar structures (Chothia and Lesk, 1986; 
Ginalski, 2006). In contrast to this behaviour, amyloids have been shown to form different 
polymorphic forms and much different structures already due to single point mutations 
(Tycko et al., 2009). Thus, the obtained structural details are quite remarkable.  
A closer look to the sequences (Figure 5-5) of the homologous domains found in 
Podospora anserina and different Fusarium species shows that most of the conserved 
residues appear in the well structured amyloid core region (pseudo-repeats 222-247 
and 258-283). The asparagine residues N226, N243, N262, N279, which form two 
 
Figure 5-4:   Typical two-residue β-arcs. 
Stick and ball representation of bl and ab arcs. 
Oxygen atoms are shown in red, nitrogen in 
blue and carbon in green (Hennetin et al., 
2006).  
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asparagine ladders along the fibril axis in PaHET-s218-289, are conserved in all homologous 
proteins. Since glutamine and asparagine ladders are crucial for prion aggregation (DePace 
et al., 1998; Osherovich et al., 2004; Ross et al., 2005), these asparagines seem to be 
essential to provide the HET-s amyloid structure. The glycines G240 and G278 that enable 
the formation of sharp β-arcs and the glycine-rich loop at the C-terminus and W287, which 
are assumed to make contacts with β-strand 2 and 4 (Van Melckebeke et al., 2010), are 
conserved, too. Several residues, which are not conserved, are substituted to homologous 
residues. Furthermore, the amyloid core region comprises numerous hydrophobic residues 
that are capable to constitute a hydrophobic core. 
 
 
Figure 5-5:  Sequence alignment of HET-s prion forming domain from Podospora anserina and 
homologues found in different Fusarium species. Primary structure of PaHET-s218-289 is compared to 
homologous domains. Sequences of the homologues correspond to GenBank accession number, FG10600 
and FG08145 are from F .graminearum, FVE13490 from F. verticllioides, FOX17314 and FOX14669 are 
from F. oxysporum, EEU42351, EEU47148 and EEU38121 are from F. solani. Conserved residues are 
highlighted in green, homologous residues in yellow. In the consensus sequence conserved residues are 
shown in red and conserved amino acid exchanges highlighted in blue, $ indicates anyone of I or V, # anyone 
of D, E, N or Q. Secondary structures elements of the β-solenoid structure of PaHET-s218-289 (Wasmer et al., 
2008) are shown on the top of the alignment. Analysis was done with the program MultAlin (Corpet, 1988).  
 
Thus, all residues that are crucial to form the β-solenoid structure of HET-s are highly 
conserved among the homologues. Similar to homologous globular proteins (Chothia and 
Lesk, 1986; Ginalski, 2006), these conserved residues enable highly similar structures at 
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reasonable levels of sequence identity. In spite of the evolutionary divergence of the HET-s 
sequences, this fact ensures the structural similarity of the two prion domains. The HET-s 
β-solenoid fold seems to be evolutionary conserved.  
 
 
5.1.4 Conclusion 
The presented results of the FgHET-s218-289 structure analysis clearly demonstrated the 
structural relationship of the two HET-s homologues (Figure 5-6) and thus explained the 
cross-seeding effect in spite of low sequence identity.  
 
Figure 5-6: Structural relationship of the HET-s homologues. (A) Secondary structure elements of 
PaHET-s218-289 and FgHET-s218-289 aligned to the amino acid sequence. Arrows indicate β-strands. 
Furthermore, salt bridges are shown as dashed lines. The amino acid sequence of both homologues is shown 
as blue bar; sequence identity is shown in white. (B) Schematic representation of the two layers of the 
amyloid core formed by PaHET-s218-289 (structure, black) and FgHET-s218-289 (model, red) showing all 
β-strands, β-arcs and asparagine ladders.  
 
The presented analysis revealed structural similarities and differences of the two HET-s 
homologues. Both prion domains share homogeneous and stable fibrils. They feature all 
major structural elements to form a highly similar β-solenoid fold. At last this structural 
similarity facilitates the amyloid templating in spite of low sequence identity. Similar to 
globular proteins, the conserved residues facilitate the highly similar structure and indicate 
an evolutionary conservation of the HET-s β-solenoid fold. 
Since the H/D exchange NMR analysis was complete and complementary data of 
PaHET-s218-289 were available, the recent H/D exchange analysis facilitated the 
identification of structural similarities and differences of the two HET-s homologues. 
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Thus, all major structure elements of the HET-s fold were detected in FgHET-s218-289 
fibrils without a complete and time-consuming solid state NMR analysis. Furthermore, the 
H/D exchange analysis enabled information about homogeneity and stability of the 
amyloids. Doubtless, H/D exchange NMR is a sensitive tool to compare homologous 
proteins with regard to their structures, homogeneity and stability and is capable to explain 
the HET-s cross-seeding phenomenon. 
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5.2 The Sophisticated Topology of the Major Curli Subunit 
The structure-function relationship of CsgA is of high interest, since CsgA is the major 
subunit of the curli fibrils, which feature manifold functions in bacterial pathogens.  
Therefore, a sequence specific analysis of the topology of EcCsgA fibrils was performed 
within this study and the corresponding results of the H/D exchange NMR experiments and 
solvent-accessibility studies revealed first residue-specific information about the major 
curli subunit. 
 
 
5.2.1 H/D Exchange NMR Experiments and Thiol-Labelling Reveal a Possible 
Fold of EcCsgA 
 
The H/D exchange analyses of the two variants EcCsgA21-151 and EcCsgA40-151 were 
congruent and complementary. Both H/D exchange experiments revealed the same 
structural pattern and indicated similar homogeneity and stability of the variants. Despite 
the lower time resolution of ctHSQC experiments, H/D exchange rates were successfully 
determined for 87 % of all backbone amides of mature EcCsgA including almost all 
residues (94 %) within the amyloid core (residues 43-151). In consequence, the obtained 
exchange rates clearly specified the flexible N-terminus and the stable amyloid core of 
mature EcCsgA (Figure 5-7). The slow exchange rates (≤ 10-2 h-1) of protected segments 
are congruent to the precedent analysis of FgHET-s 218-289 (discussed in chapter 5.1) and 
other amyloids (Luhrs et al., 2005; Ritter et al., 2005; Vilar et al., 2008) reflecting the 
extraordinary stability of EcCsgA fibrils. Strong overlap of the intramolecularly conserved 
asparagines N54, N77, N99, N122 and N144 hampered the interpretation of their 
H/D exchange behaviour. The β-strand incorporation of these residues remained elusive. 
Furthermore, a few residues revealed unexpected biphasic exchange behaviour within 
protected segments discussed in chapter 5.2.3. However, the exchange analysis identified 
distinct regions of flexible and ordered segments in a repetitive manner similar to the 
established repertoire of secondary structural elements within amyloid fibrils outlined in 
chapter 1.1.2. The presented H/D exchange NMR analysis identified ten distinct β-strands 
within five imperfect sequence repeats (Figure 5-7). Every repetitive segment forms two 
β-strands, which are connected by a short β-turn. The N-terminal β-strand (β1, β3...) of 
each repeat comprises seven residues; the C-terminal strand (β2, β4...) constitutes of seven 
to eight residues depending on the incorporation of the intramolecularly conserved 
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asparagine. The corresponding strands are connected by an intramolecularly conserved 
glycine rich turn and the β-strands of adjacent repeats are linked by five to six flexible 
residues. 
 
  
Figure 5-7: Sequence specific position of secondary structure elements within EcCsgA fibrils probed 
by H/D exchange. Sinuous lines represent flexible regions, while blue arrows present regular segments of 
β-strands. The incorporation of the intramolecularly conserved asparagines remained unclear shown in light 
blue. Residues with biphasic H/D exchange behaviour are encircled: grey indicates residues that exchanged 
in a biphasic manner in both variants EcCsgA21-151 and EcCsgA40-151; green indicates biphasic exchange in 
EcCsgA21-151, red in EcCsgA40-151. Intramolecularly conserved residues are highlighted in yellow. 
 
Furthermore, solvent-accessibility studies (chapter 4.3.7) indicated that every β-strand and 
therefore every β-sheet of the fibril core features a solvent accessible side.  
Owing to these facts, EcCsgA is suggested to form a β-solenoid structure with a solvent 
protected core illustrated in Figure 5-8. This core is constituted of two β-sheets that are 
formed by β1, β3, β5, β7 and β9, and β2, β4, β6, β8 and β10 respectively. Since the 
intramolecularly conserved glutamine and asparagine residues would stack on top of each 
other in this structure, two glutamine-ladders and one asparagine-ladder stabilise the 
amyloid core as suggested before (Collinson et al., 1999). Furthermore, the charged 
residues D127 and H149 are located in probably adjacent positions and might form a 
stabilising salt bridge. Similar to the HET-s solenoid (discussed in chapter 5.1.3), the 
distribution of polar and hydrophobic residues along the sequence enables a hydrophobic 
core. The proposed core of every coil is formed by four hydrophobic residues and the 
stacking asparagine and glutamine residues. Outside pointing side chains are mostly polar 
or charged. 
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Figure 5-8:  Schematic representation of the five repetitive layers and the proposed fold of the 
amyloid core formed by mature EcCsgA. (A) The repetitive layers each form a strand-turn-strand motif. 
Charged residues are shown in red or blue, polar but uncharged residues in green and unpolar residues in 
white circles. (B) The model of the proposed fold is shown in a ribbon diagram. 
 
In this proposed fold, each intramolecularly conserved alanine constitutes the hydrophobic 
core with three other hydrophobic residues congruent to the sequence alignment. However, 
the H/D exchange NMR analysis did not exclude a kink or a β-arc at these positions due to 
the probable fast H/D exchange behaviour of these residues. On the assumption that the 
intramolecularly conserved asparagines are involved in backbone hydrogen bonding, a 
short β-strand prior to the alanines is conceivable. The corresponding β-sheet would be 
stabilised by the asparagine ladder. In order to complement the presented data and to 
specify the microstructure of the EcCsgA amyloid core, a complete solid-state NMR 
analysis is necessary Furthermore, stable cysteine variants, which were identified to carry a 
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solvent accessible cysteine, should be used to prove intra- and intermolecular contacts by 
fluorescence excimer studies. 
In summary, the recent study indicates that the major curli subunit CsgA forms a 
β-solenoid structure with five windings per molecule illustrated in Figure 5-8. The 
proposed fold agrees with the observed H/D exchange rates, side-chain solvent 
accessibility, the distribution of polar and hydrophilic residues along the sequence and the 
repetitive sequence character. Intramolecular hydrogen bonding via the edge strands 
enables the monomers to polymerise along the fibril axis. A head to tail arrangement 
would facilitate the formation of stabilising glutamine and asparagine ladders along this 
axis. Furthermore, the formation of a β-solenoid structure is consistent to former solid state 
NMR data, which excluded an in-register parallel β-sheet architecture of EcCsgA 
(Shewmaker et al., 2009).  
 
 
5.2.2 The Repetitive Primary Structure of EcCsgA Enables a β-Solenoid Fold 
The presented data suggested EcCsgA to form a β-solenoid similar as the HET-s 
homologues (discussed above; Wasmer et al., 2008; Wasmer et al., 2010). Solenoids are 
elongated structures of repeating β-strand units that coil around the solenoid axis (Kajava 
and Steven, 2006). A closer look at the sequence of EcCsgA and the positions of regular 
secondary structural elements (Figure 5-9) already reveals a characteristic amino acid 
composition with regard to β-solenoids. 
 
 
Figure 5-9:  Primary and secondary structure of the EcCsgA amyloid core. Comparison of the primary 
structure of the five repeating units and positions of secondary structural elements along the sequence. 
Intramolecularly conserved residues are highlighted in yellow, probably hydrophobic ladders are enframed in 
grey. Sinuous lines represent flexible regions, while blue arrows present regular segments of β-strands. The 
incorporation of the intramolecularly conserved asparagines remained unclear shown in light blue. 
 
Similar to other β-solenoids (Kajava and Steven, 2006), EcCsgA contains evident sequence 
repeats (Collinson et al., 1999; Hammar et al., 1996). Every repeated unit shows the 
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consensus sequence of Sx5QxGxGNxAx3Qx1-5 (Collinson et al., 1999) and forms a 
strand-turn-strand motif. The repeats contain several xyx patterns (x denotes any 
hydrophobic residue, y denotes mostly polar residues), which correspond to the β-strands 
and enable the formation of a hydrophobic core. Turns and loops are made of glycines and 
polar residues similar to what has been found in other β-solenoids (Hennetin et al., 2006). 
The EcCsgA sequence includes intramolecularly conserved asparagine and glutamine 
residues, which are able to form stabilising ladders probably essential for amyloid 
aggregation (DePace et al., 1998; Osherovich et al., 2004; Ross et al., 2005). In general, 
β-solenoids are often enriched with asparagines forming stabilising ladders (Yoder and 
Jurnak, 1995). Therefore, the EcCsgA sequence obviously features fundamental elements 
to form a repetitive β-solenoid structure. Similar to EcCsgA, HET-s consists of two 
pseudo-repeats enabling the β-solenoid fold as discussed in chapter 5.1.  
In contrast to EcCsgA and HET-s, several fibrils of disease associated amyloids and 
numerous yeast prions have been shown to feature a parallel, in-register β-sheet 
arrangement (Balbach et al., 2002; Baxa et al., 2007; Heise et al., 2005; Shewmaker et al., 
2006; Wickner et al., 2008a). Obviously, the primary structures of these proteins differ 
from the sequences of CsgA, HET-s and other β-solenoid proteins as illustrated for Aβ1-42, 
α-synuclein and Ure2p1-89 in Figure 5-10.  
 
 
Figure 5-10: Primary and secondary structure of Aβ1-42, α-synuclein and Ure2p1-89. Asparagine and 
glutamine residues are shown in red. For Aβ1-42 and α-synuclein the positions of secondary structural 
elements are shown along the sequences (Luhrs et al., 2005; Vilar et al., 2008). Sinuous lines present flexible 
regions, while blue arrows present regular segments of β-strands.  
 
The sequences show limited repetitive character, probably stacking asparagine and 
glutamine residues appear in a random manner. Furthermore, the short peptide fragments 
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of Aβ disable repeated coils within single Aβ-molecules. In consequence, the cross-β 
structure of these amyloids is formed by parallel, in-register β-sheets via stacks of identical 
strand-turn-strand motifs (Aβ) or superpleated β-structures (Ure2p, Rnq1p, Sup35, 
α-synuclein) illustrated in comparison to stacks of β-solenoids in Figure 5-11 (reviewed 
by Kajava et al., 2010). While disease related amyloids are soluble in their native form 
(chapter 1.1.3, Table 1-1) and yeast prions form amyloid fibrils only at very low 
frequencies (Tuite and Cox, 2003), CsgA and HET-s are mostly fibrillar in the native form 
to fulfil their distinct functions (Chapman et al., 2002; Coustou et al., 1997). Similar to the 
HET-s β-solenoid fold (Ritter et al., 2005; Wasmer et al., 2010), the CsgA structure and 
sequence seem to be evolutionary optimised for amyloid fibril formation.  
 
 
Figure 5-11: Types of cross-β structure within amyloid fibrils (original figure from Kajava et al., 2010). 
Top: axial views of the repetitive structural units. Bottom: lateral view of cross-β structures formed by 
stacking of the corresponding repetitive units. 
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5.2.3 Biphasic EcCsgA Exchange Behaviour Indicated Local Heterogeneity in 
EcCsgA Fibrils 
 
Illustrated above in Figure 5-7, the H/D exchange analysis of EcCsgA21-151 and 
EcCsgA40-151 revealed several backbone amides that exchanged in a biphasic manner 
indicating less homogeneity at these positions. A few residues featured a fast and a slow 
exchanging population in both, others only in one of the two analysed EcCsgA variants 
EcCsgA21-151 and EcCsgA40-151. 
Biphasic H/D exchange was also detected in former analysis of Aβ1-42 and α-synuclein 
fibrils (Luhrs et al., 2005; Vilar et al., 2008). In contrast to the random appearance of 
biphasic exchange in EcCsgA fibrils, distinct segments of Aβ1-42 and α-synuclein revealed 
less homogeneity. In Aβ1-42 fibrils all residues of the N-terminal flexible tail exhibited two 
distinct populations in H/D exchange, while the amyloid core was highly protected (Luhrs 
et al., 2005). Contrariwise, α-synuclein fibrils featured a biphasic behaviour for all residues 
of the fibril core. The two subpopulations exchanged in a slow and a very slow manner. 
The rates of the two corresponding subpopulations vary depending on the fibril age. Thus, 
α-synuclein features two distinct structural entities (Vilar et al., 2008). Contrary to the 
biphasic exchange behaviour of these disease-related amyloids, the two HET-s 
homologues PaHET-s218-289 and FgHET-s218-289 exclusively exchanged in monophasic 
manner. 
In EcCsgA the corresponding biphasic residues appeared in a random manner along the 
protected residues and the subpopulations exchanged in a fast and a very slow manner. 
Most of these residues were located in the central repeats R2, R3 and R4. In comparison to 
R1 and R5, single peptides of these segments are less amyloidogenic (Wang et al., 2008b; 
Wang et al., 2007). R2, R3 and R4 bear so called “gatekeeper” residues (Wang et al., 
2010). Thus, the residues G78, D80, G82, D91, D104, G123 and D127 reduce the 
aggregation propensity in the distinct CsgA segments and avoid uncontrolled self-assembly 
of CsgA. In the presented H/D exchange analysis, G78, G82, G123 and D127 were 
identified at least in one EcCsgA variant to feature one less protected population. 
Therefore, it is conceivable, that the less aggregation prone repeats R2, R3 and R4 
including the gatekeeper residues result in less amyloidogenic behaviour of the distinct 
segments within the EcCsgA fibrils. 
Since in vivo the proper fibrillisation of CsgA is nucleator dependent (Hammar et al., 
1996), the absence of the nucleator protein CsgB could also result in vitro in altered CsgA 
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fibrils. Therefore, heteronucleated EcCsgA fibrils were analysed. In comparison to 
preformed EcCsgA fibrils, initial experiments revealed that in vitro formed EcCsgB fibrils 
are no adequate seed. A further discussion follows in chapter 5.2.4. In contrast to the 
in vivo fibrillisation, in vitro EcCsgA was fibrillised from high concentrated protein 
solutions (≥ 50 µM). Thus, the heterogeneity could be also a concentration dependent 
effect. 
The unexpected behaviour of a few EcCsgA cysteine variants within side-chain solvent 
accessibility studies (chapter 4.3.7) already indicated the sensitivity of the EcCsgA 
microstructure to modified fibrillisation properties. Since H/D exchange 
NMR spectroscopy is capable to specify the homogeneity and stability of the fibrils as 
illustrated in chapter 4.3.6 and discussed above, it is a sensitive tool to determine the 
influence of such modifications to the structure and stability. In order to ensure meaningful 
experiments using different protein variants and different fibrillisation conditions, 
structure, homogeneity and stability of the corresponding proteins should be probed by 
H/D exchange NMR analysis.  
 
 
5.2.4 Heterogeneity of Heteronucleated EcCsgA Fibrils 
CsgB initiates the assembly of CsgA into regular amyloid fibrils in vivo (Hammar et al., 
1996). Both proteins share 30 % sequence identity and 40 % homology (Hammar et al., 
1995). Since CsgB presents an amyloid like template to CsgA, it was believed that self-
seeding and heteronucleation are mechanistically similar processes that lead to highly 
similar CsgA structures (Hammer et al., 2007; Wang et al., 2008b). 
In contrast to the H/D exchange NMR analysis of self-seeded EcCsgA fibrils (Figure 5-7), 
heteronucleated EcCsgA40-151 fibrils revealed a less regular structure and strong 
heterogeneity (chapter 4.3.6, Figure 4-21) indicating an altered fibril structure. In recent 
heteronucleation experiments, in vitro formed EcCsgB fibrils were used to seed EcCsgA 
fibrillisation. 10 % (w/w) were added to monomeric EcCsgA40-151 to initiate the EcCsgB 
mediated assembly. While R1 and R5 featured the same protection pattern as in self-seeded 
fibrils and thus a regular structure, the central repeats exhibited less regularity and an 
increased heterogeneity.  
Explanations for this folding behaviour are the properties of in vitro formed EcCsgB fibrils 
and the different amyloidogenic behaviour of the distinct repeats within EcCsgA: In recent 
experiments EcCsgB assembles without lag phase into SDS-stable but heterogeneous 
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fibrils. Parallel H/D exchange NMR analysis revealed that in vitro only EcCsgB fibrils 
were produced showing biphasic H/D exchange behaviour for nearly all residues of the 
amyloid core (Madhu Nagaraj, unpublished). Thus, the used seeds seem to feature different 
structural entities and different contact points for monomeric EcCsgA leading into 
probably heterogeneous and less specific EcCsgA aggregates.  
The repeats R1 and R5 of EcCsgA are crucial for the EcCsgA assembly and they are the 
seeding responsive domains within this protein (Wang et al., 2008b). Thus, it was not 
plausible that R1 and R5 featured a regular secondary structure within heteronucleated 
EcCsgA fibrils, while the central repeats were heterogeneous und irregular structured. R1 
and R5 are indispensable for EcCsgA to interact with EcCsgB (Wang et al., 2008b). But 
the high seed-concentration of EcCsgB fibrils, as well as the hydrophobicity of the 
heterogeneous EcCsgB core and the monomeric EcCsgA molecules enable hydrophobic 
interactions between EcCsgB fibrils and the central repeats of EcCsgA, too. Hence it is 
conceivable that the inner repeats of EcCsgA R2, R3 and R4, which are less 
amyloidogenic, interact in an unspecific manner with EcCsgB and hamper in that way their 
own correct fibril incorporation. However, the high intrinsic amyloidogenic propensity of 
R1 and R5 (Wang et al., 2008b; Wang et al., 2007) still enables these segments to fold 
regularly. This readily explains the observed structural pattern of the recently 
heteronucleated EcCsgA40-151 fibrils. 
 
 
5.2.5 Aspects of Curli Biogenesis in CsgA Polymerisation 
In vivo, the fibrillisation of the major curli subunit CsgA is highly regulated. The curli 
biogenesis is a sophisticated mechanism involving several accessory proteins illustrated in 
chapter 1.3.1, Figure 1-10. Since in vivo each accessory protein features an indispensible 
function with regard to the specific curli assembly (Figure 5-12), an in vitro effect on the 
CsgA fibril formation is imaginable, too.  
After secretion to the extracellular space, CsgA is nucleated by CsgB into specific amyloid 
fibrils (Chapman et al., 2002; Hammar et al., 1996). Therefore, in vitro heteronucleated 
CsgA fibrils should be further investigated. Initial analysis of heteronucleated EcCsgA40-151 
within this study revealed less homogeneity and less structural regularity of the fibrils, 
which was explained by the heterogeneity of EcCsgB fibrils itself. So far, the in vitro 
assembly of EcCsgB results always in heterogeneous fibrils (Madhu Nagaraj, 
unpublished). In vivo, CsgF assists the stability and therefore the regularity of CsgB that 
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nucleates CsgA (Nenninger et al., 2009). Thus, at the cell surface, CsgA, CsgB and CsgF 
interact in a sophisticated manner with regard to the assembly of CsgA. Since CsgF is 
suggested to facilitate the entire CsgB nucleator activity, an in vitro effect is conceivable 
too. Therefore, it is obvious to investigate the effect of EcCsgF on the homogeneity and 
regular structure of EcCsgB and consequently the effect of these EcCsgB fibrils on the 
nucleation and regular structure of EcCsgA. Possibly, such an adjusted in vitro generation 
of EcCsgA fibrils and variants facilitates further mutagenesis and fluorescence labelling 
studies of EcCsgA to prove its suggested fold (chapter 5.2.1). 
So far only less is known about the function of CsgC, but loss of CsgC results in aberrant 
curli fibril formation in vivo (Gibson et al., 2007). Thus, an in vitro effect of CsgC on 
CsgA is arguable, too.  
 
 
 
Figure 5-12:   Accessory proteins during 
curli assembly and their interactions. CsgG 
forms an outer membrane channel and 
interacts with CsgE and CsgF. CsgE avoids 
premature CsgA assembly in the periplasm. 
CsgF is secreted via CsgG to the extracellular 
space, where it facilitates the cell association 
and stability of secreted CsgB. After 
secretion of CsgA, CsgB nucleates the 
polymerisation of CsgA into specific amyloid 
fibrils. For further explanations see 
chapter 1.3.1 and citations therein. 
 
 
5.2.6 Conclusion 
In summary, the presented H/D exchange NMR and side-chain solvent accessibility 
analysis of EcCsgA fibrils revealed the first sequence-specific information about structure 
elements within CsgA fibrils at all. The data enabled to propose a fold of EcCsgA. Thus, 
EcCsgA was indicated to form a β-solenoid structure with five windings per molecule and 
a strand-turn-strand motif per winding summarised in Figure 5-13. The data clearly 
demonstrated the repetitive structural character, which was already indicated by the 
characteristic repetitive sequence character (Collinson et al., 1999). The intramolecularly 
conserved residues facilitate crucial functions providing the appropriate structure and the 
fold seems to be evolutionary optimised. 
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Figure 5-13:   The proposed β-fold 
of EcCsgA. (A) EcCsgA was 
proposed to form a β-solenoid 
structure. The arrow indicates the 
fibril axis. (B) The repetitive 
sequence of EcCsgA enables the 
β-solenoid structure. The amino acid 
sequence of the sequence repeats is 
shown as lilac bar. Intramolecularly 
conserved residues are shown in grey. 
Arrows above indicate identified 
β-strands. Probably stacking 
glutamine and asparagine residues are 
highlighted. 
 
Since H/D exchange NMR spectroscopy is a sensitive tool to specify the homogeneity and 
stability of a structure, the analysis of two different EcCsgA variants indicated biphasic 
and heterogeneous behaviour of distinct residues. This fact and the heterogeneity of 
heteronucleated fibrils were reconsidered and should be probed again with regard to 
conditions that are highly similar to the in vivo settings.  
Similar to the H/D exchange NMR analysis of FgHET-s218-289 within this study, this 
technique was successfully implemented to gain residue-specific information about the 
structure, homogeneity and stability of the major curli subunit CsgA. 
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5.3 Monomeric Analogues of CsgA Oligomers – A Challenging 
Target 
 
In order to obtain soluble amyloid-like intermediates of CsgA for structural analysis, 
probable monomeric analogues of EcCsgA oligomers were designed and subjected to 
solubility and stability analyses. The proteins carried one or two copies of EcCsgA lacking 
the N22 tag and the β-sheet aggregation was to be blocked by the negative design of 
soluble β-sheet rich proteins (Richardson and Richardson, 2002) as outlined in the 
experimental strategy in chapter 4.1. Altogether, 28 fusion proteins were tested to form 
soluble monomeric analogues of CsgA oligomers (Figure 4-26). 
 
 
5.3.1 EcCsgA Protein Design Resulted in Insoluble and Soluble Fusion Proteins 
For proline and lysine variants of CsgA CM and CsgA CD fusion proteins no soluble 
protein was obtained at all. The proteins had to be purified under denaturing conditions and 
readily formed aggregates after buffer exchange to native conditions.  
Contrary to the intent of generating soluble 
analogues of EcCsgA oligomers, both proline 
and lysine variants of CsgA CM and CsgA CD 
fusion proteins seem to assemble like EcCsgA wt 
into specific amyloid aggregates. In these cases, 
the negative design of natural β-sheet proteins 
was not employable. The introduction of lysine 
residues was expected to be readily applicable, 
because no backbone distortion has to be 
designed (Richardson and Richardson, 2002). In 
former studies, de novo amyloid fibrils already were converted into monomeric β-sheet 
proteins (Wang and Hecht, 2002). However, the introduction of lysine and proline residues 
to EcCsgA fusion proteins resulted in amyloid-like aggregates indicating the high 
robustness of the sophisticated EcCsgA fold. It is imaginable, that the designated cap 
strands are not well ordered (Cherny et al., 2005) and loop out enabling intermolecular 
contacts of the inner segments (Figure 5-14). 
Similar to CsgA CM and CsgA CD fusion proteins, the recombinant production of 
Bar-(CsgA)2-Bar and Sumo-(CsgA)2-Sumo resulted in highly stable aggregates indicating an 
 
Figure 5-14: β-sheet in-corporation of 
designated cap strands. Native segments are 
shown in blue, red indicates designated cap 
segments. Arrows indicate β-sheet elements of 
each CsgA repeat. Sinuous lines present 
flexible segments. 
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amyloid like conformation. In contrast to these insoluble expression products, 
Bar-CsgA-Bar and Sumo-CsgA-Sumo were partly soluble. Thus, these fusion proteins 
successfully altered the EcCsgA amyloidogenic behaviour. For further discussion see 
chapter 5.3.2. 
 
 
5.3.2 The Single EcCsgA Moiety Is not Capable to Fold Regularly 
The barnase and sumo fusion proteins of EcCsgA, 
which carried only one copy of the CsgA moiety, 
were capable to inhibit fibril formation of EcCsgA. 
Thus, the fused proteins blocked the intermolecular 
interactions of EcCsgA segments that are crucial for 
appropriate self-polymerisation. But the recent 
experiments (illustrated in chapter 4.4.4) revealed 
that the fusion proteins are only soluble and folded 
to a certain extent. While the fusion partners are 
assumed to fold well similar to former studies on 
Ure2p fusion proteins (Baxa et al., 2002), the single 
CsgA moiety is highly suggested to stay unfolded 
within the fusion proteins as proposed in 
Figure 5-15 for Bar-CsgA-Bar. According to this, CsgA monomers are not capable to fold 
regularly. Former in vitro studies of CsgA self-polymerisation indicated the CsgA dimer to 
serve as fibrillisation nucleus (Wang et al., 2007). Thus, CsgA monomers and dimers 
obviously differ in their structures and an unfolded monomer is conceivable. In 
consequence, CsgA oligomerisation involves CsgA folding. Blocking intermolecular 
contacts inhibits the folding event as shown for the barnase and sumo fusion proteins that 
carried only one copy of the CsgA moiety. 
In order to analyse the relationship between folding and oligomerisation, fusion proteins, 
which mimic the CsgA dimer, were also addressed to analyse. The corresponding fusion 
proteins Bar-(CsgA)2-Bar and Sumo-(CsgA)2-Sumo carried two copies of the CsgA moiety. 
These proteins always accumulated in highly stable inclusion bodies, which had to be 
solubilised in 90 % (v/v) formic acid indicating already amyloid character of the inclusion 
bodies. Inclusion bodies with an amyloid specific structure have been also shown for other 
proteins (Wang et al., 2008a; Wasmer et al., 2009a). Assuming an amyloid specific structure 
 
Figure 5-15: Schematic presentation of 
Bar-CsgA-Bar. Barnase is shown as 
ribbon diagram (pdb entry 1BNI, Buckle 
et al., 1993). The probably unfolded CsgA 
moiety is shown as sinuous line. 
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of the inclusion bodies, which were formed by Bar-(CsgA)2-Bar and Sumo-(CsgA)2-Sumo, the 
mimicked CsgA dimer is capable to fold into the cross-β structure. Probably this results in a 
rearrangement of the fusion partners, barnase and sumo, enabling intermolecular contacts of 
the CsgA moieties and thus fibril formation. Another hypothesis is that the intracellular CsgA 
folding and fibrillisation event is much faster than folding of barnase and sumo disabling the 
designated blocking function of the fusion partners. 
 
 
5.3.3 Conclusion 
The effort to generate soluble analogues of EcCsgA oligomers for structural analysis 
within this study revealed that it is quite challenging to obtain soluble and at the same time 
well-folded EcCsgA analogues. The data clearly indicated that monomeric CsgA is not 
capable to fold regularly. 
In order to obtain soluble and folded analogues of EcCsgA oligomers distinct factors have 
to be considered. Since the strategy of blocking CsgA aggregation by covering the edge 
strands with well folding protein domains seems to be most promising, modifications of 
the available fusion proteins are conceivable. Gatekeeper residues control the folding 
behaviour of CsgA (Wang et al., 2010). Mutations of these residues might increase the 
folding propensity of CsgA within the fusion proteins that carry one copy of the CsgA 
moiety. Furthermore, the fusion partners require a certain arrangement around the CsgA 
moiety to enable a successful capping. Therefore, the modification of the length of the 
corresponding linker peptides might be helpful to facilitate the required orientation of the 
capping proteins/domains. 
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6 Outlook 
 
 
In the recent study, two amyloids were structurally investigated by H/D exchange NMR 
spectroscopy. The H/D exchange NMR analysis of FgHET-s218-289 and EcCsgA enabled 
further insights into their fibril properties. Similar to the analyses of PaHET-s218-289 (Ritter 
et al., 2005), Aβ1-42 (Luhrs et al., 2005) and α-synuclein (Vilar et al., 2008), the recent 
experiments revealed information about the sequence-specific positions of regular 
secondary structural elements, the stability and the homogeneity of the studied fibrils. 
Furthermore, in conjunction with complementary data, the almost complete H/D exchange 
rates enabled the suggestion of a probable fold of each studied protein. The H/D exchange 
NMR analyses within this study demonstrated differences in the homogeneity and stability 
of the investigated proteins. In case of heterogeneity, the determination of the 
H/D exchange rates still enabled the characterisation of the distinct structural entities, 
while heterogeneity would hamper other techniques. In summary, the H/D exchange NMR 
technique was successfully implemented to answer different questions within this study. 
Thus, H/D exchange NMR spectroscopy is a valuable tool for the analysis of amyloid 
structures and their stability. Especially in comparative analyses of homologous proteins, 
H/D exchange NMR spectroscopy readily provides meaningful information about 
structural similarities and differences, homogeneity and stability with regard to the protein 
settings.  
 
The structure-function analysis of FgHET-s218-289 in comparison to its distinct homologue 
PaHET-s218-289 revealed that both proteins are structurally highly related. Similar to 
globular proteins (Chothia and Lesk, 1986; Ginalski, 2006), conserved residues enable the 
formation of a certain fold. So far, amyloids have been shown to form different polymorphic 
forms and much different structures already due to single point mutations (Tycko et al., 2009). 
The present study strengthens the formation of highly evolved structures of functional 
amyloids, while disease related amyloids are often heterogeneous or polymorph (Greenwald 
and Riek, 2010; Ritter et al., 2005). To prove this general aspect of functional and toxic 
amyloids, further structural analyses of distinct homologues of amyloids and prions should be 
followed. As illustrated in this study, fingerprint analyses via H/D exchange NMR 
spectroscopy are capable to identify appropriate similarities and differences with regard to 
structure, stability and homogeneity. 
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The H/D exchange NMR analysis of EcCsgA within this study revealed the first 
sequence-specific information about structure elements of the major curli subunit at all.  
H/D exchange NMR and side-chain solvent accessibility experiments revealed a possible 
fold of EcCsgA within this study. Certainly, a complete solid state NMR analysis would 
answer remaining questions about the microstructure of CsgA. Furthermore, the 
H/D exchange NMR analysis of EcCsgA fibrils revealed biphasic exchange behaviour for 
a couple of residues indicating local heterogeneity and different structural entities. In order 
to understand this behaviour, EcCsgA fibrils should be also probed in the context of 
fragmentation and secondary nucleation at the surface of formed fibrils.  
Since heteronucleated EcCsgA fibrils revealed a limited regularity, homogeneity and 
stability in comparison to self-seeded fibrils, in vitro formed EcCsgB fibrils were identified 
as no adequate seed. Therefore, seeding experiments with homogenous EcCsgB fibrils in 
different concentrations would be helpful to analyse the effect of EcCsgB fibrils on the 
structure and stability of EcCsgA.  
Curli fibrils bind to numerous host proteins, they facilitate manifold functions as potential 
pathogenicity factor of Enterobacteria (illustrated in chapter 1.3.2 and reviewed by 
Barnhart and Chapman, 2006). Due to interactions with extracellular matrix proteins, curli 
support the attachment and invasion of host cells (Collinson et al., 1993; Olsén et al., 
1993; Olsén et al., 1989; Olsén et al., 1998). Furthermore, curli bind to intracellular 
proteins (Bian et al., 2000; Sjobring et al., 1994) and contact-phase proteins (Ben Nasr et 
al., 1996; Herwald et al., 1998; Olsén et al., 2002) enhancing the bacterial spreading 
throughout the host. As PAMPs, they are capable to induce the innate immune system 
(Froy, 2005; Kai-Larsen et al., 2010; Tükel et al., 2010). Since CsgA is the major curli 
subunit (Hammar et al., 1995), CsgA mediated interactions are most likely. Obviously, 
interaction studies of CsgA with appropriate host proteins would provide further insights 
into the pathogenic mechanisms of curliated bacteria. The recent results provide the 
background for following structure-function analyses as they enable the precise mapping 
of binding positions to structural elements of CsgA. 
 
Monomeric stable folded analogues of CsgA oligomers were identified as challenging 
target. Potentially, mutagenesis studies including the modification of gatekeeper residues 
within the CsgA moiety and a redesign of the CsgA fusion partners and the linker peptides 
of CsgA fusion proteins would ensure soluble and entire folded CsgA fusion proteins. 
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Appendix 
 
A) Amino acid sequences 
 
CsgA (curli subunit) [E. coli] – amino acid sequence (GenBank entry AAA23616) 
 
  1 MKLLKVAAIA AIVFSGSALA GVVPQYGGGG NHGGGGNNSG PNSELNIYQY GGGNSALALQ 
 61 TDARNSDLTI TQHGGGNGAD VGQGSDDSSI DLTQRGFGNS ATLDQWNGKN SEMTVKQFGG 
121 GNGAAVDQTA SNSSVNVTQV GFGNNATAHQ Y 
 
CsgB (nucleation component of curli monomers) [E. coli]– amino acid sequence (GenBank 
entry CAA62281) 
 
  1 MKNKLLFMML TILGAPGIAA AAGYDLANSE YNFAVNELSK SSFNQAAIIG QAGTNNSAQL  
 61 RQGGSKLLAV VAQEGSSNRA KIDQTGDYNL AYIDQAGSAN DASISQGAYG NTAMIIQKGS  
121 GNKANITQYG TQKTAIVVQR QSQMAIRVTQ R 
 
Het-s (hypothetical protein) [Fusarium graminearum] – amino acid sequence (GenBank 
entry FG10600) 
 
  1 MAEIFGIVSG ALSVAAIFNN CVDTFEYIQL GRRFGEDFQR YQLKLDLAKT RLGRWGEAIS  
 61 INNEPRFSSF ASADKEVNIA REILEDIASC FEGAQKKSSR YADRADQGEL EIFGESDMNP  
121 MLRRLHRHSK DIARQRQKTT SIIKKTKWAL YDAKSLERTI DQICSWIDEL EKLFPEQSAQ  
181 TQLVEREIEK IDDKPTLEAL KDAASGVDPV MEDAVQRKLN MIEGHNSAEF VNLEGSAKFL  
241 VGNVFSEKFL QRDVLLNDRT KNSMRTVSAT NQSRLQVGNV YGGRGIWED  
 
Barnase (RNase) precursor [Bacillus amyloliquefaciens] – amino acid sequence (GenBank 
entry AAA86441.1) 
 
  1 MKKRLSWISV CLLVLVSAAG MLFSTAAKTE TSSHKAHTEA QVINTFDGVA DYLQTYHKLP 
 61 DNYITKSEAQ ALGWVASKGN LADVAPGKSI GGDIFSNREG KLPGKSGRTW READINYTSG 
121 FRNSDRILYS SDWLIYKTTD HYQTFTKIR 
 
Ubiquitin-like protein SMT3 [Saccharomyces cerevisiae] – amino acid sequence (GenBank 
entry AAB64951) (Sumo) 
 
  1 MSDSEVNQEA KPEVKPEVKP ETHINLKVSD GSSEIFFKIK KTTPLRRLME AFAKRQGKEM 
 61 DSLRFLYDGI RIQADQTPED LDMEDNDIIE AHREQIGGAT Y 
 
Recombinant expression constructs 
 
All constructs carried a hexa histidine tag, highlighted in blue. 
 
CsgA21-151 – amino acid sequence 
 
 20 MGVVPQYGGG GNHGGGGNNS GPNSELNIYQ YGGGNSALAL QTDARNSDLT ITQHGGGNGA 
 80 DVGQGSDDSS IDLTQRGFGN SATLDQWNGK NSEMTVKQFG GGNGAAVDQT ASNSSVNVTQ 
140 VGFGNNATAH QYHHHHHH 
 
CsgA40-151 – amino acid sequence 
 
 39 MGPNSELNIY QYGGGNSALA LQTDARNSDL TITQHGGGNG ADVGQGSDDS SIDLTQRGFG 
 99 NSATLDQWNG KNSEMTVKQF GGGNGAAVDQ TASNSSVNVT QVGFGNNATA HQYHHHHHH 
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CsgA
 
CM – amino acid sequence 
 
    1 MRGSHHHHHH GLVPRGSNSG PNSSVNVTQV GFGNNATAHQ YSGDNSELNI YQYGGGNSAL 
 61 ALQTDARNSD LTITQHGGGN GADVGQGSDD SSIDLTQRGF GNSATLDQWN GKNSEMTVKQ 
121 FGGGNGAAVD QTASNSSVNV TQVGFGNNAT AHQYSGDNSE LNIYQYGGGN SALALQT 
 
CsgA
 
CD  – amino acid sequence 
 
  1 MRGSHHHHHH GLVPRGSNSG PNSSVNVTQV GFGNNATAHQ YSGDNSELNIY QYGGGNSALA     
 61 LQTDARNSDL TITQHGGGNG ADVGQGSDDS SIDLTQRGFG NSATLDQWNGK NSEMTVKQFG 
121 GGNGAAVDQT ASNSSVNVTQ VGFGNNATAH QYSGDNSELN IYQYGGGNSAL ALQTDARNSD 
181 LTITQHGGGN GADVGQGSDD SSIDLTQRGF GNSATLDQWN GKNSEMTVKQ FGGGNGAAVD  
241 QTASNSSVNV TQVGFGNNAT AHQYSGDNSE LNIYQYGGGN SALALQT  
 
Bar-CsgA-Bar
 
– amino acid sequence 
 
  1 MGAQVINTFD GVADYLQTYH KLPDNYITKS EAQALGWVAS KGNLADVAPG KSIGGDIFSN   
 61 REGKLPGKSG RTWREADINY TSGFRNSDRI LYSSDWLIYK TTDAYQTFTK IRGSGPNSEL 
121 NIYQYGGGNS ALALQTDARN SDLTITQHGG GNGADVGQGS DDSSIDLTQR GFGNSATLDQ 
181 WNGKNSEMTV KQFGGGNGAA VDQTASNSSV NVTQVGFGNN ATAHQYSSSM SAQVSNTFDG 
241 VADYLQTYHK LPDNYITKSE AQALGWVASK GNLADVAPGK SIGGDIFSNR EGKLPGKSGR 
301 TWREADINYT SGFRNSDRIL YSSDWLIYKT TDAYQTFTKI RHHHHHH  
 
Bar-(CsgA)2-Bar – amino acid sequence 
 
  1 MGAQVINTFD GVADYLQTYH KLPDNYITKS EAQALGWVAS KGNLADVAPG KSIGGDIFSN   
 61 REGKLPGKSG RTWREADINY TSGFRNSDRI LYSSDWLIYK TTDAYQTFTK IRGSGPNSEL 
121 NIYQYGGGNS ALALQTDARN SDLTITQHGG GNGADVGQGS DDSSIDLTQR GFGNSATLDQ 
181 WNGKNSEMTV KQFGGGNGAA VDQTASNSSV NVTQVGFGNN ATAHQYSGDN SELNIYQYGG 
241 GNSALALQTD ARNSDLTITQ HGGGNGADVG QGSDDSSIDL TQRGFGNSAT LDQWNGKNSE 
301 MTVKQFGGGN GAAVDQTASN SSVNVTQVGF GNNATAHQSS SMSAQVSNTF DGVADYLQTY 
361 HKLPDNYITK SEAQALGWVA SKGNLADVAP GKSIGGDIFS NREGKLPGKS GRTWREADIN 
421 YTSGFRNSDR ILYSSDWLIY KTTDAYQTFT KIRHHHHHH 
 
Sumo-CsgA-Sumo
 
– amino acid sequence 
 
  1 MGHHHHHHGS LQDSEVNQEA KPEVKPEVKP ETHINLKVSD GSSEIFFKIK KTTPLRRLME 
 61 AFAKRQGKEM DSLTFLYDGI EIQADQTPED LDMEDNDIIE AHREQIGGMP GRSGPNSELN  
121 IYQYGGGNSA LALQTDARNS DLTITQHGGG NGADVGQGSD DSSIDLTQRG FGNSATLDQW 
181 NGKNSEMTVK QFGGGNGAAV DQTASNSSVN VTQVGFGNNA TAHQYSSSMS GSLQDSEVNQ 
241 EAKPEVKPEV KPETHINLKV SDGSSEIFFK IKKTTPLRRL MEAFAKRQGK EMDSLTFLYD 
301 GIEIQADQTP EDLDMEDNDI IEAHREQIGG MPGR 
 
Sumo-(CsgA)2-Sumo – amino acid sequence 
 
  1 MGHHHHHHGS LQDSEVNQEA KPEVKPEVKP ETHINLKVSD GSSEIFFKIK KTTPLRRLME 
 61 AFAKRQGKEM DSLTFLYDGI EIQADQTPED LDMEDNDIIE AHREQIGGMP GRSGPNSELN  
121 IYQYGGGNSA LALQTDARNS DLTITQHGGG NGADVGQGSD DSSIDLTQRG FGNSATLDQW 
181 NGKNSEMTVK QFGGGNGAAV DQTASNSSVN VTQVGFGNNA TAHQYSGDNS ELNIYQYGGG 
241 NSALALQTDA RNSDLTITQH GGGNGADVGQ GSDDSSIDLT QRGFGNSATL DQWNGKNSEM 
301 TVKQFGGGNG AAVDQTASNS SVNVTQVGFG NNATAHQSSS MSGSLQDSEV NQEAKPEVKP 
361 EVKPETHINL KVSDGSSEIF FKIKKTTPLR RLMEAFAKRQ GKEMDSLTFL YDGIEIQADQ 
421 TPEDLDMEDN DIIEAHREQI GGMPGR 
 
 
FgHet-s218-289 – amino acid sequence 
 
217 MKLNMIEGHN SAEFVNLEGS AKFLVGNVFS EKFLQRDVLL NDRTKNSMRT VSATNQSRLQ  
277 VGNVYGGRGI WEDHHHHHH  
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B) Supplementary Methods 
 
 
Table App-1: Conditions for labelling with thiol-reactive agents. 
Native conditions (post assembly) 
No. Desalting Fibrillisation Labelling buffer Labelling 
agent Molar excess 
AF488 2.5 x 
1 50 mM KPi pH 7.2 2.5 % (w/w) wt 
seed, mild agitation 50 mM KPi pH 7.2 PM 3 x 
AF488 2.5 x 
2 
50 mM Tris/HCl 
pH 7.5, 150 mM 
NaCl 
2.5 % (w/v) wt seed, 
5 mM TCEP,  
mild agitation 
50 mM Tris/HCl 
pH 7.5, 150 mM 
NaCl PM 3 x 
AF488 2.5 x 
3 
50 mM Tris/HCl 
pH 7.5, 150 mM 
NaCl, presence of 
10 %(w/w) wt 
2.5 % (w/v) wt seed, 
5 mM TCEP,  
mild agitation 
50 mM Tris/HCl 
pH 7.5, 150 mM 
NaCl PM 3 x 
4 
50 mM KPi pH 7.2, 
5 mM DTT,  
presence of 
10 %(w/w) wt 
without seed, 
no agitation 50 mM KPi pH 7.2 PM 3 x 
AF488 2.5 x 
PM 10 x 
IAA 20 x 
5 
50 mM KPi pH 7.2, 
5 mM DTT,  
presence of 
10 %(w/w) wt 
2.5 % (w/w) wt 
seed, mild agitation 
50 mM Tris/HCl pH 
8, 150 mM NaCl, 
0.1 mM TCEP 
IAM 20 x 
Denaturing conditions (pre assembly) 
No. Labelling buffer  Labelling 
agent  
Molar 
excess  
Desalting Fibrillisation 
6 
50 mM KPi pH 7.2, 
150 mM NaCl, 
8 M GdmHCl 
PM 3 x 
20 mM DTT added to 
labelling sample, 
dialysis against 
50 mM KPi pH 7.2 
dialysis 
7 
50 mM Tris/HCl 
pH 8, 8 M GdmHCl 
150 mM NaCl 
5 mM TCEP 
PM 3 x 
20 mM DTT added to 
labelling sample, 
50 mM Tris/HCl 
pH 7.5, 150 mM NaCl 
2.5 mM (w/w) wt seed, 
mild agitation 
IAA 25 x 
IAM 25 x 8 
50 mM Tris/HCl 
pH 6, 8 M GdmHCl 
150 mM NaCl, 
5 x DTT PM 15 x 
10 mM CH3COONa 
pH 7.5 - 
No. Labelling buffer Labelling 
agent 
Molar 
excess 
Desalting Fibrillisation 
IAA 25 x 
IAM 25 x 9 
50 mM Tris/HCl 
pH 6, 8 M GdmHCl 
150 mM NaCl, 
5 x TCEP PM 15 x 
10 mM CH3COONa 
pH 7.5 - 
IAA 100 x 
10 
50 mM Tris/HCl 
pH 6, 8 M GdmHCl 
150 mM NaCl, 
20 x DTT 
IAM 100 x 
10 mM CH3COONa 
pH 7.5 - 
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Prior labelling studies of fibrils, protein samples always were desalted via Nap5 after reduction of the thiol 
groups as described in chapter 3.4.5. Under native conditions 20 - 100 µM of two days old fibrils were 
incubated in presence of at least 2.5 molar excess of an appropriate thiol-reactive agent for 30 min (AF488) 
and 3 h (IAA, IAM, PM) respectively. The sample volume was around 250 - 500 µl. The labelling reaction 
was quenched by centrifugation (20800 g, 5 min, RT) and three washing steps comprising repetitive re-
suspension in 50 mM KPi pH 7.2 and centrifugation (20800 g, 5 min, RT). In the first washing step the buffer 
was supplemented with 5 mM DTT. 
Under denaturing conditions 100 – 200 µM protein were applied to an appropriate thiol-reactive agent. The 
sample volume was around 100 – 500 µl. The labelling reaction was quenched by adding 20 mM DTT. In 
order to desalt the samples, they were dialysed or applied to a Nap5 column (Table 3-13). 
 
 
 
 
C) Supplementary Figures 
 
 
 
Figure App-6-1: Relative exchange behaviour and population of EcCsgA residues with biphasic 
H/D exchange behaviour. Fast exchange is shown in grey, slow exchange in blue. (A) EcCsgA40-151 fibrils. 
(B) EcCsgA21-151 fibrils. 
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Figure App-6-2: H/D exchange NMR data of EcCsgA21-151 and secondary structure prediction. Red 
and grey bars indicate exchange rates of EcCsgA21-151 kex (h-1). Grey bars indicate exchange rates of the fast 
first phase in case of biphasic behaviour. Patterned bars present the exchange rates of the asparagine ladder. 
Residues marked with a rectangle were analysed as one unit. Residues marked with an asterisk were 
excluded from the analysis due to fast intrinsic exchange in DMSO (N46, A58, A79, A124) and missing 
assignments. Blue arrows indicate β-strands. 
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Figure App-6-3: H/D exchange NMR data of EcCsgA40-151 after seeding with EcCsgB fibrils. Red 
and grey bars indicate exchange rates of EcCsgA40-151 kex (h-1). Red bars correspond to the major population, 
grey bars to the minor population. Residues marked with a rectangle were analysed as one unit. Residues 
marked with an asterisk were excluded from analysis due to fast intrinsic exchange in DMSO (A79, A124) 
and missing assignments. Blue arrows indicate β-strands, which were localised in homonucleated 
EcCsgA40-151 fibrils. 
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Figure App-6-4: MALDI spectra after thiol-labelling of EcCsgA21-151 cysteine variants with PM. 
Approximately 50 µg of wet fibrils were applied to mass analysis after PM-labelling. Covalent PM-labelling 
results in a mass shift of ∆m = 297 Da. The observed masses were masked due to N-Formylation and a 
probably missing start methionine. 
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Figure App-6-5:   Stability of aggregates 
formed by Bar-CsgA-Bar and Sumo-CsgA-
Sumo. 4-12 % NuPAGE (Coomassie staining). 
Pellet fractions were solubilised in 98 % (v/v) 
FA (PFA), 8 M urea (PU) and 0.1 % (w/v) SDS 
and loaded onto the gel after TCA precipitation. 
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